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Amyloids are fibrillary aggregates identified in over 40 human diseases, including 
neurodegenerative diseases encompassing Alzheimer’s (AD), Parkinson’s (PD), 
Huntington’s and Prion diseases. Amyloids form by spontaneous self-assembly of 
monomeric precursor peptides known as intrinsically disordered proteins (IDPs). 
Experiments suggest that soluble low molecular weight oligomers formed in the early 
stages of assembly are toxic, and hence, most promising drug targets. However, 
experiments are insufficient to characterize oligomers due to their inherent polymorphic 
and short-lived nature. This thesis advances our mechanistic understanding of the 
formation of amyloid oligomers by delineating signature features of IDP monomers and 
‘profibrillar’ oligomers through predictive computational modelling techniques 
employing atomic resolution molecular dynamics (MD) computer simulations. We 
additionally predict the assembly of non-aggregating low molecular weight oligomers. 
We first probe the molecular signatures of experimentally indicative non-aggregating 
folded a-helical conformers, and aggregation-prone partially folded a-helices of 
amyloid-b42 (Ab42) and a-synuclein (aS) IDPs implicated in AD and PD, respectively 
across a broad spectrum of physical models. We predict a common intra-peptide route to 
helix stabilization, showing that the terminal groups (N-terminal or NTR in Ab42 and C-
terminal or CTR in aS) frequently indulge in hydrophobic interactions with the central 
hydrophobic domains (CHDs) and secondary salt bridges with other domains. Lack of 
such short-range contacts during complete helix unfolding coupled with destabilized 
helices in terminal-deleted variants confer the aggregation protective role by terminal 
groups in folded helical conformers. Further, we reveal a shared feature of dynamic 
coupling between the partially folded helical regions of the CHD and the charged terminal 
ends (NTR in Ab42 and CTR in aS). Absence of such intra-peptide modulation in 
helically folded and unfolded states confer long-range allosteric regulation of the CHD 
by the termini that may render the partially folded helical states prone to initial 
oligomerization. Next, we design structural assemblies of experimentally uncharacterized 
aggregation-resistant low-weight aS tetramer. We model a de novo broken a-helical 
tetramer by reconstructing loop motif that optimizes packing of aS helical monomers. 
We show that monomers attain activated conformations during tetramer assembly, and 
familial missense mutations double the energy barrier to tetramerization, thus preserving 
the pool of aggregation-prone disordered monomers, and confirming the experimentally 
observed low tetramer:monomer ratios with mutants. In order to investigate the effect of 
helical continuity and periodicity, we model a de novo extended 11/3-helical tetramer. 
Broken a-helical tetramers show a more favourable assembly than the extended 11/3-
helical tetramers, the ease of their interconversions diminishing with homologous E → K 
mutations. Additionally, rationally designing a series of broken a-helical multimers from 
dimers to octamers shows that tetramers have lowest activation energy, providing a 
rationale for the experimental observation that tetramers are the most populated 
oligomers. Finally, we investigate the molecular determinants of higher aggregation rate 
of Ab42 over Ab40 by simulating their profibrillar oligomers (dodecamers) on graphene-
water interface. Our data reveals that Ab dodecamers may facilitate a single layer growth 
along the graphene surface, with Ab42 presenting a more closed conformation with 
possibilities of unidirectional growth in Ab40, but not in Ab42. Oligomer height profiles 
on graphene indicate that dodecamers may be formed post mature fibril formation. 
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Chapter 1. Introduction 
 
1.1. Background 
More than 600 neurological disorders are recognized to date. Among these, 
Neurodegenerative Disorders (ND) have a significant share of the Global Burden of 
Disease (GBD).1 NDs, the blanket term used for a range of disorders, includes 
Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), Prion 
diseases, and Amyotrophic Lateral Sclerosis (ALS), to name but a few. These typically 
involve lethal and debilitating senile progressive loss of neuronal functions leading to 
ataxia (loss of voluntary movements) and dementia (loss of memory).2 In 2006, the World 
Health Organization (WHO) projection of deaths as percentage of total deaths by 2030 
was estimated as 0.92% for Alzheimer’s and other dementia, and 0.23% for Parkinson’s 
disease.3 The cost of care for people with dementia across Europe alone is approximately 
€130 million yearly.4 Currently, only 5 drugs for AD,5 and a handful of drugs for other 
NDs, are approved by FDA. Unfortunately, these provide only symptomatic relief and 
fail to address the underlying cause of the diseases. Hence, to date there is no effective 
cure for NDs, only lifestyle recommendations to offset cognitive decline.6 
Over the last two decades, a significant departure from the ‘Amyloid Cascade 
Hypothesis’7 has been evident. This hypothesis proposed that the deposition of amyloid 
plaques (that are formed through a cascade of events starting from unstructured 
monomers to create b-structure rich oligomeric protofibrils that mature into poorly 
soluble fibrils8) is the central event in disease pathogenesis. However, a lack of 
connection between amyloid deposits and degree of cognitive impairment, the 
observation of persistent fibrillar structures long after the first symptoms have occurred, 
and the failure of many amyloidocentric drugs have strongly favoured an alternative 
hypothesis.9 The molecular mechanisms of the diseases, in particular the events that 
trigger aggregation of the small protein monomers into higher order assemblies (and 
eventually plaques) remain unclear, despite huge and increasing research efforts to better 
understand and find an effective treatment for the NDs. A large body of evidence now 
supports the hypothesis that it is the small soluble oligomers (perhaps dimers or trimers) 
that are the most neurotoxic species and hence more important drug targets than amyloid 
fibrils or fibers.10 
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Fig. 1.1. Recently solved structures of (A) monomorphic Ab42 fibril (PDB code 5KK311 
containing residues 11-42) by ssNMR, showing the distinctive S-shaped amyloid fold and 
disordered N-terminal domain, (B) full-length Ab42 fibril (PDB code 2NAO12) 
polymorph by ssNMR, with residues 15-42 as double-horseshoe shaped cross b-sheets 
and ordered N-terminal, (C) full-length Ab42 fibril  (PDB code 5OQV13) by cryo-EM, 
showing a ‘LS’ shaped topology with partially ordered N-terminal region, (D) full-length 
a-synuclein fibril (PDB code 2N0A14) showing a central Greek-key motif, and (E) cryo-
EM derived atomic model of PHFs of Tau neurofibrillary tangles (PDB code 5O3L15), 
comprising residues 306-378. The fibril assemblies show in-register arrangement of the 
b-sheets, which runs parallel to the fibril axis (black arrow) as seen from ssNMR, and an 
inherent cross-b spine which is depicted by the b-strands (held together in parallel by 
intermolecular hydrogen bonds) oriented perpendicular to the fibril axis. The structures 
are coloured based on VMD16 fragment indices and the N-terminal of each monomer 
within the fibril is denoted as red liquorice. 
 
1.2. Disordered peptides are monomeric precursors of amyloid fibrils 
The insoluble amyloid fibrillar assemblies share an inherent cross b-sheet structural 
motif17 consisting of numerous monomers stacked together in a highly ordered fashion as 
deduced from X-ray diffraction (XRD) and in-register parallel-b-sheets as demonstrated 
by solid-state nuclear magnetic resonance11,12,14 (ssNMR) or more recently through cryo-
Electron Microscopy13,15 (cryo-EM) (Fig. 1.1). At least 30 different proteins are known 
to adopt the fibrillary conformation in vivo.18 In Chapter 6 of this thesis, we have 
rationalized the differences between fold propensities, thermodynamic stabilities, and 
interactions of profibrillar oligomers of Ab40 and Ab42 to identify the fibril-forming 
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seed for Ab42. More than 20 distinct Neurotoxic Proteins (NPs)19 leading to NDs have 
been found to belong to the class of Intrinsically Disordered Proteins (IDPs)20 or have 
locally disordered regions (Intrinsically Disordered Regions or IDRs) with folded 
domains, which may promote fibril formation. Under near-physiological conditions, IDPs 
do not show regular secondary or tertiary structural patterns nor do they fold completely 
– in contrast to ordered globular proteins – but instead remain in a partially or completely 
unfolded state consisting of disordered regions.21 That is why, they are referred to as 
‘natively unstructured proteins’ – the native state itself is under constant fluctuation. 
However, they may undergo a ‘disorder-to-order’ transition by post-translational 
modifications22 and by binding to physiological partners.23 These modifications and 
events can trigger folding and lead to formation of ‘static’ complexes.24 Folding may 
precede binding (conformational selection) or vice versa (induced fit) depending on the 
free energy landscape of the particular IDP.25 However, in some cases, structural disorder 
is retained even after binding, and these so-called ‘fuzzy complexes’ are an important 
aspect of the allostery that these IDPs display.26  
 Molecular recognition in IDP interactions is not the regimented, ordered process 
observed for folded proteins but rather a highly dynamic process, which switches between 
different folding states and involves a larger number of putative complexes spanning a 
broad range of binding affinities and specificities.27 Understanding the driving forces in 
IDP complexation is crucial for resolving their roles in several important biological 
processes including storage, transcription, translation, and signal transduction.26 The lack 
of a well-defined native structure allows IDPs to have multiple fluctuating conformational 
states in their free, unbound state, some of which may misfold (as opposed to folding 
‘correctly’). Misfolding is governed by many factors including mutations, post-
translational modifications, and exposure to harmful environmental conditions, and the 
consequent aggregation of misfolded IDPs into build-ups of amyloid fibrils is associated 
with a range of acquired and hereditary conditions including the progressive 
neurodegenerative disorders of AD, PD, HD and prion disease, as well as type 2 diabetes, 
and some cancers.28 Some of the most common disease-causing amyloid-forming IDPs 
(also known as ‘amyloidogenic’ IDPs) include Amyloid b (Ab), a-synuclein (aS), Prion, 
Tau, and polyglutamines. 
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1.3. Amyloidogenic self-assembly 
Amyloidogenic self-assembly (amyloidogenesis) is a process starting from monomers 
aggregating into oligomers, finally leading to insoluble filamentous structured fibrils 
(protofilaments or filaments) and fibers.29 Several experiments and simulation studies 
have attempted to elucidate the kinetics and thermodynamics of amyloid aggregation.30 
The possible mechanisms of amyloid aggregation are still debated,31 but the kinetics of 
fibrillation can generally be described by a nucleation-dependent polymerization (NDP) 
mechanism, where the rate-limiting step is formation of an oligomeric nucleus32 (Fig. 
1.2). Following the initial lag phase,33 monomers undergo primary nucleation into 
ordered or partially order oligomers (believed consisting mainly of b structures). 
Polymerization of this primary nucleus elongates the chain which leads to evolution of 
higher-order structures (which eventually form insoluble fibrils), followed by the plateau 
phase, where the monomers and aggregates are at equilibrium. This can be accompanied 
by secondary processes of elongation such as fragmentation,34 branching and/or lateral 
nucleation (secondary nucleation) (Fig. 1.2),30 and off-pathway aggregate formation.35,36 
In addition to the NDP model originally proposed for prions,37 two other models proposed 
for prion peptide self-assembly are (1) an autocatalytic model involving branched chain 
mechanisms,38 where elongation of fibrils occurs through propagation of fibril active 
centres as a result of fragmentation, and (2) conformational models, which undergo 
template-assisted replications.39 These non-NDP prion models inevitably overlap to some 
degree with the secondary NDP processes of replication and elongation. Similarly, a fibril 
template dependent dock-lock mechanism of monomer addition is also proposed for 
Ab fibril growth (Fig. 1.2).40 
Structural order increases along the amyloid aggregation pathway. Highly toxic, 
transient metastable oligomeric states41 have been shown to have common structural 
features42 (Fig. 1.2), that are distinct from protofibrils and fibrils. However, it remains 
challenging to identify pathogenically important oligomers, because they are extremely 
difficult to characterize using bulk techniques.43,44 These low molecular weight soluble 
oligomers might be produced as a result of key conformational changes that form highly 
stable or metastable states, making both the oligomeric states and the monomers 
important potential drug targets.45 Apart from the very many environmental directors of 
amyloid aggregation such as interaction with metal ions46 and biological surfaces47 ionic 
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strength and pH,48,49 post-translational effects including phosphorylation,50 non-specific 
inter-peptide attractions,51 and solubility and supersaturation,52 the specific alignment or 
ordering of the monomer building blocks (in oligomers) during aggregation is of critical 
importance.53  
 
Fig. 1.2. Overview of the proposed mechanisms of amyloid formation (amyloidogenesis). 
The figure depicts routes to fibrillogenesis through nucleation and elongation phases, 
with associated secondary pathways and formation of off-pathway aggregates (specific 
ones shown here for Ab35). Disordered amyloidogenic monomers (IDPs) undergo an 
activation step to transform from their natively unfolded state into partially-folded 
monomers, which further nucleate to form ordered toxic oligomers (one-step primary 
nucleation). Disordered monomers may also form toxic oligomers through intermediary 
formation of disordered oligomers by assembly and conformational re-arrangement (two-
step primary nucleation). The monomers can self-assemble off-pathway into amorphous 
oligomers, which may or may not be toxic. These oligomers do not go on to form the 
fibril structure directly but may participate in the on-pathway route by either promoting 
or inhibiting fibril formation. Proposed mechanisms of secondary nucleation, lateral and 
longitudinal growths, and fragmentation are also shown. The amyloid fibril is based on a 
cryo-electron microscopy (EM) structure of a quadruplet cross-b fibril polymorph54 
obtained as an EM density map and visualized using UCSF Chimera software.55  
 
1.4. Amyloidogenic monomers: primordial signatures of amyloidogenesis?  
Amyloidogenic monomers have no known direct toxicity in the physiological 
environment and at cellular concentrations.56 However, studies indicate that transient b-
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strand-turn-b-strand-like (b-hairpin) monomeric conformations57-59 may initiate 
nucleation by forming small soluble toxic oligomers, which are thought to have extended 
antiparallel b-sheet structures. Experimental techniques such as Nuclear Magnetic 
Resonance (NMR) generally probe the structure of full-length amyloidogenic peptides in 
the presence of binding agents or affinity “affibody” proteins,60 and hence cannot fully 
characterize the polymorphic nature of the free, unbound monomers state. However, it is 
well established that a decrease in b-strand content lowers the rate of aggregation (from 
Ab experiments in which a key methionine residue was oxidized61) and b-sheet 
oligomeric assemblies have been proposed to be an extension of b-hairpins62 or very 
recently, a hairpin-like structural motif.63 A brief survey of the structural, functional and 
pathogenic features of two amyloidogenic peptides – Ab and  aS – are presented below 
and forms the focus of the research presented in this thesis. For further reading on other 
amyloidogenic proteins, such as Tau and Prions, please see our review article 64. 
1.4.1. Amyloid b (Ab) 
Ab is a peptide composed of 39 to 43 amino acids which aggregates to form neurotoxic 
cross-b amyloid fibrils, and is the crucial constituent of the extracellular senile plaques 
observed in AD.65 In addition to the extracellular deposits observed in patients, 
intracellular accumulation of Ab is a key early event in AD pathogenesis.66 Ab peptides 
are synthesized via proteolytic cleavage of the cell-surface membrane protein Amyloid 
Precursor Protein (APP) by b- and g-secretases.67 It has two common alloforms made of 
40 and 42 residues (henceforth referred to as Ab40 and Ab42); the latter has two extra 
residues (Ile41 and Ala42) at the C-terminal end and is the more aggregation-prone and 
cytotoxic (oligomers) of the two, although its in vivo concentration is significantly lower 
than Ab40.68 Studies have indicated that low concentrations of Ab peptides in normal 
(non-AD) brains have beneficial physiological functions, including regulation and 
maintenance of synaptic plasticity, memory and learning, neuronal development and 
viability, and metal homeostasis.69 The IDP nature of Ab monomers has limited their 
characterization by bulk experimental techniques in physiological aqueous environments, 
and therefore the structure is generally described as a random coil.43 However, structures 
obtained in organic solvent have shown significant helix character, which decreases as 
the solvent polarity increases. Figs. 1.3A and B shows two structures each of Ab40 and 
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Ab42, where the amount of helical content at the C-terminus for both decreases as water 
is added.70  
 A typical Ab42 structure presents the N-terminal region (residues Asp1-Lys16), 
which is mostly disordered and the C-terminal region (residues Val36-Ala42), which has 
the propensity to form b-hairpins. The central hydrophobic core region (CHC, residues 
Leu17-Ala21) and C-terminus patch (residues Ala30-Met35) are connected by a 
hydrophilic turn region (residues Glu22-Gly29).71 Ab misfolding and aggregation, 
particularly that of the more toxic Ab42, is believed to be involved in the early stages of 
AD, as the aggregates block and break synaptic connections between neurons.72 Familial 
pathogenic mutations of Ab peptides are known to cause differential structural changes 
in the monomeric and oligomeric forms, and affect their neurotoxic aggregation.73 It is 
now well established that there exists a strong collaboration and interdependency between 
build-up of extracellular Ab peptides and appearance of intracellular neurofibrillary 
tangles of hyper-phosphorylated Tau proteins in AD pathogenesis.74 Sporadic AD 
pathogenesis has also been associated with a number of risk genes75 and recent data 
indicates that the progression and severity of AD follows the inflammatory pathway.76  
1.4.2. a-synuclein (aS) 
aS is a 140-residue peptide that is abundant in presynaptic nerve terminals.77 Though its 
normal cellular function is not fully understood, studies have shown that it is associated 
with long-term synaptic maintenance, such as synaptic vesicle trafficking and plasticity, 
as well as possible roles in regulation of neurotransmitter release.78 aS is a major 
component of Lewy bodies and neurites, which are proteinaceous deposits characterizing 
PD, as well as other “synucleopathies”.79 Mutations in the aS encoding genes (both 
familial and sporadic) result in the substitution of key residues in the protein that in turn 
trigger pathogenic aggregations leading to PD.80 The protein is expressed at different 
levels in several regions of the brain tissue such as hippocampus, substantia nigra, 
neocortex, etc., which affects PD progression.81 Originally identified as the Non-Amyloid 
b Component Protein (NACP),82 recent studies show that aS may83 exist in a dynamic 
equilibrium between aggregation-prone disordered monomers and non-aggregating a-
helically folded tetramers, and the distribution of these states may change depending on 
the intracellular environment.84 Very recently, aS monomer structures were visualized in 
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a cellular milieu, which confirmed that the protein remains in an unstructured, disordered 
state.85  
 
Fig. 1.3. NMR structures of monomers of (A) Ab40 obtained in (I) 40% 
trifluoroethanol/water (v/v) (PDB code 1AML86) and (II) aqueous solvent: 93% 
water/7% D2O (v/v) (PDB code 2LFM87). The one-letter residue codes are coloured 
according to their degree of hydrophobicity (Kyte-Doolittle scale).88 The protein 
structures were visualized using the VMD software.16 (B) Ab42 solved in (I) 20% 
water/80% deuterated-hexafluoroisopropanol (PDB code 1IYT89) and (II) 70% 
water/30% deuterated-hexafluoroisopropanol (PDB code 1Z0Q70). (C) Human aS solved 
in (I) micelle-bound aqueous solution with sodium dodecyl sulphate (PDB code 1XQ890) 
and (II) SLAS-micelle-bound aqueous solution (PDB code 2KKW91). The N-, C-
terminal, and the central hydrophobic regions of the peptides are coloured red, green, and 
grey respectively, while the additional turn region in both Ab40 and Ab42 is coloured 
blue. 
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 The structural features of aS has been shown to change in different 
microenvironments, and also in bound and unbound states.92 For example, though aS is 
predominantly cytosolic, it has high affinity for membranes, and on binding to neural 
membranes, adopts a range of different helical conformations.93 Figs. 1.3CI and II shows 
the structural features of aS when bound to micelles, which are amphipathic in nature.90,91 
In the figure, the two curved antiparallel a-helices (connected by a disordered linker) are 
formed by the N-terminal domain (Met1-Lys60), and a highly hydrophobic central region 
(Glu61-Val95) that plays a key role in aggregation known as the NAC (non-amyloid b 
component). This is followed by a highly acidic and proline-rich disordered C-terminus 
(Lys96-Ala140).94  
1.4.3. Overview of amyloidogenic peptide structures 
A list of available structures of Ab and aS at different stages of their assembly deposited 
in the Protein Data Bank (PDB) are listed in Table 1.1.  








Aβ 1Z0Q helix Solution NMR structure of Aβ(1-42) in HFIP/H2O solvent 
 1IYT helix Solution NMR structure of Ab(1-42) in HFIP/H2O 
solvent 
 2FLM helix Solution NMR structure of Aβ(1-40) in 50 mM NaCl 
solution 
 1BA4 helix Solution NMR structure of Aβ(1-40) in a hydrated micelle 
environment 
 2OTK β-hairpin Solution NMR structure of Aβ(1-40) in complex with an 
engineered binding protein 
 4MVI β-hairpin 1.7 Å resolution XRD structure of Aβ(1-40) in complex 
with an engineered lipocalin (Anticalin US7) 
 4MVL β-hairpin 2.3 Å XRD structure of Aβ(1-40) in complex with an 
engineered lipocalin (Anticalin H1GA) 
aS 1XQ8 helix Solution NMR structure of micelle-bound aS(1-140) 
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 2KKW helix Solution NMR structure of SLAS-micelle bound aS(1-
140) 
 4BXL β-hairpin Solution NMR structure of aS(35-56) trapped by an 
engineered binding protein 
Oligomer 
Aβ 5HOW β-hairpin 2.3 Å XRD structure of Aβ(17-36) trimer and higher-
order oligomers 
 5SUS β-hairpin 2.35 Å XRD structure of Ab(17-36) covalent trimer 




Aβ 2BEG Cross β-sheet Solid-state NMR structure of Aβ(17-42) fibril 
 5KK3 Cross β-sheet Solid-state NMR structure of Aβ(1-42) fibril 
 2NAO Cross β-sheet Solid-state NMR structure of Aβ(1-42) fibril 
 2MXU Cross β-sheet Solid-state NMR structure of Aβ(1-42) fibril 
 2MVX Cross β-sheet Solid-state NMR structure of Aβ(1-42) fibril of Osaka 
mutation (E22D) 
 5AEF Cross β-sheet Electron cryo-mcroscopy structure of Aβ(1-42) fibril 
 2MPZ Cross β-sheet Aβ(1-42) fibril of Iowa mutant (D23N) solved by ss-
NMR, EM and Rosetta modelling 
aS 2N0A Cross β-sheet Solid-state NMR structure of aS(1-140) fibril 
  
  
 While many studies in the past have focussed on identification of the most 
pathogenic amyloid oligomers,95,96 conformational switches between the initial natively 
disordered monomeric states and partially folded/misfolded states might be the first, most 
fundamental trigger for aggregation. Conformational polymorphisms exist at all levels of 
aggregation from monomers to fibrils, and the monomers themselves, as IDPs, are known 
to be highly polymorphic.97 Aggregation is thought to involve an initial monomeric 
activation step,32 necessitating destabilization of amyloidogenic monomers away from 
their native state (which allows them to form partially folded or misfolded intermediates). 
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One recent study raises the intriguing possibility that it is the free energy difference 
between the native and aggregation-prone monomeric states that determines the 
propensity of a monomer to form fibrils.98 Similarly, a model for earliest aggregation 
steps has been presented, where it was proposed that diffusion-controlled reconfiguration 
rates between aggregation-prone and non-aggregating monomers must match the rate of 
aggregation, in order for aggregation to proceed.99 In addition, the unusually high 
mechanical stabilities measured for certain structured monomeric conformations could 
also be a property that controls their aggregation.45,100 Also, it was recently proposed that 
the aggregation propensity of  Ab monomers may be determined by the probability of 
adopting a collapsed (fibril-like) or an extended (oligomer-like) conformational state at 
the conformational equilibrium.101 Finally, a very recent study on Tau monomer 
fragments of two hexapeptides (thought to be responsible for fibril formation) 
investigated this new paradigm of identifying an earliest signature of aggregation in 
amyloidogenic IDPs, by defining the ‘stable’ (compact) vs. ‘aggregation-prone’ 
(extended) states in monomers, which could be represented by distinct ensembles.102 
Therefore, characterization and identification of monomers with a propensity to form 
small oligomers is the first crucial step in addressing neurodegenerative disease 
pathogenesis and prognosis. Improved understanding of molecular recognition should 
provide leads for rational design of drug molecules that can hinder aggregation of IDP 
monomers into toxic oligomers. 
 
1.5. Computational modelling approaches: building interface with experiments 
It is clear then that the large structural heterogeneity of amyloidogenic peptides coupled 
with their propensity to form multi-protein complexes limits most experimental structure 
determination methods to ensemble-averaged information.103 On the other hand, 
computational modelling using Molecular Dynamics (MD) computer simulations has 
come of age as an essential research tool to provide accurate atomistic descriptions of 
biomolecules.104 MD simulations use statistical mechanics (linking atomic-level 
microscopic properties to bulk/thermodynamic properties) to calculate molecular 
properties that are difficult if not impossible to obtain using experiments alone and have 
been used to compute relevant IDP conformational ensembles, see for example ref 105. Of 
course, the relevance of simulation data to experiments is an issue when assessing the 
quality of computed IDP properties (compared with, say, globular enzymes with a well-
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defined 3D structure) and so multiple, long, and sometimes quite complicated simulations 
are required to ensure the phase space is sufficiently well sampled.106 In this context, the 
idea is to provide a sufficiently accurate description of representative conformations and 
their corresponding statistical weights. A successful model provides an experimentally-
relevant conformational ensemble to characterize the Boltzmann distribution of the IDP 




Fig. 1.4. Schematic overview of the methods for constructing IDP ensembles shows two 
broad classifications: Knowledge-based approaches and de novo MD simulations. It is to 
be noted that though this figure aims to give a detailed representation at different levels 
of organization of the methods, it represents one plausible, not exclusive, view of how it 
works. For example, Bayesian weighting methods such as BW/VBW may be used before 
experimentally biasing conformations, and also in cases where conformations are 
generated by restrained MD or completely as a separate method for generating 




 - 13 - 
1.5.1. Conventional modelling approaches, shortcomings and recent improvements 
A priori knowledge of thermally accessible states of amyloidogenic IDPs is crucial to 
uncover experimentally-relevant details of the mechanisms by which IDPs can aggregate 
in the genesis of neurological diseases. A representative model ensemble should allow 
for robust predictions of experimentally-testable properties that could be used to define 
the structural patterns of IDPs as they interconvert between near iso-energetic states. 
Broadly speaking, there are two prevalent approaches to model IDP ensembles103,107: (i) 
Integrating experimental data with computational methods, where experimental 
observables are used as an input to construct ensembles, also known as the knowledge-
based (and sometimes the ensemble-based) approach, and (ii) Generating ensembles by 
de novo MD simulations without using new experimental data (validation with 
experimental observables may or may not follow). A schematic representation of the 
different ensemble construction methods is given in Fig. 1.4. 
 The first, knowledge-based approach uses measurements from experiments and 
biophysical methods to direct the construction of ensembles. The experimental restraints 
or constraints used are typically NMR-based values such as scalar J-coupling constants, 
Chemical Shifts (CSs), Paramagnetic Relaxation Enhancements (PREs), Residual 
Dipolar Couplings (RDCs), etc., and/or measurements from small angle X-ray scattering 
(SAXS) and single molecule Förster (or Fluorescence) Resonance Energy Transfer 
(smFRET).108-111 The approach can be further sub-divided into two related methodologies 
(Fig. 1.4): (a) creation of a library or a pool of conformations from the primary sequences 
by a statistical coil model112 by a stochastic Monte Carlo approach113 (Fig. 1.4). Then, 
through a number of iterations, subsets of configurations are selected from the larger 
datasets, ultimately leading to an ensemble of conformations that most closely fits the 
experimental data by a selection algorithm, either stochastic or deterministic; (b) use of 
experimental observables as restraints or constraints in MD simulations (Fig. 1.4), so as 
to bias the simulations toward the experimental structures. This commonly involves 
simulating multiple ‘replicas’ of random conformers in parallel, independent of 
experimental measurements. Experimental restraints (usually averaged over replicas) are 
then applied to the ensemble.109 This usually leads to the ensemble-averaging, a property 
coherent with most experimental observables. Studies have used long-range interatomic 
distances from PRE measurements as restraints for generating ensembles of aS.114 The 
disadvantage of these methods is that they tend to rely lightly, or not at all, on atomic-
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scale MD simulations, which greatly reduces the computational time and effort, but the 
quality of the final models depends strongly on the sample size and diversity of the initial 
structures used in the study.115 For the purpose of this thesis, I will focus only on the 
second broad modelling approach – de novo MD simulations. For further details on the 
knowledge-based approaches, please refer to the review article 64, where we have 
extensively reviewed these methods. 
 De novo MD simulations (Fig. 1.4) generate conformational ensembles without 
any prior knowledge from experimental data beyond the long-established atomic and 
molecular parameters contained in the simulation force field. The standard MD protocol 
samples the potential energy surface of biomolecules and creates a Boltzmann-weighted 
ensemble at, typically, microsecond time scales and nanometre length scales. There are 
two well-known challenges when it comes to the use of de novo MD methods for IDPs: 
firstly, since biomolecular systems are ergodic116 in nature (which means temporal 
averages should equate to ensemble averages in conformational space), extensive 
sampling of phase space is required in order to establish convergence of IDP 
simulations.117 Current massively-parallelized supercomputing facilities and the latest 
simulation software make it feasible to sample for hundreds of microseconds (with 
milliseconds in reach),118 and make more efficient explorations of the sampling space,119 
respectively. However, the second problem is more fundamental – the accuracy of the 
force fields used to simulate IDPs is in question,120 and so prospects for refinement of 
IDP force fields is discussed in detail below in section 1.9. Protein force field and water 
model. 
 Amyloid structural ensembles generated by de novo simulations are 
independently validated by complementary experimental data; they do not use 
experimental data as restraints in simulations (Fig. 1.4). The advantage of this method is 
that the under-determined nature of IDP ensembles built with knowledge-based 
approaches is circumvented, but at the expense of far greater computational effort.121 The 
experimental observables are usually back-calculated from theoretical models as 
synthetic experimental data to test for agreement with ‘true’ experimental observables. 
The simulation data needs to be tested against a wide array of experimental measurements 
for a robust and conclusive validation, and there are several software codes that generate 
predicted experimental values from theoretical models. For NMR observables, the CS 
values (measured in parts per million or ppm) can be predicted using programs such as 
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SHIFTS,122 SHIFTX/SHIFTX2,123 SPARTA/SPARTA+,124 etc., while the PALES,125 
MODULE126 and REDCAT127 packages can be used to generate RDCs from computed 
ensembles. SHIFTS program can predict backbone and side-chain 15N and 13C CSs. 
These values are predicted from conformational effects derived from a database of density 
functional theory (DFT) calculations on more than 2000 peptides. Empirical models of 
contributions from CSs are then calculated. SHIFTX and its advanced version SHIFTX2 
can predict 15N, 13C and 1H CSs by using the PDB coordinates from computational models 
of simulations. SHIFTX2 was developed by training a dataset of 197 proteins and testing 
on a dataset of 61 proteins (both sets consisting of high-resolution X-ray structures) by 
combining an ensemble machine learning approach with sequence alignment-based 
methods. SPARTA+ (previously known as SPARTA) also employs an empirical CS 
prediction method similar to SHIFTX2 developed by training artificial neural network on 
580 high-resolution X-ray structures of proteins, by using information such as backbone 
and side-chain conformation, hydrogen bonding, electric fields and ring-current effects. 
For back-calculating RDCs, PALES program is widely used. A global alignment 
orientation of the protein is generated by utilizing its steric properties. The angle between 
the backbone amide bond vectors and the external magnetic field is then utilized to 
compute the average ensemble RDC. 
 The scalar coupling (J-coupling) constant (in units of frequency, Hz) is a measure 
of the interaction between a pair of protons in NMR. The most commonly measured J-
coupling constant, 3JHNHa (“3” in superscript denotes that the coupled protons are three 
bonds away from each other) is back-calculated using the optimized form of the Karplus 
equation (Eq. 1.1)128,129 as a function of three-bond backbone dihedral angle between 
protons: 
 
                            (1.1) 
 
where 𝜙 is the three-bond backbone dihedral angle between the hydrogen atoms, and A, 
B and C are coefficients derived from parameter sets obtained empirically depending on 
the type of atom and substituents involved.130,131 This equation is based on the theoretical 
consideration that H-H couplings will be maximal between protons which present an anti 
or eclipsed conformation (dihedral angles of 180° and 0° respectively), and that coupling 
will be minimal (near 0) for protons that form an angle of 90° to each other. 
𝐽(𝜙)	 = 𝐴	𝑐𝑜𝑠2(𝜙 − 60) + 𝐵 cos(𝜙 − 60) + 𝐶 
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 The most reliable spin cross-relaxation 15N-1H NOE and ROE peak intensities 
(from spectral densities) can be computed using time correlation functions.132 The 
software package AUREMOL133 has the additional capability of back-calculating both 
2D and 3D NOESY protein spectra. On the other hand, theoretical SAXS scattering 
profiles (for interpreting the size and shape of IDPs) can be predicted from atomic-
resolution structures (obtained from MD simulations) and fitted against available 
experimental SAXS intensities by various methods, of which the most popular ones are 
CRYSOL134 and FoXS135 (both available as web servers). CRYSOL back-calculates the 
SAXS scattering intensities from atomic coordinates. The software works as an 
interactive Fortran77 program, which involves tabulation of angular directions and form 
factors followed by identification of atomic groups, their displaced volumes and their 
contributions to the partial amplitudes and envelope functions from atomic coordinates. 
Finally, the SAXS intensity is computed and fitted to the experimental data (if provided). 
FoXS uses the Debye formula136 to calculate SAXS intensities (Eq. 1.2).  
 






9CD                                     (1.2) 
where q = (4π sin θ)/λ, where 2θ is the scattering angle and λ is the wavelength of the 
incident X-ray, and I(q) is the intensity as a function of the momentum transfer q; fi(q) 
and fj(q) are the form factors for atoms i and j respectively, which takes into account both 
displaced solvent and hydration layer; dij is the distance between atoms i and j; and N is 
the number of atoms in the molecule. The computed intensity profile from here is then 
fitted against experimental SAXS profile. All these methods suffer from degeneracy of 
representation, with usually many atomistic structures “agreeing” with the available 
experimental data and so the most reliable studies cross correlate the results of fitting 
theoretical data to multiple experimental datasets and parameters. 
 The latest developments in IDP ensemble modelling allow easier handling of 
complex datasets and large model sizes. For example, the latest SAXS-based Ensemble 
Optimization Method (EOM) allows working with flexible ensemble size, optimized 
conformational weights and, crucially for studying aggregation of monomers, including 
support for oligomers and complexes.137 On the other hand, a multi-parametric approach 
using the experimental 15N NMR relaxation rates combined with MD simulation data was 
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very recently used to characterize the dynamic time scales and local and global fluctuation 
of IDP ensembles.138 Similarly, the variational Bayesian weighting (VBW) algorithm was 
used to generate Ab40 ensembles from experimental measurements,139 which gives faster 
ensemble average calculation by including a variational approximation, saving much 
computational time. The VBW algorithm was also used to generate ensembles of aS from 
a structural library of monomers and multimers.140 
 Brookes and Head-Gordon recently developed the Experimental Inferential 
Structure Determination (EISD)141 method which provides better refinements than 
conventional Bayesian inferential structure determination (ISD)142 methods, and uses the 
posterior probability distribution of IDP sampling uncertainty for model selection. 
"Posterior" in this context means the distribution after taking into account experimental 
observations, and this method manages to significantly reduce the “nuisance” back-
calculated errors (calculated using CSs and scalar J-coupling values) and intrinsic 
experimental errors that were heretofore purposefully treated as random variables with 
known Gaussian distributions. By doing so, it not only allows accommodation of very 
large ensemble sizes and better ranking of ensembles, but also promises improvements in 
back-calculated parameters and allows a preliminary assessment of the quality of an 
ensemble, before restraints are applied. This exhaustive study used seven qualitatively 
different Ab42 ensembles, which included ensembles generated from random coil, 
statistical coil, replica exchange de novo MD (REMD) and NMR (four derived 
parameters) restrained MD. Aspects that require further attention include the over-/under-
fitting of data and under-/over-restraining of parameters,143 development of methods to 
select the most physically realistic and experimentally relevant ensembles from a set of 
similarly weighted ensembles,144 and expansion of the number and types of experimental 
measurements that can be used for model refinement and validation.145  
 Ball et al. carried out a comparative study between the knowledge/ensemble-
based approaches and de novo MD simulations recently for Ab40 and 42.132 While noting 
that knowledge-based approaches yielded more expanded configurations on average than 
the MD-based methods, the authors highlight the crucial point that the knowledge-based 
approaches (unlike Boltzmann-weighted MD methods) have the shortcoming of 
assigning equal statistical weights to different conformations in order to retain 
homogeneous statistical properties within an ensemble of conformations,107 which 
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essentially hampers direct comparison with NMR measurements. They propose that a 
concerted approach involving generation of initial libraries of conformations by MD 
methods (henceforth I refer to de novo MD simulations as MD simulations or MD 
methods) followed by further refinements using knowledge-based methods could 
potentially provide models that better represent the (very) complex free energy landscape 
sampled by IDPs in NMR experiments. 
   
 
Fig. 1.5. (A) Solution NMR structure (PDB code 2OTK146) of b-hairpin (green) from 
Ab(17-36) solved in complex with an engineered binding protein dimer: affibody ZAb3 
(light grey). (B) Solution NMR structure (PDB code 4BXL147) of b-hairpin (red) from 
aS(37-54) solved in complex with an engineered binding protein dimer: b-wrapin AS69 
(light grey). (C) A 2.3 Å XRD structure (PDB code 5HOW148) of a representative b-
hairpin (green) of Ab(17-36) from macrocyclic b-sheet peptides forming triangular 
trimers (two other monomers are shown in light tan), and (D) a 1.97 Å XRD structure 
(PDB code 5F1T 149) of a representative b-hairpin (red) of aS(36-55) from macrocyclic 
b-sheet peptides forming triangular trimers (two other monomers are shown in light tan; 
one nanomer and a hexamer from another nanomer was deleted from the original 
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1.6. MD simulations for validation of experimentally observed amyloidogenic 
conformational signatures 
Amyloidogenic monomers or oligomers are not amenable to X-ray crystallography or 
diffraction (XRD) in their free, unbound states, as they contain poorly-resolvable 
disordered regions.21 Hence, solution state NMR spectroscopy is the experimental tool to 
characterize atomic resolution structures of amyloidogenic IDPs; NMR relaxations show 
signals that distinguish local IDP/IDR motions from global motions.150 Two recent 
studies on macrocyclic b-sheet peptides, using a single 15N isotopic probe by NMR 
experiments, highlights the predisposition of peptides containing the aggregation-prone 
central hydrophobic residues 17-23 and C-terminal residues 30-36 of Ab to assemble and 
co-assemble largely into heterotetramers (and homotetramers).  They do this by forming 
a b-sheet sandwich of two hydrogen-bonded dimers.151,152 These studies provide 
significant insights into how Ab fibrils may segregate into b-sheets through the central 
and C-terminal regions and co-assemble into fibrils. 
 It has been corroborated that an increase in monomeric b-strand content increases 
the rate of aggregation61 and b-sheet oligomeric assemblies have been proposed to be an 
extension of b-hairpins62 or very recently, a hairpin-like structural motif.63 It was 
observed that Ab40 can form persistent b-hairpin structures when sequestered with an 
affibody protein ZAb3, which prevents its fibrillation and could potentially aid in 
identifying early pathogenic events leading to oligomer formation (Fig. 1.5A).146 Follow-
up studies showed that sequestration and capture of the b-hairpin in aS (Fig. 1.5B),147 
Ab, and islet amyloid polypeptide monomers impedes toxic aggregation. These studies 
used NMR experiments (BEST-TROSY, 3D [1H-1H-15N] NOESY-HSQC, etc.) in 
conjunction with other techniques.153 The b-hairpin-stabilizing agent (termed “b-
wrapins”; b-wrapin AS10 in this case) specifically binds to aS, Ab and islet amyloid 
polypeptide monomers, but not to a construct of the four-repeat domain of Tau protein or 
a variant of human Prion protein. However, a different b-wrapin (TP4) was shown to have 
two alternative binding sites for the four-repeat K18 construct of Tau, which resembles 
the b-hairpin motif observed in Ab and aS.154 This provides leads to a common route of 
therapeutics for a subgroup of amyloidogenic peptides. The binding specificities and 
conformational properties of b-wrapins bound to hairpins were later confirmed by MD 
simulations for Ab and aS.155 Another recent simulation study on Ab peptides found that 
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a b-hairpin conformer obtained by spectral clustering shares a Ca root-mean-square 
deviation (RMSD) of as low as 0.4 Å with the experimental hairpin structure in ref 101,146. 
Key b-hairpin motifs spanning residues 38-53 in full-length aS were also observed in 
simulations using a hybrid-resolution coarse-grained (CG) model – PACE,59 which 
resemble the hairpin structure found in NMR experiments.147 Another experimental study 
obtained high-resolution X-ray crystallographic structures of oligomers formed from 
macrocyclic b-sheet peptides of Ab(17-36)148 (Fig. 1.5C) and aS(36-55)149 (Fig. 1.5D) 
that display the arrangement of b-hairpin motifs of Ab(17-36) and aS(37-54) in 
oligomers. These structures not only provide plausible insights into the hierarchical 
oligomeric assembly of Ab and aS, but also underline the importance of the b-hairpin in 
oligomer formation. Interestingly, the b-hairpin captured/constructed in both ref 147 and 




Fig. 1.6. Representative calculated conformations of Zn-bound Aβ40 with either D1 or 
E11 coordinated to Zn along with three stabilizing histidine residues (H6, H13, and 
H14).156 The distribution of Gaussian fitted Gibbs free energy for each conformational 
ensemble is shown by the red bell-shaped curves. 
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 It was noted from MD simulations that Zn2+ prefers binding to Glu11 compared 
to Asp1 of Ab40, according to the calculated Gibbs free energies (Fig. 1.6); the non-
overlapping complexes of Zn2+-Ab40 suggested several misfolding pathways (through 
metastable intermediates) as revealed by Markov state modelling.156 b-hairpin models 
have been obtained in different regions (especially in the C-terminal and the CHC) of Ab 
from other studies by using either MD simulations.57,157 Likewise, using PRE data as 
restraints, MC simulations have revealed transient intramolecular tertiary contacts (not 
part of the well-known long-range N- and C-terminal tertiary contacts) between b-strands 
in monomeric ensembles of aS that could be responsible for initial on-pathway 
aggregation.158 A very recent  and interesting REMD simulation study proposed that the 
fluctuating N-terminal of Ab stabilizes the b-hairpin motif (Fig. 1.7) by an entropy 
compensation.159 Further dynamic network analyses revealed that the propagation of 
disorder does not pass directly through the b-hairpin motif formed from Ab(1-40) and 
Ab(1-34) but rather via Ab(17-40), suggesting a protective role of the N-terminal in 
stabilizing the b-hairpin in Ab. 
 Contrary to the above findings, some studies highlight the importance of 
monomeric a-helical conformations. A recent experimental study raises the intriguing 
possibility that transient a-helical conformations (formed on the C-terminus) in the Ab42 
monomer ensemble might be involved in the formation of an initial a-helical oligomeric 
bundle mediated by the C-terminal region and might define a non-nucleated initiation of 
aggregation.160 The authors reasoned that these a-helical conformers (in an otherwise 
predominantly disordered Ab42 monomer ensemble) might fall below detectable limits of 
NMR experiments. Formation of a-helical (or 310 helical) conformations have also been 
reported in MD simulations highlighting helical interactions for initiation of Ab 
aggregation.161 Similar subtle effects were revealed in solution-state and ssNMR studies 
of the membrane-bound behaviour of aS.162,163 The N-terminal region acts as a membrane 
anchor and remains a-helical irrespective of the membrane composition, the central 
region which includes the NAC (residues 61-95) can act as a second anchor to stimulate 
vesicle clustering, while the highly disordered C-terminal region interacts only weakly 
with the membrane.162 Moreover, it was shown that the N-terminal and the NAC regions 
of wild-type aS follow independent binding modes, where they can bind to two different 
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vesicles at the same time, favouring a ‘double-anchor’ model of binding and maintaining 
vesicle clustering.163 This also provided a structural basis for the functional loss 
associated with A30P familial mutations, where low binding affinity in the N-terminal 
region disrupts synaptic vesicle clustering. In Chapters 3 and 4, we have evaluated and 
justified the observed varied aggregation propensities related to differential a-helical 
stabilities in Ab42 and aS monomers. In addition, a soluble a-helical monomeric 
extended construct of aS was solved most recently by transient interaction with lipid 
interfaces,164 opening up further avenues into the mysteries of the helically folded αS 
tetramer that has been shown to be aggregation resistant under physiological 
conditions.83,165,166 (discussed later under section 1.8.1. a-synuclein helical tetramers).  
 
 
Fig. 1.7. Computed MD structures of a β-hairpin of Aβ(1-40)cc, Aβ(1-34)c, and Aβ(17-
40)cc in which residues L17 and L34 were mutated to C17 and C34, and linked by a 
disulfide (cc) bond.159 (A) Representative β-hairpin conformations of Aβ(1-40)cc, Aβ(1-
34)c, and Aβ(17-40)cc taken from the most populated cluster of individual 
conformational ensembles. (B) Dynamic network analysis of the propagation of disorder 
within Aβ(1-40)cc, Aβ(1-34)c, and Aβ(17-40)cc suggests that the fluctuating N-terminal 
of Aβ(1-16) displays a protective role in stabilizing the β-hairpin conformation.  
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1.7. MD simulations generated predictive models of amyloidogenic signatures: 
verification by experiments 
A major contribution from MD simulations to amyloidogenic proteins research has been 
their ability to identify molecular fingerprints of aggregation at atomistic resolution 
through models of dynamic local and long-range interactions, which are difficult and 
often impossible to obtain using experiments alone. Predictions from MD provide testable 
hypotheses and novel mechanistic insights into the early stages of aggregation that have 
been subsequently tested by experimental methods. Experimentally validated predictive 
models would provide invaluable leads to (re-)engineer less toxic amyloidogenic peptides 
(with these “safer” sequences eventually being incorporated into the cellular protein 
synthesis machinery). One of the earliest examples is a predicted model for the 
conformational conversion of PrPC (cellular prion) to PrPSc (pathogenic prion) involving 
multimerization.167 The only information available from experiments at that time was that 
the conformational shifts occurred at low pH. Short simulations revealed unfolding of the 
a1 helix, increased b-sheet content, and conformational changes in the N-terminal region 
that were due mainly to breaking of charge-stabilized hydrogen bonded interactions at 
low pH. These features were later confirmed by amide-proton exchange NMR 
experiments.168  
 An unfolding intermediate from partial unfolding of prions with a novel 
architecture – the a-sheet, was identified in under amyloidogenic conditions by MD 
simulations.169 It was proposed that these intermediate a-sheets might promote self-
assembly into higher order oligomers or protofibrils, which in turn convert favourably to 
b-sheets in fibrils, and that the a-sheets themselves might be the soluble toxic precursors 
in amyloidogenesis. A conformation-specific antibody, A11 preferentially binds 
oligomeric intermediates, but not fibrils,42 which supports the idea of transition from a-
sheets in oligomers/protofibrils to b-sheets in fibrils. Furthermore, the polyglutamine-
binding peptide, QBP1 was shown to bind polyQs in an a-extended chain conformation, 
which inhibits elongation of the a-sheet conformation formed by QBP1-polyQ 
complex.170 In a more recent study, specific a-sheet peptides were computationally 
designed to complementarily bind the predicted a-sheet conformations of Ab42 and 
transthyretin (TTR) from MD simulations.171 Following a series of comprehensive 
aggregation assays and biophysical characterization, it was observed that the 
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experimentally synthesized a-sheet peptides inhibit both Ab42 and TTR aggregation in 
solution and bind to specific configurations of the two amyloidogenic proteins. This 
experimental validation corroborates the proposed hypothesis that a-sheet secondary 
structures may be present in the toxic oligomeric intermediates. The most recent follow-
up of this work involved reverse-engineering a novel hairpin peptide, AP90, which 
presents alternating D- and L-amino acids and inhibits amyloidogenic aggregation in 
three proteins:  Ab42, TTR and human islet amylin polypeptide (hIAPP).172 
 In a further example of the power of predictive MD modelling, a novel approach 
was used to predict the b-aggregation propensity of three amyloidogenic oligomers: Ab42, 
hIAPP and N-terminal domain of yeast prion protein Ure2 (Ure2p1-94).173 The peptide 
sequences were decomposed into seven-residue stretches of overlapping segments, and 
MD simulations was performed on wild-type (WT) and mutant oligomeric units to 
generate a position-dependent b-aggregation profile for fibril formation. Apart from 
revealing distinct ‘hotspots’ for aggregation in Ab42 and hIAPP, the Ure2p-N47/48S1-94 
double mutant removed one of the hotspots (residues 45-49) present in WT, and ThT 
assays verified that the N to S double mutation impedes the aggregation propensity of the 
WT prion. Other recent examples include experimental validation of calculated inhibitory 
effects on amyloidogenic aggregation, such as MD design and characterization of short, 
synthetic b-sheet breaker peptides to inhibit in vitro Ab40 fibril formation, which was 
verified experimentally by ThT assay, UV CD spectrometry, and MS.174 Similarly, the 
predicted inhibitory effect of caffeine on the aggregation of Ab-derived switch-peptides 
was experimentally verified using parallel UV and CD studies.175 
 
1.8. MD simulation studies of low molecular weight oligomers 
With the identification of Ab dimers as the smallest toxic oligomers176 that could 
potentially assemble into neurotoxic protofibrils,177 many recent MD studies have 
attempted to probe the detailed assembly and characterize the structural and 
conformational features of WT and mutant Ab dimers. Such information is not readily 
obtainable by high-resolution experimental techniques due to the broad distribution of 
short-lived dimer states which rapidly aggregate into higher order structures.44 Simulating 
dimerization starting from monomers requires sampling to supramicrosecond timescales, 
and thus most studies are limited to qualitative CG models with implicit solvent 
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models.178,179 On the other hand, results from atomistic REMD simulations in explicit 
water show broad sampling of Ab dimer conformational space, but with a pronounced 
dependence on the force field (discussed under section 1.9. Protein force field and water 
model). The earliest comparative study on force field benchmarking for Ab(16-22) 
oligomerization showed that OPLS/AA might correctly represent the large 
conformational distribution for dimerization (and trimerization), whereas Amber ff99 had 
artificial bias towards a-helical structures.180 In addition to monomers, CHARMM22* 
(with TIP3P water) was recently used to determine the equilibrium ensemble of WT Ab40 
dimer which displayed predominantly disordered states.181  
 Follow-up studies of toxic A2V mutant Ab40 dimers using the same force field 
showed significant reduction of disordered states (including assembly of a three-stranded 
b-sheet) for the heterozygous single mutant (WT-A2V) whereas the homozygous double 
mutant (A2V-A2V) dimer did not, in agreement with the observed protective effect of 
A2V mutations in heterozygotes.182 A very recent dimer simulation study compared the 
WT Ab42 dimer with its intermolecular disulphide-bonded S8C double mutant, which 
does not assemble into larger oligomers despite being toxic.183 Both the WT and the 
mutant Ab42 sampled double b-hairpin states, similar to the one found in the single A2V 
mutant Ab40 dimer,182 but not found in WT Ab40 dimer simulations,181 which suggests 
that the neurotoxicity associated with WT and S8C Ab42 can be related to this three-
stranded b-sheet or double b-hairpin structure. The authors noted significant 
discrepancies between secondary structure propensities and computed collision cross-
sections across different studies of Ab dimers, owing mainly to the choice of all-atom 
force fields (and water models) in the simulations. Hence, the expected conformations 
and distributions of Ab dimer structures remain largely unknown due to a paucity of 
experimental data to benchmark force fields. A specific combination of protein force field 
and water model that provides an accurate description (in comparison to experiments) of 
the monomeric ensemble should be transferable to studies of initial aggregation into 
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1.8.1.  a-synuclein helical tetramers 
As mentioned earlier, latest experimental findings by a number of groups that aS may 
exist as a-helically folded tetramer that resists further aggregation under normal 
physiological conditions,83,166 have stirred controversies over the native state of aS. Thus, 
there are many contradictory viewpoints on whether aS is predominantly disordered 
cytosolic monomer that is aggregation-prone,85 as long understood82 or a cytosolic a-
helically folded tetramer that is aggregation-impeding as recently discovered.184-186 It is 
now thought that the unfolded monomeric and helically folded tetrameric states might 
actually be in dynamic equilibrium with each other,84,165 as evident from the familial PD 
causing missense mutations which shifted the tetramers to pro-aggregating monomers 
precipitating neurotoxicity by decreasing aS solubility.187 It was also shown that 
homologous E→K mutations destabilize αS multimers (including helical tetramers) and 
induce monomer aggregation at membranes to form vesicle-rich inclusions.185,188 
 However, there is very limited computationally verified models or simulation 
studies till date on the helical aS tetramers. One simulation study that used a fragment-
based approach to construct energetically favourable full-length aS suggested that 
the sampled structures with amphipathic helices can self-assemble via hydrophobic 
contacts to form tetramers.189 In another study, a combination of REMD and VBW 
methods was used to generate monomers, a-helical- and b-strand-rich aS trimers and 
tetramers in an attempt to resolve the controversy regarding experimentally observed aS 
native structure.140 The authors noted that the ensemble is dominated by disordered 
monomers, with very little helical trimers and tetramers, although the tetrameric states 
had significant helical content. Another simulation study observed that aS tetramer from 
a completely disordered state exhibited appreciably reduced stable β‐sheets in 
comparison to dimers, and a more stable helical content than either monomer or dimer.190 
Finally, by employing a steric parameter, correlations were obtained between the main 
and side chains of aS monomers and tetramers revealing residues consisting mostly parts 
of KTKEGV repeats that could potentially mediate formation of helical tetramers.191 In 
Chapter 5, we provide significant insights into the helical stabilities of aS tetramers, and 
identify why helical tetramers may be the most populated oligomer amongst other 
multimers. 
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1.9. Protein force field and water model 
The accuracy and precision of atomistic MD simulations depend on the physical model 
(combination of protein force field and water model) employed. Over the years, additive 
or empirical protein force fields have been used extensively in simulations of structured 
proteins in explicit water,104 with the potential energy function fitted using parameters 
derived from quantum chemical calculations and known properties of organic liquids. 
Several popular choices include Amber,192 CHARMM,193 GROMOS,194  and OPLS-
AA,195 and they differ mostly in the functional form of the potential and the level of 
details included. Popular models of water include the three-site TIP3P and SPC/E or the 
four-site water models such as TIP4P, TIP4P-Ew, and TIP4P/2005.196 However, some 
intrinsic biases of the physical models include an abnormal propensity for helical 
structure formation compared with NMR experiments197 and a tendency to misfold 
peptides in protein folding simulations.198 These tendencies are magnified for simulations 
of IDPs. 
 In the past decade, MD force fields have been extensively upgraded and where 
necessary reparametrized to better match available protein structural dynamics data. The 
temporal upgrades in the Amber force fields199 involved backbone and sidechain torsional 
potential corrections to give better agreement with RDCs and J-coupling data from NMR. 
The resulting ff03* and ff99SB*199 force fields have upgraded the backbone energy 
definitions to improve the ratio of helix to coil populations. Further improvements gave 
Amber ff99SB-ILDN200 with better sidechain torsion parameters on Iso, Leu, Asp and 
Asn residues. Amber ff03w201 upgraded on ff03 to work with the TIP4P/2005 water 
model, showed an enhanced cooperative helix-coil transition compared to ff03*. 
Contemporaneous developments to CHARMM force fields involved first the all-atom 
CHARMM22,202 then the CHARMM22/CMAP203 with protein backbone dihedral 
corrections, which deviated from quantum mechanical data, but yielded better agreement 
with crystallographic data. However, these force fields were shown to over-stabilize 
helical structures197,198 and so were re-parametrized with modified partial charges and 
backbone torsion terms to yield CHARMM22*204 keeping the “star” nomenclature of 
Amber ff03* and ff99SB*.199 The subsequent CHARMM36205 force field provided a 
more accurate distribution between secondary structures via optimized sidechain torsion 
parameters and refined backbone CMAP potentials. The above force field variants 
provide models that agree well with NMR data, which led to a general consensus that the 
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force fields are improving. Nevertheless, it is clear that the use of different physical 
models affects simulation outcomes, which hampers attempts to make robust 
comparisons to experiment.  
 Neither the traditional nor upgraded force fields described above correctly 
represent IDP conformational ensembles – one of the central problems being that the 
natively unstructured proteins either over-collapse in water or excessively unravel at 
physiological conditions, neither of which extremes reproduce experimental 
observations.201,206 Most IDPs contain a high net charge per residue (leading to strong 
inter-residue electrostatic repulsions) coupled with low mean hydrophobic content per 
residue.207 The calculated trends of IDPs to collapse into ‘molten globular’ states is a 
supposedly simulation artefact.208 Hence, realistic MD simulations should show IDPs 
adopting persistent expanded states, because these allow the proteins to be more solvent-
exposed. Exceptions to this rule include polar IDPs with few or no charged residues, IDPs 
having large segregation between oppositely charged residues, IDPs which are natively 
pre-molten globules, and hydrophobic IDPs.21  
 Consequently, the high proportion of solvent-exposed regions in IDPs has 
necessitated a paradigm shift in how water is modelled.209,210 The quality of the data 
produced depends strongly on the explicit water model used in addition to the protein 
force field, and the disordered residues are usually not well modelled by “traditional” 
water models. The rigid three-site water models (TIP3P and SPC/E) are able to capture 
the experimental bulk water properties and are computationally efficient. However, they 
are not well-suited for replicating complex hydration water behaviour, such as the 
protein-water interfacial  xl thermodynamic and kinetic properties of IDPs.211 The earlier 
versions of CHARMM (except CHARMM36, which is optimized for the standard TIP3P) 
were parametrized by a modified TIP3P (mTIP3P),202 which adds Lennard-Jones (LJ) 
potential on the water hydrogen atoms. To address the deficiencies of three-site models, 
rigid additive four-site water models (TIP4P, TIP4P/2005 and TIP4P-Ew) were 
introduced, which places a dummy atom along the bisector of the H-O-H angle, which 
gives a more realistic electrostatic charge distribution and improves the thermodynamic 
properties. These re-optimized water models combined with small modifications of 
protein force fields201,212 have shown impressive results for modelling globular proteins, 
but further refinements were required to reproduce measured IDP properties. 
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1.9.1 Specialized force fields and water models favouring IDPs 
Three recent advances have accelerated the development of physical models for 
modelling IDPs. The first approach involved modifying the protein-water interaction 
parameters while preserving the existing protein-protein and water-water interactions 
parameters, motivated by the need for improved treatment of water-mediated interactions 
of IDPs. The ‘balanced’ force field named Amber ff03ws213 is an upgrade of Amber 
ff03w,201 obtained by precise adjustments to the LJ e (epsilon) parameter between the 
TIP4P/2005 water oxygen and all protein atoms by an adjustable scaling factor (g = 1.10). 
The results obtained with Amber ff03ws on three model IDPs gave expanded protein 
configurations in excellent agreement with experimental SAXS and FRET measurements 
and was generally considered “transferable” to other protein systems as well. The second 
approach involved increasing the water dispersion interactions (LJ C6 parameter 
increased by 50% over the TIP3P model) using a revised theoretical model of water: 
TIP4P-D,214 starting from the original geometry of TIP4P/2005. The charges and the C12 
coefficient were scaled to fit enthalpy of vaporization temperature and density profiles, 
leading to more accurate treatment of the water-water London attractive forces. The study 
performed on five model IDPs (including aS) (Table 2) showed that combinations of 
TIP4P-D gave excellent agreement with NMR and SAXS radius of gyration (Rg) values. 
The third approach and the most recent development involved re-parametrization of 
CHARMM36 with further refinements of the backbone CMAP potential, and improved 
treatments of the guanidinium and carboxylate salt-bridge interactions. The force field 
named CHARMM36m215 was parametrized for use with the mTIP3P model and was 
mainly developed because a previous study reported that ensembles with CHARMM36 
gave an abnormally high population of ‘left-handed’ a-helices.216 This anomaly was 
attributed to CHARMM36 having too-strong aliphatic LJ s attractions. The 
comprehensive study (comparing mainly CHARMM36 and CHARMM36m) conducted 
on 20 proteins and 15 peptides gave a superior performance with CHARMM36m 
consistent with NMR and SAXS data. However, the ensemble-averaged Rg for two IDPs 
were smaller than SAXS estimates. To address this, an alternative water model was 
proposed where the LJ parameter eH was further increased over mTIP3P, while preserving 
the water-water interactions with NBFIX terms. This led to selectively favouring the 
protein-water dispersion interactions. This enhanced the overall chain dimensions in 
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simulations, but for few proteins produced overly expanded ensembles.215 It is worth 
mentioning another development based on the Kirkwood-Buff theory217 of solutions, the 
Kirkwood-Buff Force Field or KBFF.218 KBFF used the same principle of improved IDP 
solvation as TIP4P-D water but involved a very different approach that relates the radial 
distribution function of solute molecules to solution thermodynamics. KBFF (with SPC/E 
water) produced near perfect match with experimental estimates of Rg. The authors 
concluded that non-canonical force fields like KBFF could be a good alternative to 
canonical force fields, which tend to over-stabilize folded configurations.  
 
 
Fig. 1.8. Representative conformations of the most populated clusters of wild type Ab42 
and its mutants sampled by REMD simulations using Amber ff99SB force field and GB 
implicit solvent.219,220 The N- and C- terminal of each conformation are represented as 
orange and green spheres, respectively. The mutated residues are represented as vdW 
spheres. For E22Δ mutant, E22 is removed and so D23 is shown instead. 
 
 
 Recent REMD simulations using Amber ff99SB with implicit GB solvent model 
sampled more helical and compact conformations of wild type and mutant Ab42 (Fig. 
1.8).219,220 One recent study showed that the heterogeneous conformational ensemble of 
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Ab42 could be related to its non-uniform entropy gains,71 displaying highly 
heterogeneous water dynamics around its non-globular structure with weakly bound 
water molecules around the core, suggesting elution of water leading to aggregation due 
to hydrophobic collapse. Perhaps then, rescaling the protein-water interactions (as with 
Amber ff03ws or TIP4P-D or CHARMM36m with the alternative mTIP3P) could 
potentially skew the ensemble features of Ab towards sampling more conformers with 
relatively large Rg values. Three recent comparative studies of physical models for Ab 
peptides underline the usefulness of CHARMM22* in sampling ‘less compacted’ 
conformations,221-223 and simulations of prothymosin-a have suggested that 
CHARMM22* even with a standard ‘unscaled’ water model (TIP3P or mTIP3P) might 
yield the correct dimensions of ‘highly charged’ IDPs.214 For further details, refer to our 
review article 64. 
 The new knowledge into amyloidogenic conformational and ensemble features 
gleaned from recent modelling studies highlights the need to correct the balance between 
peptide charge and hydrophobicity, and between scaled and unscaled protein force field 
and water model parameters. This can only be achieved by rigorous benchmarking 
against, and fine-tuning with respect to, experimental measurements. An extensive list of 
recent benchmarking studies of protein force fields and water models for different model 
IDPs is presented in Table A1 under Appendix A. Experimental sensitivity limits can 
hamper the comparison of MD predictions with observations from NMR such as CS and 
J-coupling constants,132 and so experimental data from a multitude of techniques should 
be compared when assessing the accuracy of IDP force fields. In addition to this 
challenge, in all likelihood one “universal” model will not fit every IDP, or even many 
IDPs. 
 
1.10. Motivation, research questions and hypotheses 
Although integrated studies are beginning to understand the structure and assembly of 
low molecular weight oligomers – the primary toxic species in the neurodegenerative 
pathway – several open-ended questions still remain, which the experiments alone are 
inadequate to address at the atomic level. In this regard, predictive modelling through 
atomistic MD simulations are an absolute necessary tool to characterize the molecular 
signatures of amyloidogenesis. In the light of experimentally inaccessible atomic 
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resolution structures of Ab42 and aS oligomers, I have employed two computational 
modelling approaches for the research presented in this thesis: (1) understanding the 
formation of oligomers through signature models prone to pathogenic aggregation and/or 
aggregation impedance in monomers (IDPs) and designed large ‘profibrillar’ oligomers, 
and (2) predictive models of aggregation resistant small oligomers. The first, that is 
models of monomers and large oligomer aggregability are studied in Chapters 3, 4 and 6, 
and the second design approach is employed and studied under Chapter 5 of this thesis. 
Based on the survey of previous research on amyloid proteins discussed earlier in this 
chapter, I have identified the following research questions (RQ): 
 
RQ1: Could the population of stable a-helical conformations of amyloidogenic 
monomers be optimized to make them more resistant to toxic oligomerization and if so, 
what are the molecular signatures that govern such stabilities? 
RQ2: What causes the partially folded a-helical amyloidogenic monomers to be so 
aggregation-prone, compared to the helically folded or unfolded states? 
RQ3: What are the molecular determinants in the formation of non-aggregating a-
synuclein helical tetramers over the aggregation prone disordered monomers? In more 
detail, how does familial pathogenic mutations shift the equilibrium towards disordered 
monomers, how does helical periodicity (11/3-helix vs. a-helix) and continuity (extended 
vs. broken) govern the stabilities of a-synuclein tetramer, and why are the helical 
tetramers the most populated species amongst helical multimers of different monomeric 
sizes? 
RQ4: What are the molecular determinants of the difference in aggregation profiles 
between amyloid-b40 and amyloid-b42 from the perspective of a preformed, profibrillar 
oligomer? 
 
The research questions were investigated on the basis of following research hypotheses 
(RH): 
 
RH1: Re-engineering terminal residues may control initial neurodegenerative 
aggregation of amyloidogenic monomers by optimizing their a-helical stabilities.  
 - 33 - 
RH2: The native state of a-synuclein may exist as an aggregation resistant helical 
tetramer in addition to amyloidogenic disordered monomers which are in dynamic 
equilibrium with each other, and the shift in population from a potentially ubiquitous 
(amongst all helical multimers) tetramers to monomers determine pathogenicity. 
RH3: Pro-aggregating properties of preformed dodecamers can potentially explain the 
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Chapter 2. Predictive Modelling Techniques 
2.1. Molecular dynamics simulation 
Simply put, molecular dynamics (MD) simulation224,225 is a method to computationally 
mimic what atoms do in real life, in order to calculate their equilibrium and dynamical 
properties, and their interactions. MD simulations initially assume a potential energy 
function (since the contributions made to the total energy by the motions of the atoms are 
not included), which computes the properties pertaining to motions of atoms through 
evolution of the atomic trajectories. This potential energy function generates the so-called 
predictive model, as it attempts to determine the possible energy of the model system 
utilizing information such as bonds stretching, opening and closing of angles, and bond 
rotations. This energy function allows calculations of the conservative force experienced 
by any atom relative to the positions of the other atoms, based on equations of motion for 
a molecular system. The force is represented as the negative gradient of a scalar potential 
energy function:  
 
?⃗?(𝑥) = 	−∇𝑈(𝑥)		                                                 (2.1) 
 
where ?⃗?(𝑥) is the force acting on coordinates of all atoms x, Ñ is the gradient with respect 
to the coordinates of the atom, and 𝑈(𝑥) is the potential energy acting on coordinates of 








; ?⃗?(𝑥) = 𝑚?⃗?                                       (2.2) 
 
where x is the coordinates of all atoms,  ?⃗? is the velocity of movement of atoms as 
derivative of atomic positions, ?NO⃗
?K
 is their corresponding acceleration ?⃗? or derivative of 
the velocity, and m is the mass. The primary goal of MD simulations is to accurately 
compute macroscopic behaviour from microscopic properties. In classical MD, the 
discretized numerical solution (analytical solution is impossible for large number of 
atoms) to represent the equations of motion can then be obtained as:  
 
𝑥9TD = 𝑥9 + 𝛿K?⃗?9	                                                     (2.3) 
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?⃗?9TD = ?⃗?9 + 𝛿K?⃗?9                                                 (2.4) 
 
where 𝑥9 is the atomic coordinate (position) x at ith step,  𝑥9TD is the atomic coordinate x 
at (i+1)th step, 𝛿K is the integration time step, ?⃗?9 is the velocity at ith step, ?⃗?9TD is the 
velocity at (i+1)th step, and ?⃗?9  is the acceleration at step i. 
 Some common MD software packages are Gromacs,227-229 Amber,230,231 and 
NAMD.232 For the research presented in this thesis, we have used Gromacs MD code to 
perform all simulations. The most common integration method in Gromacs uses the 
leapfrog integrator.233 The atomic positions and velocities are updated in leapfrog 
algorithm as: 
 
𝑥9TD = 𝑥9 + 𝛿K?⃗?9TD/W                                               (2.5) 
 
?⃗?9TD/W = ?⃗?9XD/W + 𝛿K?⃗?9                                             (2.6) 
 
where ?⃗?9TYZ
 is the velocity at step (i+1/2), and ?⃗?9XYZ
 is the velocity at step (i-1/2) (the other 
variables are defined under Eqs. 2.3 and 2.4). Thus, the integration time points between 
velocity and position in this method get interleaved and hence the name, leapfrog. We 
have also used the velocity Verlet234 integrator for some simulations in this thesis, whose 
algorithm is very similar to that of leapfrog, but with velocity and position integrated at 
same time points as shown in Eqs. 2.7 and 2.8: 
 




W                                        (2.7) 
 
?⃗?9TD = ?⃗?9 +
D
W
[?⃗?9 + ?⃗?9TD]𝛿K                                        (2.8) 
 
where 𝑎9TD is the acceleration at (i+1)th step. The other variables are same as in Eqs. 2.3 
to 2.6. 
 In addition to equilibrium MD simulations (EMD), we have also used 
Hamiltonian replica exchange simulations (HREX) with solute scaling in this thesis. 
 - 36 - 
Standard temperature replica exchange MD (T-REMD, also known as parallel tempering) 
simulations have been used extensively to enhance the conformational sampling spaces 
of IDPs.235 Multiple replicas (N copies) of a IDP system, which are non-interacting, are 
usually concurrently simulated at different temperatures (Ti) with periodic 
conformational exchanges between replicas based on Metropolis criterion.236,237 Simply 
put, the Metropolis criterion decides whether a certain conformational exchange is 
accepted or rejected, such that that their transition probability depends only on the change 
in potential energy of the ith copy or replica.  This leads to sampling of structures at higher 
temperatures, which might have been unexplored at physiological temperature (usually 
310K). Finally, the conformations are obtained at physiological temperature to represent 
an ensemble of accurately sampled conformations. However, the number of replicas with 
standard T-REMD method increases with system size as O(f1/2), where f = total number 
of degrees of freedom.238 A suitable method for bypassing the poor scaling of replicas is 
to only sample through parallel tempering the solute (proteins in this case), leaving the 
solvent to be simulated at physiological temperature of interest. This method is known as 
Replica Exchange with Solute Tempering or REST.239 An improved version of REST – 
the more recent Hamiltonian scaling or replica exchange with solute scaling or REST2 is 
found to enhance sampling efficiency greatly.240 This method scales the solute at different 
Hamiltonians (rather than at different temperatures). A Hamiltonian is an operator which 
includes the sum of the potential energies plus the kinetic energies for all the atoms in the 
simulation system. Thus, the Lennard-Jones potential well depths (e) of the protein atoms 




                                                        (2.9) 
 
Where 𝑇[0] is the initial temperature/temperature of interest and 𝑇[𝑖] is the subsequent 
higher temperature, such that higher temperatures have lower l values within a range of 
0 – 1.  
 The choice of performing an EMD simulation or a HREX here depends on the 
sampling requirements of the given system. For e.g., for studies of helical unfolding of 
amyloidogenic peptides (Chapters 3 and 4), modelling helical aS tetramer assembly 
(Chapter 5), and studying profibrillar b-sheet oligomers of Ab (Chapter 6), we have used 
 - 37 - 
EMD, as reaching a thermodynamic equilibrium (for obtaining equilibrium related 
properties typical to a real system) would satisfy adequate sampling from a structured 
protein. However, for systems starting with an IDP structure, like in Chapter 4 here, we 
have used HREX to validate the sampling space generated by traditional EMD, which 
requires extensive sampling for long timescales in order to reach convergence. For all the 
research Chapters presented in this thesis, we perform equilibration in canonical 
ensemble (number of particles, volume and temperature are conserved, NVT), followed 
by equilibration in isothermal-isobaric ensemble (number of particles, pressure and 
temperature are conserved, NPT), and finally production simulations in NPT ensemble. 
 
2.1.1. Force field parameters 
I have provided a detailed discussion on the force fields (specifically for IDPs) and 
explicit water models under Chapter 1, section 1.9. Protein force field and water model. 
Some of the popular force fields are Amber,192 CHARMM,193 GROMOS,194  and OPLS-
AA195 as I have discussed earlier. Here, I will briefly highlight the formalism of empirical 
force fields used in protein simulations. Atomistic force fields use the potential energy 
functional form to describe several properties of biomolecular systems. The formalism of 
a standard force field parameters can be simply expressed as: 
 
𝑈(𝑥) = 𝑈bcd?e? + 𝑈dcdXbcd?e?                                       (2.10) 
 
where U(x) is the potential energy function of all interactions within the system, Ubonded 
is the potential energy of bonded interactions, Unon-bonded is the potential energy of non-
bonded interactions. Bonded interactions include bonds, angles, proper dihedral angles 
and improper dihedral angles, while the non-bonded interactions include long-range 
electrostatic (coulomb) and van der Waals (vdW): 
 
𝑈bcd?e? = 𝑈bcd?f + 𝑈gdhief + 𝑈jkcjekf + 𝑈9Qjkcjekf = ∑ 𝐾b(𝑏 − 𝑏_)Wbcd?f +
∑ 𝐾n(𝜃 − 𝜃_)Wgdhief + ∑ ∑ 𝐾pq1 + 𝑐𝑜𝑠(𝑁𝜒 − 𝛿)uBjkcjekf + ∑ 𝐾v(𝜙 − 𝜙_)W9Qjkcjekf      
 (2.11) 
𝑈dcdXbcd?e? = 𝑈wcxicQb + 𝑈N?y = ∑
>@>A
z{|}k@AwcxicQb









N?y   
(2.12) 
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where åbonds, åangles, åpropers, åimpropers, åcoulomb and åvdw represent the summation of 
potential energies of covalent bond stretching that do not allow bond breaking, bond 
angles, proper dihedrals, improper dihedrals, coulomb’s electrostatic interactions and van 
der Waals (vdW) interactions, respectively. The first term in Eq. 2.11 represents covalent 
bonded interactions between two atoms. A harmonic potential 𝐾b (force constant) 
determining the strength of the bond is used with 𝑏 and 𝑏_ being the bond distance and 
the equilibrium bond distance, respectively. The bonded force constant is a classical 
harmonic oscillator (see Fig. 2.1) here, which ensures that covalent bonds can only be 
stretched, but can never be broken. The second term represents the bond angles, where 
Kq is the force constant, and 𝜃 and 𝜃_ are the angles and the equilibrium angles, 
respectively formed between three covalently bonded atoms. The third term represents 
the proper dihedral angles (𝜒), or angles formed between planes through two sets of three 
atoms. 𝐾p  is the force constant here, d is the phase angle and N is the bond multiplicity. 
The fourth term represents improper dihedral angles (𝜙), which are torsion angles 
between four atoms not sequentially bonded. A harmonic potential or force constant 𝐾v 
is applied with the equilibrium angle 𝜙_. Improper torsion angle helps maintain the 
shapes of planar groups, such as aromatic rings. Thus, the difference between proper and 
improper dihedrals is that proper dihedrals holds together the opposite ends of a bond, 
while improper dihedrals wraps on the same end of a bond.  
 In the CHARMM193 force field, an additional Urey-Bradley (UB) potential202 
(harmonic term) is added on top of the bond and angle potential, introducing a virtual 
bond, and further restraining the atomic motions. The UB potential is a cross-term that 
accounts for the angle bending using 1 – 3 non-bonded interactions. Another term added 
on top of the dihedral terms for the CHARMM force field is the CMAP203 (initially 
introduced in CHARMM22241 force field) correction. CMAP is a cross-term for the 
backbone dihedrals and are grid-based energy correction maps to improve the 
conformational properties of protein backbones. Thus, the energy function of the 
CHARMM force field includes two additional terms, and can be represented as: 
𝑈(𝑥) = 𝑈bcd?e? + 𝑈dcdXbcd?e? + ∑ 𝐾q𝑏DX − 𝑏DX,_u
W
keXkg?ie +
∑ 	𝜇(𝜙, 𝜓)                                                                            
 (2.13) 
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where åUrey-Bradley and åCMAP are the summation of potential energies of Urey-Bradley 
term and CMAP term, 𝐾 is the Urey-Bradley force constant, 𝑏DX is the distance 
between atoms 1 and 3 in the harmonic potential and is introduced on a case by case basis 
during the final optimization of vibrational spectra, 𝑏DX,_ is their corresponding 
equilibrium distance, and 𝜙 and 𝜓 are the backbone dihedral angles. 
 
 
Fig. 2.1. Harmonic potential for bonded interactions showing that the equilibrium bond 
length b0 corresponds to the minimum potential energy.  
 
 
 The non-bonded potentials (Eq. 2.12) are further decomposed into two terms: the 
coulombic or the electrostatic potential and the vdW or the Lennard-Jones (LJ) potentials.  
The first part, Ucoulomb calculates the non-bonded partial charge-charge interaction 
between atoms i and j, where e0 is the permittivity of the free space. The second part, Uvdw 
or LJ potentials242 approximate interactions between pairs of neutral atoms. It is 
sometimes referred to as vdW potential as the second attractive term (sixth power) 
represents long-range vdW dispersion interactions, while the first repulsive term (twelfth 
power) represent short range interactions based on Pauli exclusion principle of orbital 
overlap. This 12-6 form of LJ potentials is widely used in MD simulations, due to their 
ease of implementation and computation, and for their ability to well describe the vdW 
interactions in molecular systems. rij is the distance between interacting atoms, rij,0 is the 
distance between the atoms at potential energy minima or the atomic radius in the LJ 12-
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6 term, and eij is the potential well depth (see Fig. 2.2). These bonded and non-bonded 
potential functions need to be parametrized separately for different force fields.  
 
 
Fig. 2.2. Lennard-Jones (LJ) potential for non-bonded interactions showing the regions 
of repulsive (12th power) and the attractive (6th power) forces. The strength of the 
interaction is given by the potential well-depth eij, which corresponds to the minimum 
interatomic distance rij,0. 
 
 
 Most improvements in recent force fields (and water models) for IDPs (discussed 
in Chapter 1) are based on corrections or scaling in the protein-water212,213 or water-
water214 LJ potentials or backbone potentials215. I have discussed the nuances of model 
parametrization in these newer force fields and water models under section 1.9.1 
Specialized force fields and water models favouring IDPs in Chapter 1. Here, I will 
summarize the specific corrections made in these ‘IDP-friendly’ physical model 
parameters. The first, the ‘balanced’ force field named Amber ff03ws213 was 
parametrized by scaling the LJ e parameter between all protein atoms represented by 
Amber ff03w force field and oxygen atom represented by TIP4P/2005 water model by a 
factor of 1.10, selected by precise benchmarking against experimental SAXS and FRET 
measurements, such that: 
 
𝜀9 = 𝛾𝜀9 = 𝛾(𝜀𝜀9)D/W                                       (2.14) 
 
where 𝜀9 is the LJ 𝜀 parameter between water oxygen O and all protein atoms i, as shown 
in second non-electrostatic term of Eq. 2.12,  𝜀 and 𝜀9 are the LJ on the water oxygen 
and  atom i, 𝜀9is the result obtained by the Lorentz-Barthelot (LB) combination rule,243 
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g is the adjustable scaling parameter found optimal in this case, i.e. 1.10. The second, the 
dispersion corrected water model named TIP4P-D214 was parametrized by increasing the 
weakly interacting London dispersion (induced dipole-induced dipole attractions, sixth 
power) water-water interactions by ~50% over standard TIP3P water model, while 
retaining the geometry of four-site TIP4P/2005 water model. This is achieved by 








                                                  (2.15)  
 
where  𝑉 is the 12-6 type of LJ potential, C12  and C6 are the repulsive  and the attractive 
coefficients, respectively, and r12 and r6 are the distances to the twelfth and sixth powers 
corresponding to repulsion and attraction, respectively. In TIP4P-D, the C6 dispersion 
coefficient of water-water interaction is scaled over standard water model to reduce the 
protein-water interaction dispersion error to a minimum, with precise benchmarking from 
experimental NMR and SAXS data. Finally, the force field with improved backbone 
torsion potentials named CHARMM36m215 was parametrized by optimization of the grid-
based CMAP (fourth term in Eq. 2.13) potential over the standard CHARMM36 force 
field. This optimization was inspired by the fact that previous CHARMM36 force field 
was shown to sample an unusually high content of non-natural left-handed a-helices. 
Thus, the goal was to minimize perturbation of the current CMAP potential energy, E, 
that would potentially reduce the left-handed a-helix sampling to a desired value. Thus, 
the target function that required minimization is: 
 
𝐸 = 𝑘𝑇	𝑙𝑛𝑃 + 𝑤𝑅𝑀𝑆                                      (2.16) 
 
where P is the probability of ensembles sampling left-handed a-helix, w is the adjustable 
weighting factor, and RMSCMAP is the root mean square difference between the two 












            (2.17) 
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where m = n are the two dimensions of the CMAP potentials. Given a force field 
parameter set l, the ensemble average of certain property A under a new parameter set 
(l+Dl) obtained by reweighting is computed as: 
 
〈𝐴¢T∆¢〉 = 〈𝐴¢𝑒X¦(§¨©ª¨X§¨)〉/〈𝑒X¦(§¨©ª¨X§¨)〉                            (2.18) 
 
where Eλ and Eλ+Δλ are the potential energies with parameters λ and λ+Δλ for each 
sampled conformation, and β is the reciprocal of the thermodynamic temperature. The 
probability associated with a certain CMAP for the left-handed a-helices, can then be 
calculated by the reweighting equation: 
 







                                               (2.19) 
 
where n is the number of frames, hi is the binary which is equal to 1 if the ith conformation 
samples left-handed a-helix and is equal to 0 if it samples different conformation, and 
∆𝐸9 is the change in potential energy associated with the modification done by 
CMAP at the ith conformation. A simulated annealing simulation is then combined with 
Eq. 2.19 to obtain the optimized CMAP potential. 
 
2.1.2. Periodic boundary conditions 
For fully atomistic simulations, the system usually consists of protein, water and ions. 
The water is used for fully solvating the protein in a box. The water box in this case needs 
to be big enough in size so that it does not allow the protein molecule to move out of the 
box. However, realistically speaking, this is impossible, especially in case of IDPs, where 
the protein is so fluctuating. Thus, bigger the size of the simulation box, greater the 
computational cost and time. In order to simulate the bulk of the system accurately at 
decreased computational cost, simulations usually employ boundary conditions that give 
an impression that the bulk phase is infinite by forming a periodic image on the opposite 
side of the box. This is known as periodic boundary condition or PBC and is applied to 
all our MD simulations. PBCs need the unit cell to be such a shape that it can tile perfectly 
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into a three-dimensional crystal. Thus, a spherical or elliptical shape cannot be used. 
A cubic or rectangular cell is commonly used in simulations. Further PBCs require to be 
carefully applied such that there is no direct interaction between the protein and its 
periodic image, which could lead to simulation artefacts. In our simulations, we have 
applied PBC in such a manner that there is at least a gap or padding of 15 Å between the 
protein molecule and each edge of the periodic box. 
 
2.1.3. Long range interactions 
Calculation of long-range non-bonded interactions (especially electrostatic interactions, 
as the vdW forces decay quickly from Eq. 2.12) in MD simulation is necessary, but a 
time-consuming and resource-hungry process, since the number of calculations increase 
as the square of the number of atoms. In this context, a suitable approach is to set cut-off 
distances, such that only interactions within that cut-off would be computed. This is 
sometimes achieved by applying a switching function. However, applying cut-offs would 
mean that some ‘important’ interactions may be missed out. A better method to include 
all possible interactions is the Ewald summation,244 where the long-range interactions are 
divided into short-range (direct space) and long-range (reciprocal space) contributions. 
To apply the Ewald method, the system under consideration needs to be periodic. Thus, 
PBC must be applied to simulations. In a system with applied PBC, the coulomb 
electrostatic part of the non-bonded potential energy can be computed245 as: 
 
𝑈wcxicQb = 𝑈ww + 𝑈bw + 𝑈bb                                      (2.20) 
 
where 𝑈ww is the inter-particle interaction energy, 𝑈bw is the interaction energy between 
the charges and the background charge density, and 𝑈bb is the interaction energy between 
the uniform background and itself. The lattice sums in Eq. 2.20 are then converted into a 
rapidly converging sums of real-space sums (𝑈k), reciprocal Fourier-space sums (𝑈µ), 
and a constant term (𝑈_), such that, 
 
𝑈wcxicQb = 𝑈k + 𝑈µ + 𝑈_                                       (2.21) 
 
where                                 𝑈k =
D
W





9CDd                               (2.22) 








𝑄µ𝑄µ∗¹µ                                    (2.23) 
 






                                            (2.24) 
  
where 𝑁 in Eqs. 2.22 and 2.24 is the number of particles in the system, 𝑛 in Eq. 2.22 
represents periodic images of the simulation cubic lattice with edge length L(n = (n1, n2, 
n3)L, where n1, n2 and n3 are integers, 𝜂 is the Ewald parameter, Ω in Eqs. 2.23 and 2.24 
is the volume of the system, 𝑄µ in Eq. 2.23 is the charge density of the reciprocal lattice 
vector (𝑘 = 2𝜋(𝑘D, 𝑘W, 𝑘)/𝐿, with 𝑘D, 𝑘W and 𝑘 being integers), 𝑈_ in Eq. 2.24 includes 
a self-term and a correction term. A variant of the Ewald summation method known as 
the Particle Mesh Ewald246 (PME) is used in most MD simulation packages (like Gromacs 
used in this work) to treat long-range electrostatics. In the case of PME, the particles are 
interpolated by using a grid instead of direct summation of interaction energies between 
point charges. Fast Fourier transformation algorithm is used to treat the long-range part 
of interactions in grid. 
 
2.1.4. Thermostats and barostats 
As mentioned earlier, thermostats (for temperature coupling) apply to canonical (constant 
number of particles, volume and temperature) or NVT and isothermal-isobaric (constant 
number of particles, pressure and temperature) or NPT ensemble (but not 
microcanonical), while barostats (for pressure coupling) apply to only isothermal-isobaric 
or NPT ensemble, which is an ideal ensemble to simulate production runs. For all NVT 
and NPT equilibration runs in this thesis, we have used the Berendsen thermostat247 
implemented in Gromacs, which rescales the velocity of atoms with coupling to the 
temperature. To maintain the temperature of the system, the Berendsen thermostat 
facilitates weak coupling to an external heat bath. This weak coupling with first order 
kinetics ensures slow relaxation of the temperature to a desired value (usually 
physiologically relevant 310K). This is of utmost importance during equilibration 
simulations, where the water molecules around the constrained protein need to be well 
relaxed before production simulations. At each simulation step, the velocities are scaled 
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in such a manner that the rate of change of temperature is proportional to the difference 






                                                      (2.25) 
 
where 𝜏 is the time constant or coupling parameter that determines how tightly the bath 
and the system are coupled for an exponential decay of the temperature deviation, 𝑇_ is 
the fixed (desired) temperature in the heat bath, while 𝑇 is the temperature at time stamp 




(𝑇_ − 𝑇)                                                (2.26) 
 
where 𝛿𝑡 is the integration step. The scaling factor (𝜆) for the velocities can then be 
computed as: 
 




− 1Ê                                         (2.27) 
 
where 𝑡 − ÆK
W
  is the time integration for the leapfrog algorithm. An issue with the 
Berendsen thermostat is that it suppresses the fluctuations in the kinetic energy, which 
hampers the true ensemble generation in NPT production runs. Therefore, for production 
simulations, we have used the velocity rescaling248 thermostat. The velocity rescaling 
thermostat is a modified algorithm of the Berendsen method with an additional stochastic 
term, which ensures correct distribution of the kinetic energy, such that: 
 








                                  (2.28) 
 
where 𝐾 is the kinetic energy, 𝐾_ is the equivalent kinetic energy, 𝑁¶ is the number of 
degrees of freedom, 𝑑𝑊 is a Wiener process, which is the continuous-time stochastic 
process, and 𝜏^ is the temperature coupling time constant. 
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 On the other hand, pressure coupling in NPT equilibration was achieved using 
Berendsen barostat.247 Similar to the Berendsen thermostat, the Berendsen pressure 
coupling algorithm rescales both the coordinates and box vectors with a first-order 
kinetically slow relaxation of the pressure via coupling to a reference constant pressure 
bath. The slow relaxation allows enough freedom for the water molecules to move and 






                                                    (2.29) 
 
where 𝑃 is the pressure at time 𝑡, 𝑃_ is the desired reference pressure, and 𝜏j is the 
pressure coupling time constant. Thus, the box vectors (volume and the coordinates) can 
be rescaled at every pressure coupling step (𝜂) with a scaling matrix (𝜇9:): 
 
𝜇9: = 𝛿9: −
·²¯∆K
ÃÑ
𝛽9:Ó𝑃_9: − 𝑃9:(𝑡)Ô                               (2.30) 
 
where 𝑖 and 𝑗 correspond to the two-dimensional box vector directions such as xx, yy, zz, 
xy, yz and xz, 𝑃_9: is the reference pressure, 𝑃9:(𝑡) is the pressure at time 𝑡, and 𝛽9: is the 
isothermal compressibility of the system. For water at 1 atm pressure (used in Gromacs) 
and 300 K, 𝛽 = 4.6 × 10XD_	𝑃𝑎XD = 4.6 × 10XÙ	𝑏𝑎𝑟XD. For an isotropic system having 
cubic box, 𝛿9: = 1. However, the Berendsen algorithm is not a suitable method for 
pressure coupling in NPT production simulations, as the approximation does not yield an 
exact NPT ensemble of the protein in question. Especially, calculation of thermodynamic 
properties of proteins necessitate fluctuations in pressure in addition to volume, which 
the Berendsen pressure coupling cannot provide precisely due to the weak coupling. In 
this regard, a true NPT ensemble can be generated using the Parrinello-Rahman 
barostat.249 The box vectors can be represented by matrix b that follows the matrix 




= 𝑉𝑊XD𝑏¹XD(𝑃 − 𝑃ke¶)                                    (2.31) 
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where  𝑉 is the volume of the box, 𝑊 determines the strength of the coupling, 𝑃 and 𝑃ke¶ 
are the pressure at time 𝑡 and the reference pressure, respectively, and 𝑏¹ is the transpose 
of the box vector matrix 𝑏. Thus, the equation of motion of particles with the Parrinello-








                                                (2.32) 
 




𝑏′Ý 𝑏′XD                                      (2.33) 
 
where 𝑟9, 𝐹9  and 𝑚9 are the coordinates, force acting and mass at ith position. Finally, the 






                                                 (2.34) 
where 𝐿 is the largest box matrix element. 
 
2.2. Free energy calculations 
Free energy here refers to the thermodynamic free energy, which estimates the 
thermodynamic work done by thermal energy (constant temperature). In statistical 
mechanics, free energy can be calculated as Helmholtz free energy,250 which is obtained 
by evaluating integrals consisting of Hamiltonians. However, in atomistic MD 
simulations, such integrals are difficult to solve as the high energy regions are not often 
sampled. Therefore, the most common free energy calculated from MD data is the Gibbs 
free energy (G),251 which can be simply expressed as: 
 
𝐺 = 𝐻 − 𝑇𝑆                                                     (2.35) 
 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆                                                 (2.36) 
 
where H is the enthalpy in Joules or Calories of the simulated system, T is the temperature 
in kelvin, and S is the entropy in joules or calories. When calculating protein-protein (or 
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ligand-protein) binding free energies, the Gibbs free energy change (DG) due to binding 
is calculated, along with entropy (DS) and enthalpy (DH) differences.  
 There are several methods to calculate Gibbs free energy from MD simulation 
data. For this thesis, we have used two methods to calculate free energies (and binding 
free energies): molecular mechanics energies combined with the Poisson–Boltzmann 
continuum solvation252,253 (MM/PBSA) implemented in Amber 12230,231 program and as 
g_mmpbsa254 integrated in GROMACS,227-229 and Generalized Born using Molecular 
Volume (GBMV) implicit solvent model employing the GBMV II algorithm,255-257 and 
implemented in the CHARMM (v40b2) program.193 Both these methods employ 
continuum solvation or consider the water implicitly, which significantly reduces 
computational resources and time. MM/PBSA is used in Chapters 3 and 6, and GBMV is 
used in Chapter 5 to calculate protein only conformational energies. GBMV is used in 
Chapter 5 and MM/PBSA is used in Chapter 6 to calculate binding free energies. 
Additionally, the protein only conformational entropy was estimated in Chapter 3 by 
normal mode analyses258 also implemented in Amber 12 through MM/PBSA. A step by 
step calculation of both conformational and binding free energies (with their 
corresponding decomposed energy terms) is given as follows: 
 
Conformational (free) energy 
  
𝐺/à 	= 	𝐺NgwxxQ 	+	𝐺fciNgK9cd                                 (2.37) 
where GMM/PBSA is the free energy calculated by MM/PBSA method (same energy 
decompositions apply to GBMV method as well), Gvacuum is the free energy in vacuum/gas 
phase, which could be further expressed as:  
𝐺NgwxxQ 	= 	𝐸	– 	𝑇𝑆                                            (2.38) 
TS is the entropy contribution, where T is the absolute temperature and S is the 
configurational entropy. EMM is the molecular mechanics potential energy, which could 
further be broken down as: 
𝐸 = 	𝐸bcd?e? 	+	𝐸N?y 	+	𝐸eiew                               (2.39) 
where Ebonded is the covalent bonded interaction energy including bond, angle and dihedral 
energy terms, EvdW is the van der Waals interactions described by the Lennard-Jones 
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potential function, and Eelec is the electrostatic interactions described by the Coulomb 
potential function.  
Gsolvation is the solvation free energy comprised of two terms259,260 expressed as: 
𝐺fciNgK9cd 	= 	𝐺jcigk 	+	𝐺gjcigk                                (2.40) 
where Gpolar is the electrostatic contribution to solvation and is obtained by solving the 
Poisson-Boltzmann (PB) equation;261 Gapolar is the nonpolar contribution and is estimated 
from a linear relation to solvent accessible surface area (SASA) as: 
𝐺gjcigk 	= 	𝛾. 𝑆𝐴𝑆𝐴	 + 	𝑏                                      (2.41) 
where g is a coefficient set to the surface tension of the solvent and b is a fitting parameter. 
The conformational energy EMM/PBSA is the molecular mechanics potential energy in 
vacuum and the solvation free energy, and is expressed as: 
𝐸/à 	= 	𝐸 	+	𝐺fciNgK9cd                               (2.42) 
 
Binding (free) energy 
 
∆𝐺b9d?,fciN 	= 	∆𝐺b9d?,NgwxxQ 	+	∆𝐺fciN,wcQjieJ	–	q∆𝐺fciN,QciD 	+	∆𝐺fciN,QciWu            
(2.43) 
 
where DGbind,solv is the total binding free energy in water, DGbind,vacuum is the binding free 
energy (molecular mechanics energy = electrostatic energy + vdW energy) in vacuum, 
DGsolv,complex is the solvation free energy of the complex comprising molecule 1 (protein 
or ligand) and molecule 2 (protein or receptor), DGsolv,mol1 is the solvation free energy of 
molecule 1, DGsolv,mol1 is the solvation free energy of molecule 2. 
 
∆𝐺fciN 	= 	∆𝐺jcigk 	+	∆𝐺gjcigk                                      (2.44) 
 
DGpolar is the polar component of solvation energy containing the electrostatic terms, and 
DGapolar is the nonpolar component of solvation energy. 
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2.3. Dynamic cross-correlation network analysis 
Networks are usually defined as a set of binary interacting entities (nodes or vertices) 
connected by links (edges or lines) showing relations between them, and are based on the 
formalisms of graph theory.262 In a crowded cellular environment, many biological 
macromolecules have to function by interacting with each other.263 Thus, understanding 
the mechanisms at the cellular level necessitates delineating the interacting network 
structures of biomolecules.264 Protein-protein interaction (PPI) networks have been 
exceptionally useful in identifying functional and disease related states of the cell.265-267 
Interestingly, due to their innate promiscuity (multiple specificity to bind many partners), 
IDPs are usually found to form hubs in PPI networks.268 Several algorithms for biological 
network analyses exist based on the level of cellular organization and the type of 
predictive model desired.269 Among these, Dynamic Network Analyses (DNA) have 
emerged as a powerful tool to identify functionally relevant intra-peptide residue-residue 
interactions within proteins or protein complexes.270-272 Especially, DNA models have 
served greatly to account for allostery and signalling regulation within proteins and 
enzymes.273 As such several variants of the DNA method exists. 
 For the research presented in Chapter 4, we have used a variant of DNA called 
dynamic cross-correlation network analysis (DCCNA) to investigate intra-peptide 
allosteric communications in Ab42 and aS (see 4.2. Methods). DCCNA274 method 
designed by Grant and group is a modified version of the originally developed DNA 
method275 by Luthey-Schulten and group and included in the R package Bio3D.276,277 The 
modification in the DCCNA method is that it uses multiple correlation matrices derived 
from the input ensemble instead of contact maps, and the network edges are weighted 
based on the Ca-Ca cross-correlation values to include long-range interactions between 
residues that are not in direct contact. Here, I will describe very briefly how the method 
works. It is simple to implement, and have been discussed further under section 4.2 in 
Chapter 4. Simply put, DCCNA can be divided into two parts: generating network model 
and path analysis. 
 
Generating network model. The first step in generating a cross-correlated network model, 
is defining the nodes and the edges. Nodes are usually represented by each residue in a 
protein centralized on the Ca atoms. This gives an overall coarse-grained representation 
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of the system rather than considering all atoms, which significantly decreases 
computational time and complexity. A pair of nodes or residues are annotated i and j. The 
linear displacement of the atoms from MD simulation data are then implemented to 











                                       (2.45) 
 
where â𝜎9:ä
 is the 3X3 residue-residue sub-matrix of the 3NX3N (i and j represent all 
3N Cartesian coordinates, and N is the number of atoms), covariance matrix for 
fluctuations between residues i and j,  [𝜎99] is the 3X3 diagonal sub-matrix for residue i, 
â𝜎::ä
 is the 3X3 diagonal sub-matrix for residue j, and Tr(.) is the trace (sum of the 
eigenvalues or elements in the main diagonal) of the matrix. Next, the network edges are 
constructed based on the minimum Ca-Ca cross-correlation (𝑐9:) value between all 
residues. While generating a consensus network, as in our case, these cross-correlations 
are usually computed following mass-weighting superposition of MD trajectories. Then, 
the network edges are ‘computed’ based to pair of nodes based on specific criteria. These 
criteria may differ based on the type of biomolecular system, but may generally follow a 
scheme where residue pairs above a certain threshold of 𝑐9: (0.4 in our case) is considered, 
and network similarity between certain 𝑐9: ranges (usually three values) is taken into 
account, and the middle value is selected. Network similarity is assessed by the 
community (group of similarly fluctuating nodes forms a community generated by 
hierarchical clustering) structure and eye estimation of network graphs. For a step by step 
R script written for this part, refer to section B1 under Appendix B. 
 
Note: The Pearson Correlation Coefficient (P.C.C.) calculated between the overall 
conformational energy and the domain-domain interaction energy, and between back-
calculated (from simulations) and experimental NMR values in Chapter 3 (between two 
series of values) differs slightly from the Pearson inner-product cross-correlation above. 
Given paired data {(𝑥D, 𝑦D), …	, (𝑥d, 𝑦d)} consisting of 𝑛 pairs, P.C.C. (𝑟J) can be 
obtained by substituting estimates of covariances and variances on a sample, such that: 
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                                          (2.46) 
 
where 𝑛 is the sample size, 𝑥9 and 𝑦9 are the individual sample points, ?̅? and 𝑦ì are the 
sample means, and 𝑖 is the index point. 
  
Path analysis. After the network model or structure is generated, the ‘optimal’ (most 
visited and shortest) and ‘sub-optimal’ (subsequent paths longer than optimal) paths 
connecting nodes need to be calculated. This is achieved by annotating particular “source 
and sink residue pairs” (pairs of residues between which all traversing paths will be 
calculated), and generating the optimal and suboptimal paths using the K shortest loopless 
path algorithm.280 Then, other properties from the network paths (see Chapter 4 for 
detail), such as normalized network node degeneracies, and path length distributions can 
be estimated to give an overall picture of dynamic coupling between residues. Node 





∑ 𝐴9:𝑥::íî                                                (2.47) 
 
where xi is the centrality of node i, xj is the centrality of node j, Aij is the ith and jth entry 
of the adjusted adjacent matrix A, λ is a constant to be determined and G is the set of all 
nodes. Using the above equation (Eq. 2.47), one can calculate the eigenvalues and 
eigenvectors of A. Then, the eigenvector corresponding to the largest eigenvalue gives 
the node centralities. For an example R script written for this part, refer to section B2 
under Appendix B. 
 
2.4. Analysis of simulation data 
2.4.1. Convergence of simulation 
The initial assessment of the statistical quality of sampling in all-atom MD simulation is 
done through convergence test. Simply speaking, one has to determine how long 
(simulation time) the simulations should be performed before a certain property must 
reach a stable state. There are several methods to assess convergence of a given 
 - 53 - 
simulation data or at least check for self-consistency.281 Below I discuss only the methods 
that are used for the research presented in this thesis: 
 
Bootstrapped block covariance overlap method. In the Block Covariance Overlap 
Method282 (BCOM), the trajectories are divided into temporally equal block sizes or 
chunks. The Principal Component Analyses (PCA) is then calculated for each block on 
the conformational matrix (of backbone atoms), and the covariance overlap is estimated 
between the blocks and the full trajectory. The whole process is iterated for blocks of 
temporally increased sizes. The difference between BCOM and Bootstrapped Block 
Covariance Overlap Method (BBCOM) is that BBCOM uses a bootstrapping procedure 
in which the trajectory frames are selected randomly rather than contiguously, enabling a 
more robust assessment of convergence. The covariance overlap method283,284 assesses 
both similarities in eigenvectors and eigenvalues, which are the directions of atomic 
motion and their relative significance respectively. These values range from 0 to 1 scaled 
according to their similarities in fluctuations, with 0 being the least and 1 being most 
similar. The covariance overlap between two PCA of ensembles A and B (Ω,) can be 
expressed as282: 






















	          (2.48) 
 
where  Nmodes is the number of most significant modes for (backbone) atomic fluctuations 
obtained from PCA, 𝜆9 is the ith eigenvalue from ensemble A,  𝜆9 is the ith eigenvalue 
from ensemble B,  𝜆: is the jth eigenvalue from ensemble B,  𝑣úOOOO⃗  is the ith eigenvector from 
ensemble A, and 𝑣ûOOOO⃗  is the jth eigenvector from ensemble B. For this work, the Lightweight 
Object-Oriented Structure Library (LOOS)285 was used to perform BBCOM. 
 
Fraction of native contacts. Fraction of native contacts or Q assesses the property of 
retainment of contacts in the native folds of proteins as a function of time. This method 
was designed by Best, Hummer and Eaton286 to show that Q is a good folding coordinate 
for atomistic simulations. We have used this method for testing convergence in a-helical 
monomers and tetramers of aS and cross-b sheet profibrillar oligomers of Ab. However, 
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as the native state of IDPs is disordered and fluctuating, this method is not suitable for 
assessment of convergence of these peptides in their IDP state without any secondary 
structure in the native state. The fraction of native contact for configuration X, Q(X) can 







                                  (2.49) 
 
where N is atoms (i, j), which are in contact if the distance between them is less than 5 Å 
and are separated by at least 3 residues. rij(X) is the distance between i and j in 
conformation X and r0ij is the distance in the native state. β is a smoothening parameter 
taken as 5 Å-1 and λ is a factor that describes fluctuations when the contact is formed, 
taken to be 1.8 for all-atom models. The details of this method is provided in ref 286. 
 
Cumulative averages of secondary structure content. As opposed to block averages 
(discussed in section 2.5) which compute averages for a time interval or blocks of time, 
cumulative averages calculate average property at every time stamp of simulation, such 
that each sliding averaged property over the time interval is computed. In other words, 
cumulative averages are moving averages of equally weighted series of measurements up 





                                          (2.50) 
 
where x1, x2, x3, …, xn are measurements of the property in question up to n number of 
values. We have used this method to assess the convergence of secondary structure 
content (such as a-helical percentages) in this thesis. 
 
2.4.2. Estimation of error 
The procedure for estimating standard error of mean (Eq. 2.51) would not apply to the 
data (measured properties: properties analysed for this research are detailed in Chapters 
3-6) generated by MD simulations, as these are highly correlated data having a sparse 
population distribution, and would lead to underestimation of the actual error.287 
 







                                            (2.51) 
 
where 𝜎J̅ is the standard error of mean, N is the number of conformations in the trajectory, 
𝑥9 is the value of the data generated for each conformation by simulation having a mean 
value of ?̅?. In light of the above shortcoming, we have employed the block averaging 
procedure225,288,289 for error estimation in our MD simulation data. Block averaging is a 
simple method to implement for time-correlated trajectories (as in our case), where first 
the total time of simulations performed is divided into N blocks of equal size 𝜏b such that, 
 
𝜏f9Q = 𝑁𝜏b                                                    (2.52) 
 
where 𝜏f9Q is the total time of simulation performed. The average measured property for 







9CD                                                 (2.53) 
 
where 〈𝐴〉b	is each block average comprising the measured property in the ith block, 𝐴9. 
The 〈𝐴〉b tends to become more independent (being initially correlated with small block 
sizes) as the block size (𝜏b) is increased. The idea here is to find the limit or threshold 
when the measured properties pertaining to trajectory conformations become 
uncorrelated or independent, so that a suitable block size can be selected for computing 
errors. Thus, the variance of the mean (𝜎〈〉$
W ) in the measured average property of each 





∑ (〈𝐴〉b − 〈𝐴〉f9Q)WBbCD                                     (2.54) 
 
where  〈𝐴〉f9Q is the average property of the entire simulated ensemble. From here on, the 







Z                                                   (2.55) 
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where 𝜎W is the variance corresponding to the property A. Finally, from this threshold 
value s (which is basically the block size, 𝜏b corresponding to first uncorrelated data), the 
error (𝜎〈〉ø@ô) can be estimated as: 
 





Z                                             (2.56) 
 
where M is the number of steps used in simulation, and 𝜎 is the standard deviation of the 
property A. Therefore, the error calculated by blocking procedure is actually the standard 
deviation of the mean of block averages or square root of the variance of block averages. 
 
2.5. Validation of simulation data with NMR experiments 
As I have discussed in Chapter 1 of this thesis, comparing de novo MD simulation data 
of IDPs with the corresponding experimental NMR measurements is the standard 
procedure to validate the accuracy of ensemble. Since we assume ergodicity116 (ensemble 
average = time average) in MD simulations, the average NMR measurements that are 
back-calculated from simulations should correlate well with average NMR observables 
obtained from experiments, subject to the MD ensemble being close to representative. In 
Chapter 1, I have described methods to obtain some common NMR observables such as 
chemical shifts (CSs), 3JHNHa coupling constants, and residual dipolar coupling (RDC) 
constants. To reiterate, we have predicted these values from our simulations by using the 
program SHIFTX2123 for CS, MDTraj290 employing Karplus equation128,129 (refer to Eq. 
1.1 under Chapter 1) for J-coupling constant, and the PALES125 program for RDC 
constants. The error in all back-calculated observables were estimated by the method 
described in section 2.4.2 in this Chapter. A detailed description of how these 
methods/software work is given under section 1.5.1. Conventional modelling 
approaches, shortcomings and recent improvements in Chapter 1. 
 For the peptide monomers investigated in Chapter 3, the secondary CS were 
calculated by subtracting the predicted random coil CS values (obtained through 
CamCoil291) from the back-calculated/experimental CS values: 
 
𝛥𝛿	 = 	𝛿cbfekNe?	–	𝛿kgd?cQ	wc9i                                    (2.57) 
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where Δδ is the respective atoms’ secondary CS, δobserved is the primary CS calculated 
either from simulations or obtained from experiments, and δrandom coil is the predicted 
random coil CS from CamCoil. The secondary CS is sensitive to the IDP secondary 
structures, e.g., a positive Ca secondary CS denotes a-helical structures, whereas a 
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As discussed in Chapter 1, a central challenge in amyloid research is the identification 
and characterization of key pathological intermediates involved in the early stages of 
amyloidogenic assembly.64 It is now well-documented through in vitro experiments and 
simulations that the native monomeric conformations of these amyloidogenic peptides – 
although predominantly disordered (IDPs) – might undergo several conformational 
transitions posing folded states that transiently populate the ensemble, but with residence 
times commensurate to aggregation competence, before leading up to formation of the 
full blown cross-b fibrils.99 These intermediate states might range from simple monomers 
to small soluble low molecular weight oligomers (mostly toxic) to higher-order 
oligomers. One of the least understood features in the field of amyloid research for a long 
time has been the contribution of helical intermediates in modulating the aggregation of 
amyloidogenic proteins.292  
 Although the diseases pathogenicity of amyloidogenic peptides are commonly 
associated with assembly of soluble oligomers rich in b-sheet content,293 including 
amyloid-b (Ab) in Alzheimer’s disease (AD),43 and α-synuclein (αS) in Parkinson’s 
disease (PD),294 an increasing body of evidence have pointed towards formation of on-
pathway α-helical oligomers in the early stages of aggregation.160,292,295-301 These locally 
folded monomeric intermediates might undergo early oligomerization through helix-helix 
associations (studied in Chapter 4). At the other extreme, fully folded stable helical 
conformers have also been reported to resist amyloid formation.302 One hypothesis is that 
intermediary helical states might populate the initial lag phase and subsequently transition 
to b-sheet oligomers and pre-fibrillar aggregates that accumulate downstream to form 
mature fibrils.292,301 Aggregation of both Ab and aS has been shown to involve a-helical 
oligomers,160,296-299 potentially formed by association of partially helical monomers,296 
suggesting that stabilization of predominantly α-helical monomers300 may reduce the pool 
of toxic intermediates for amyloidogenesis. 
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 The detailed conformational and pathogenic features of Ab have been extensively 
discussed in Chapter 1. NMR measurements of Ab42 reveal varying degrees of a-helicity 
in mixtures of nonpolar and polar solvents70,89 and a partially folded helical conformation 
of Ab40 in water.87 Fig. 3.1A and C shows a typical helix-kink-helix conformation of 
Ab42 determined in a nonpolar environment (PDB ID: 1IYT89), with mostly polar and 
charged N-terminal region (NTR; residues 1 – 15), amyloidogenic central hydrophobic 
cluster (amyloidogenic CHC; residues 16 – 21), hydrophilic turn region (residues 22 – 
29) and largely hydrophobic C-terminal region (CTR; 30 – 42). The amyloidogenic CHC 
of charged Lys16 followed by a nonpolar 17LVFFA21 motif is the minimal fibril-forming 
sequence.303 The turn region shares the U-shaped morphology of the alternative b-hairpin 
(b-turn-b) motif with contacts between the CHC and the CTR.146 While the hydrophobic 
CHC and CTR are major contributors to aggregation,304 the NTR was shown to be mostly 
disordered in Ab fibrils and not part of the fibril core.11,305 However, recent ssNMR and 
cryo-EM experiments revealed that the NTR of some fibril polymorphs can form 
structured b-strand motifs,12,13 consistent with earlier inferences from experiments and 
molecular dynamics (MD) simulations that the NTR in monomeric Ab42 has a high 
propensity to sample b-sheet structures and is more compact than the NTR of Ab40.306,307 
The importance of the NTR at different levels of organization of Ab42 is further 
supported by sequence and site dependent shifting of the b-hairpin populations in mutants 
with single substitutions in the NTR region, which may in turn modulate the aggregation 
propensity.220,308 For example, the AD-protective N-terminal A2T mutants show 
increased contact between the NTR and the CHC,308 which persists as tertiary and 
quaternary contacts in the A2T-WT heterodimer309 that may protect against aggregation. 
Also, WT full-length Ab42 was shown to sample non-standard C-terminal b-hairpin 
conformations when complexed with A2V or A2T Ab6 hexapeptide,310  and the NTR has 
been posited to help stabilize the b-hairpin motif of Ab(17-34) allosterically. 
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Fig. 3.1. Molecular models derived from experimental Nuclear Magnetic Resonance 
(NMR) structures of helical monomers of (A) Ab42 solved in 20% water/80% deuterated‐
hexafluoroisopropanol (PDB code 1IYT89), and (B) micelle‐bound human aS solved in 
aqueous solution with sodium dodecyl sulphate (PDB code 1XQ890), with their 
corresponding sequences. The different regions are coloured red – NTR, green – CTR, 
grey – central hydrophobic region (amyloidogenic CHC in Ab42 or NAC in aS), and 
blue – turn. Regions Helix 1 and Helix 2 are overlaid with red and green transparent 
surfaces in both Ab42 (Ser8-Gly25 and Lys28-Gly38) and aS (Val3-Val37 and Lys45-




 The much larger 140-residue peptide aS is also discussed in Chapter 1. Despite 
being an IDP under physiological conditions,85 aS but adopt a multitude of extended and 
broken helical structures when complexed with phospholipids,311 which facilitate self-
assembly.312 Fig. 3.1B and D shows a typical helix-turn-helix structure of micelle-bound 
WT αS (PDB ID: 1XQ890) comprising three distinct regions: a lipid-binding amphipathic 
N-terminal region (NTR; residues 1–60) with the consensus KTKEGV sequence present 
in four 11-residue imperfect repeats, a central hydrophobic non-amyloid b component 
region (NAC, residues 61–95)313 which has three 11-residue imperfect repeats, and an 
acidic C-terminal region (CTR; residues 96–140). Even in the absence of membrane, aS 
can adopt a-helical conformations.164 Although the NAC is known to be critical for aS 
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aggregation and neurotoxicity,314 the negative charge on the disordered CTR was found 
to play a major role in regulating αS self-assembly.315,316 CTR-truncated variants of αS 
that thrive under physiological conditions, have been shown to be more cytotoxic and 
aggregation-prone in vitro than the WT.317-319 While tertiary contacts between the CTR 
and other regions of aS are believed to be important for providing resistance to 
aggregation and preserving the native monomeric state,320,321 these contacts have been 
shown to be preserved in PD-linked aggregation-promoting mutants,322 making it difficult 
to determine the role of the negatively charged disordered C-terminus in modulating toxic 
aS aggregation. 
 For Ab42, monomeric helical conformations in both the central hydrophobic 
region323-325 and the NTR326 have been stabilized by small molecules to reduce pathogenic 
aggregation, while for aS, a small molecule (phthalocyanine tetrasulfonate, PcTS) 
stabilized helical monomers of the central NAC has been proposed to resist its 
aggregation on membrane.327 In a membrane-free environment, the same porphyrin 
molecule induces the formation of helical monomers and off-pathway a-helical 
oligomers in aS,328 thus strengthening the view that helicity can persist (and impede 
aggregation) in the monomeric solution state of aS.164,166,329 While aggregation resistant 
helical forms have been identified in the small-molecule bound state,330-334 little is known 
about the distribution of helical conformations in Ab42 and aS monomers in aqueous 
solution.335,336 An important question (RQ1) is whether the population of stabilized 
helical conformations in free aqueous environment of amyloidogenic peptides could be 
increased, to make them more resistant to toxic oligomerization. 
 We employed microsecond-scale all-atom molecular dynamics (MD) simulations 
of helix unfolding and free energy calculations in this study to reveal a common terminal 
group-mediated stabilization of helical Ab42 and aS monomers. The IDP-specific 
physical models64 have employed a range of modified solute–water van der Waals (vdW) 
potentials,213 corrected water dispersion interactions,214 and most recently, potentials 
parametrized against both ordered and disordered peptides.215,337 we exploited this broad 
range of model biases to map helix conformational sub-spaces across three strengths of 
helically folded intermediates of Ab42 and aS (folded, partially folded and during the 
course of complete unfolding) across ten different force field and water model (FF/WM) 
combinations derived from the CHARMM and Amber parameter sets (full description of 
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these parameter sets with justification for their choices is given under Appendix C. Notes 
1. Physical models used in this study). 
 Here we show that the helical sub-space reveals stabilization of helically folded 
states in both Ab42 and aS through direct interactions with the flexible terminal groups. 
Control simulations indicate that these specific interactions disappear during the course 
of complete helix unfolding, and also that terminal-deleted variants of both peptides show 
destabilized helical conformations in their (aggregation-prone) cores, supporting the 
hypothesis that terminal residues may influence oligomerization pathways. 
 
3.2. Methods 
The initial structures for equilibrium MD simulations were obtained from PDB 
coordinates of Ab42 (PDB ID: 1IYT89) and aS (PDB ID: 1XQ890) solved by NMR (see 
Fig. 3.1). We note that another NMR structure of Ab42 (PDB ID: 1Z0Q70) solved in 70% 
water/30% HFIP also shows a-helical propensities, but has significantly less helical 
content than that of 1IYT, and thus further promotes conformational changes from a-
helix to b-strand on increasing the content of water. Since our main focus was starting 
from a predominantly helical conformation (to monitor unfolding), we chose the helix-
kink-helix conformation captured in NMR structure 1IYT as our starting geometry. We 
also note that for aS, another broken helical structure (PDB ID: 2KKW91) was solved by 
NMR. In this structure, aS was bound to a micelle of the detergent sodium lauroyl 
sarcosinate and displayed similar helical regions as 1XQ8. The peptides were represented 
by five different force field (FF) parameters of CHARMM and Amber family – 
CHARMM36205 (C36), CHARMM22*204 (C22*), CHARMM36m215 (C36m), Amber 
ff03338,339 (A03) and Amber ff03ws213 (A03Ws), and solvated in water boxes (minimum 
distance between any protein atom and any box edge was 20 Å) containing four different 
water models (WM) – CHARMM-modified TIP3P202 (mTIP3P), TIP4P340 (TIP4), 
TIP4P/2005341 and scaled TIP4P/2005213 (2005), TIP4P-Ew342 and TIP4P-D214 (D) 
resulting in ten distinct combinations of force fields and water models: C36/mTIP3, 
C36/TIP4P, C36/2005, C36/Ew, C36/D, C22*/D, C36m/mTIP3, C36m/sTIP3, A03/D 
and A03Ws/2005. MD simulations were carried out using the Gromacs 5.1.4227 package 
with an integration time step of 2 fs (adequate for generating accurate ensemble properties 
with sampling for long microsecond timescales) implemented in the velocity Verlet 
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integrator234 with bond lengths to hydrogen constrained using the LINCS343 (protein) and 
the SETTLE344 (water) algorithms. Structures were saved every 20 ps. Background ions 
were added to neutralize protein formal charges and to mimic physiological ionic 
strengths (0.15 M NaCl). Long-range electrostatics were treated by the Particle mesh 
Ewald (PME) method.246 Protein and non-protein molecules (water and ions) were 
coupled separately to an external heat bath (310 K) with the coupling time constant of 
1ps using the velocity rescaling method.248 All systems were minimized for 100 ps, and 
equilibrated for 1 ns in constant volume NVT ensemble followed by another 1 ns of NPT 
equilibration with the reference pressure at 1 bar and a time constant of 4 ps using the 
Berendsen barostat.247 The production runs were carried out in constant pressure NPT 
ensemble. Simulations were run with each of the ten combinations of protein force fields 
(FF) and water models (WM) for full-length Ab42 and aS, and with four chosen 
combinations of physical models for terminal deleted peptides, amounting to a total run 
time of ~36 µs. For details on MD simulations, refer to Chapter 2. 
 Adequate sampling of the helical IDPs were ascertained by monitoring covariance 
overlap during the simulated time. Bootstrapped Block Covariance Overlap Method 
(BBCOM)282 was used to check for covariance overlaps using the Lightweight Object-
Oriented Structure Library (LOOS)285 library. Here, the trajectories were initially divided 
into equal blocks as small as 10 ns and iterated by increasing block sizes of further 10 ns, 
until half of the total trajectory/simulation time (two blocks) was reached. The 
convergence plots for the F, P and U states of Ab42 and aS are shown in Fig. C1 under 
Appendix C. For more details on the BBCOM method, please refer to Chapter 2. 
 The F (folded), P (partially folded) and U (unfolding) states across the ten physical 
models were defined by their ranges of the fraction of native contacts in which they fell 
was calculated using the definition from Best, Hummer and Eaton,286 implemented in the 
MDTraj290 python library (for details see Chapter 2. Methods).                                                              
 The Gibbs free energy, GMM/PBSA or GTotal was calculated using the molecular 
mechanics energies combined with the Poisson–Boltzmann continuum solvation 
(MM/PBSA) method252 using the Amber 12230,231 package. The configurational entropies 
were estimated by normal mode analyses.258 For details on these specific methods, see 
Chapter 2. Tertiary structure analyses was performed by mapping the contact 
probabilities between all residue pairs using the CONAN345 contact analysis tool with a 
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cut-off of 5 Å as the minimum average distance between the heavy atoms of each residue. 
In addition, the intramolecular interaction maps were then generated using a truncation 
lifetime of 0.5, which means only physically meaningful interaction types (classified as 
hydrophobic, hydrogen bond and salt bridge) with contact probabilities more than 50% 
are taken into account. Interaction energies were estimated using the NAMD232 energy 
plugin in VMD,16 using non-bonded electrostatic and van der Waals (vdW) energies. 
Predicted NMR measurements such as secondary chemical shifts (CSs), three-bond 
HNHa J-coupling or scalar coupling constants and Residual Dipolar Coupling (RDC) 
constants were back-calculated from simulations and compared with relevant in vitro 
experimental NMR parameters (for details, see Chapter 2). 
 
3.3. Result and Discussion 
3.3.1. Classifying the ‘foldedness’ of helical conformers 
I initially obtained a broad distribution of monomeric helical intermediates of Ab42 and 
aS by extensively sampling helix-coil transitions across ten physical models (FF/WM 
combinations) for a total of ~33 µs atomistic MD simulations. The starting helix-kink-
helix structures (Fig. 3.1) of Ab42 (PDB ID: 1IYT89; sampling structures arising during 
the time period 1.1 – 2.1 µs) and aS (PDB ID: 1XQ890; 1.1 – 1.5 µs), details of which are 
shown in Table 3.1. (also see 3.2. Methods). The convergence of these simulations was 
assessed by using the Block Covariance Overlap Method282 (see 3.2. Methods and Fig. 
C1). In order to distinguish between unfolding events and events where the helically 
folded states are preserved, we monitored the fraction of native contacts (Q) (see 3.2. 
Methods) in which a native contact occurs between non-consecutive residues with a pair 
of heavy atoms within a cut-off distance of 5 Å. Q is a well-defined reaction coordinate 
for folded proteins286,346 and has also been used as an order parameter to identify coupled 
helical folding and binding mechanisms in IDPs.347,348 Q ³ 0.5 identifies folded (F) states, 
Q = 0.1 – 0.5 partially unfolded/folded (P), and Q £ 0.1 unfolding (U).286 we discounted 
very short-lived states with lifetimes <1 ns. Fig. 3.2. shows that temporal decay in native 
contacts for both Ab42 (Fig. 3.2A) and aS (Fig. 3.2B) results from loss of helicity (a-
helix + p-helix + 310-helix), confirming the predominantly helical nature of the 
intermediary folded states. 
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Table 3.1. MD simulations for the full-length peptides of (A) Ab42 and (B) aS showing 
the force field/water (FF/WM) model combinations used, total simulation times, 
complete unfolding times (where applicable), average helical content and average number 









Average Helical content 
(%mean±SD) 





a-helix p-helix 310-helix 
C36/mTIP3 (F) 2014 N/A 50±4 0±0 1±1 21 
C36/TIP4 (F) 2018 N/A 52±4 0±0 2±2 22 
C36/2005 (F) 2011 N/A 42±3 1±1 1±1 18 
C36/Ew (F) 2011 N/A 43±4 0±0 1±1 18 
C36/D (P) 2157 N/A 21±4 0±0 3±2 10 
C22*/D (U) 2011 206 18±6 0±0 10±4 12 
A03/D (F) 2041 N/A 28±4 1±1 7±3 15 
A03Ws/2005 (U) 2020 1527 20±4 0±0 4±2 10 
C36m/mTIP3 (U) 1111 1111 34±5 1±1 1±1 14 








Average Helical content 
(%mean±SD) 




a-helix p-helix 310-helix  
C36/mTIP3 (F) 1540 N/A 44±8 1±1 1±1 63 
C36/TIP4 (F) 1411 N/A 37±5 0±0 1±1 52 
C36/2005 (U) 1340 1328 13±11 0±0 1±1 19 
C36/Ew (F) 1165 N/A 37±8 0±0 2±2 54 
C36/D (U) 1384 1325 22±9 0±0 1±1 31 
C22*/D (U) 1413 625 8±6 0±0 3±3 16 
A03/D (U) 1321 1065 14±11 0±0 4±3 24 
A03Ws/2005 (U) 1488 1160 6±6 0±0 4±3 14 
C36m/mTIP3 (F) 1263 N/A 43±6 0±0 1±1 60 
C36m/sTIP3 (P) 1300 N/A 28±6 0±0 1±1 41 
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Fig. 3.2. Temporal evolutions of fraction of native contacts Q286 (Left) and percentage 
helicity (Right) for (A) Ab42 and (B) aS. The FF/WM combinations are categorized 
according to their placements in the Q ranges as ³ 0.5 (Folded or F), 0.1 – 0.5 (Partially 
unfolded/folded or P), and £ 0.1 (Unfolding or U). The helix content in different regions 
for both proteins is shown. The horizontal green and red lines on the Q timelines mark 
the boundaries of completely folded and completely unfolded states, respectively. The 
broken red lines in the U models (% Helicity vs. Time) mark the point of complete 
unfolding (Q=0.1). Note: I deliberately used the nomenclature of “Unfolding” as opposed 
to “Unfolded” which would imply an FF/WM yielding completely disordered/unfolded 
states. For the helical percentages, running averages over 20 data points are shown. 
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3.3.1.1. Ab42 helical states 
Here, the temporal evolution of helical percentages of the full-length protein, Helix 1 and 
Helix 2 including their two-residue linker (initial helical regions), the longer Helix 1 and 
the Helix 2 are recorded (refer to Fig. 3.1.). In most cases where complete, but slow 
unfolding is observed, the shorter Helix 2 (from the CTR, Fig. 3.1.) is the first to unfold 
(Fig. 3.2A), except for model C22*/D (refer to 3.2. Methods and Appendix C, Note 1 
for the abbreviations used) where the tip of Helix 1 (from NTR) quickly becomes more 
disordered (Fig. C2B). Full-protein unfolding generally follows the same trend as the 
unfolding of Helix 1 and not Helix 2 (Fig. C2B). Helical hydrogen bond populations 
confirm that most of the helical states are α-helices (Fig. S2C). Given the smaller size 
and comparatively less complex conformational space of Ab42, I will focus below on 
detailed analysis of aS, highlighting features common to both proteins. 
 
3.3.1.2. aS helical states 
I monitored the unfolding transitions in different regions of aS, considering full-length 
total helix content (here, including the disordered region Gly93-Ala140 after the CTR 
and the first two residues Met1 and Asp2), initial helical regions (including the kink), 
shorter Helix 1 and longer Helix 2. It is important to note that, unlike in Ab42, Helix 2 in 
aS does not contain CTR residues, but instead the distal end of NTR following the kink 
and the full NAC. Three examples of FF/WMs sampling the F (C36/mTIP3), P 
(C36m/sTIP3) and U (C22*/D) states are shown in Fig. 3.2B. Despite having a much 
larger disordered region (50 residues) than Ab42 (11 residues) in the initial structures 
(Fig. 3.1), we found negligible helix formation in the unstructured regions, which may be 
due to the high population of hydrophobic proline residues along the CTR.349 However, 
unlike Ab42, four of the five U cases show propensity to form helices in the disordered 
CTR: C36/2005 (in the interval 200 – 400 ns), C36/D (800 – 1200 ns), A03/D (250 – 
1000 ns) and A03Ws/2005 (almost the whole trajectory). Q, % helicity and H-bond 
populations show that the FF/WM combinations giving F, P and U states for aS is similar, 
but not exactly the same, as for Ab42 (Fig. C3). As expected,64 the two most IDP-
favourable combinations C22*/D and A03Ws/2005 favour complete helix unfolding.  
 The unfolding of aS almost always proceeds via helix breaks (for details see Fig. 
C4). Helix unfolding was completed in the present simulations when the two helical 
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domains (Helix 1 and Helix 2) moved sufficiently far away from each other to allow 
favourable unfolding from the kink region. Fast unfolding occurs early for aS simulated 
using C22*/D and is also a common feature with the smaller Ab42, where the helices 
unfold concertedly (Fig. C3B). On the other hand, slow unfolding is mostly (three out of 
four other cases of aS unfolding, except C36/D) characterized by the NTR Helix 1 
unfolding first and helical conformations persisting in a single stretch of Helix 2 for >1 
µs before completely unfolding. Residue-wise secondary decomposition for Ab42 and 
aS are described under Note 2 in Appendix C (Fig. C5). For further details on the 
structural distributions including radius of gyration (Rg), end-to-end distance (Re) and 
solvent accessible surface area (SASA), refer to Note 3. Conformational distribution 
of helical intermediates under Appendix C (Table C1, Figs. C6, C7). 
 
3.3.2. Free energy balance facilitates IDP helix unfolding  
To probe further into the helix unfolding characteristics of Ab42 and aS, we computed 
their Gibbs free energies using molecular mechanics energies combined with Poisson–
Boltzmann continuum solvation (MM/PBSA)252 energies as implemented in Amber 
12230,231 (see 3.2 Methods). In addition, normal mode analyses258 was used to estimate 
contributions from configurational entropy. In Fig. 3.3 reports the average free energies 
in vacuum/gas phase (Gvacuum) including the entropic terms (TS), the average solvation 
free energies (Gsolvation), and the average total free energies (Gtotal) sampled from the F, P 
and U states of Ab42 and aS. Here I have discussed the CHARMM and the AMBER 
variants of the force fields separately (refer to Appendix C, Note 4. Free energies with 
AMBER parameters) due to the innate differences in charges used for parametrization 
(which change the calculated MM/PBSA energies).  
 It is noted that for both Ab42 and aS, overall unfolding of helices has favourable 
Gsolvation, due to improved hydration of the peptide backbone.350 Energy decompositions 
(Fig. C8) show that polar solvation free energies (electrostatic interactions between solute 
and continuum solvent) are more negative in U states, with negligible contribution from 
apolar (nonpolar) solvation (Table C2). The combined effect of more favourable van der 
Waals (vdW) and electrostatic energies facilitates compact folded conformations for F 
states, which creates more negative overall Gtotal than in the U states. 
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Fig. 3.3. The average total free energies (Gtotal) and their subsequent decomposed free 
energies in vacuum (Gvacuum) and solvation free energies (Gsolvation) for all the F, P and U 
states of (A) Ab42 and (B) aS computed by MM/PBSA252 method employed in Amber 
12.230 Configurational entropy was computed by normal mode analysis.258 The estimation 
of standard error was done by a blocking procedure. As explained in Methods, we sample 
structures during the last 200 ns before structural transitions, as this is the time frame 
within which the events leading to preservation of helices or complete helix unfolding are 
magnified. 
 
 On the other hand, for aS with a comparatively high net charge per residue, the 
scenario is a bit different from Ab42 (detailed in Appendix C, Note 5). The F and the U 
states could be distinguished by their contributions from Gvacuum in vacuum (apart from 
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the hydration free energies) (Fig. 3.3B). For all the CHARMM variants except C36/TIP4, 
it is noted that Gvacuum is positive and unfavourable. There is also a gradual increase in the 
Gvacuum values from F to the U states – compensating the favourable solvation energies, 
except the noted anomaly with C36/mTIP3. The decomposed energies (Fig. C8B) show 
that the positive Gvacuum originates from electrostatic repulsions, which get more 
pronounced as αS prepares to completely unfold (U states). Such events are only 
perceptible during the end stages of helix unfolding via extended conformations. 
However, for C36/mTIP3, the positive electrostatic energy acting opposite to negative 
polar solvation energy does not facilitate complete helix unfolding. Instead, extended 
helical conformations form, due to strong interactions between the highly acidic CTR and 
the residues of NAC (discussed in detail below under section 3.3.3.2). For a note on the 
conformational entropies, please refer to Appendix C, Note 6 (Fig. C9). 
 
3.3.3. Tertiary structure analyses 
3.3.3.1. N-terminal interaction stabilizes the helical folds in Ab42 
Based on the distinct NTR-CHC contacts identified in the contact maps (for details on 
intramolecular contact maps of Ab42, refer to Appendix C, Note 7 with accompanying 
Figs. C10A and C11A), we used interaction maps to identify H-bond, salt bridge and 
hydrophobic networks associated with fold retention or complete unfolding. It is observed 
that for Ab42, the contact lifetimes for the F and the P states between amyloidogenic 
CHC and/or turn and CTR were slightly reduced during the last 200 ns of simulations. 
These losses are compensated by more frequent NTR contacts with the amyloidogenic 
CHC and the turn regions (Fig. C11A). These NTR contacts are sparse or absent during 
the last 200 ns of the U states. Fig. 3.4A shows that the interactions between these regions 
in the F states are identified mostly as being hydrophobic (circled broken black line) 
centred on the hydrophobic cluster, V24 in the proximal turn region and the CTR.  
 Salt bridges form in four out of six of the F and P states, between either D23 and 
K28 (C36/mTIP3, C36/2005 and C36/D) or E22 and K28 (C36/TIP4), which stabilize the 
characteristic turn-like motif from V24 – K28351 along with the other hydrophobic 
interactions. Intermolecular D23 – K28 salt bridges contribute to the loop region in Ab42 
fibrils.305 Such turn-like structures are thought to stabilize the b-hairpin (or a b-turn-b) 
motif146 and have been proposed to form the folding nucleus that facilitates fibril 
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aggregation.351 The stability of this turn-like region is important for controlling 
oligomeric aggregation, as familial mutation of the negatively charged E22 and D23 to 
polar or positively charged residues destabilizes the fold leading to increased 
aggregation.352 The turn-like motif also presents an overall negatively charged surface, 
which may help protect effect against aggregation via hydrophobic interactions.157  
 By contrast, we observe no salt bridges (circled by broken red lines) between 
E22/D23 and K28 in the U states (Fig. 3.4B). Hydrophobic interactions persist in the U 
states (for C22*/D and C36m/mTIP3) but are more concentrated than in F and P states, 
mostly between CHC and the proximal CTR (30–35). Model C36m/sTIP3 samples only 
the V24–A30 hydrophobic interaction, which collapses the CTR while keeping the NTR 
extended. 
 The major difference between conformational states in the U states is the lack of 
interactions between the extended NTR (red rectangle) and other domains (Fig. 3.4B), as 
noted earlier from the contact frequencies. These specific interactions collapse the NTR 
in the F/P states. The involvement of E22/D23/K28 in forming these salt bridges with the 
proximal NTR implies that the E22/D23 – K28 salt bridge is disrupted. However, the 
NTR – turn and turn – turn salt bridges can co-exist (with ~50% populations, for model 
C36/mTIP3). In other cases where a E22/D23 – K28 interaction is formed near-100% of 
the time (C36/TIP4, C36/2005 and C36/D), the NTR – turn salt bridges are supplemented 
by hydrophobic interactions with the NTR. 
 Likewise, in the presence of predominant E3/R5 – E22/D23/K28 salt bridges 
(C36/Ew and A03/D), the turn – turn salt bridge is rarely formed. The presence of these 
salt bridges contributes to the calculated favourable electrostatic energy in the F states 
(Fig. C8A). The proximal NTR and the amyloidogenic CHC actively engage in 
hydrophobic interactions with the largest calculated contribution from aromatic F4, such 
as F4–L17 (C36/TIP4 and C36/Ew), F4–F19/20 (A03/D) and F4–A21 (C36/Ew) (Fig. 
3.4A). F4 also engages in hydrophobic interactions with the CTR in the most strongly 
folded structures, such as F4–I31 in C36/Ew and F4–M35 in C36/TIP4.  
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Fig. 3.4. Interaction maps of Ab42 computed from the last 200 ns of simulations using 
the CONAN345 tool for analysing tertiary structures for the (A) Folded (F) and the 
Partially folded (P, C36/D), and the (B) Unfolding (U) states. Specific interactions in the 
maps are coloured: orange – hydrophobic, green – hydrogen bond, and purple – salt 
bridge. The hydrophobic interaction zones are circled by broken black lines, while the 
salt bridges zones are circled by broken red lines. The red rectangle on the map marks the 
boundaries of NTR interactions with other domains. Representative conformations are 
shown alongside the maps and coloured by domain (red – NTR, green – CTR, grey – 
amyloidogenic CHC and blue – turn). We constructed the interaction maps from contacts 
with probabilities >50%. 
 - 73 - 
 Also notable is the involvement of F19 with the NTR (Y10–F19 in C36/mTIP3 
and F4–F19 in A03/D). F19 is the only residue in the amyloidogenic CHC that does not 
engage in interactions with either the turn or the CTR. Other persistent interactions 
created by the distal part of the NTR (10–15) are hydrophobic interactions such as Y10 – 
I31/M35/V40 in the F states, and Y10 – F20/V24/A30/I31/I32 and V12 – F20/I31/I32 in 
the P states. Y10 also forms a hydrogen bond through its hydroxyl group with K16 
(models C36/mTIP3 and C36/Ew). However, long-lived hydrogen bonds are few, the 
others being S8–K16 (C36/mTIP3) and H6–D23 (A03/D). There is also a salt bridge E11–
K16 (C36/mTIP3) which may stiffen the distal part of the NTR. In stark contrast to F and 
P states, we found just one instance of NTR interactions with the other regions in the U 
states (Fig. 3.4B), A03Ws/2005 showing a 53% salt bridge between D7 and K16. 
 
3.3.3.2. C-terminal interaction stabilizes the helical folds in aS  
We used contact frequencies to identify the specific interactions associated with helix 
unfolding and helical stabilities of aS. With respect to the contact probabilities of the full 
trajectory (Fig. C11B), the F states show more prominent contact frequencies of the CTR 
(especially with NAC region) during the last 200 ns, except for model C36/mTIP3 (Fig. 
C11B, and below). 
 Fig. 3.5 maps the specific tertiary interactions of aS helical states.  The highly 
folded three-helical F states (model C36/TIP4, Fig. 3.5A) show the prevalence of 
hydrophobic interactions between the proximal part of NTR (M1–E20) and the NAC 
region, which to some extent also appears in the P states (with the highly hydrophobic 
proximal end of NAC, 61 to 79; model C36m/sTIP3). The proximal NTR residues have 
been shown to have a very high helical propensity and determine aS membrane binding 
affinity.353 For all the other F states (except C36/mTIP3), the NTR – NAC interactions 
occur more between the distal parts of the NTR (V40–K60) and the NAC, indicating an 
overall extended N-terminal helical tail. Helical hydrophobic associations are also 
observed between the proximal and the middle NTR due to the unfolded kink region from 
L38 to T44. 
 In the case of model C36/mTIP3, the NTR does not interact with distant domains 
(Figs. C10B and C11B), even though aS shows significant helicity. One possible reason 
for this behaviour might be that the N-terminal helices of aS are ordered even in solution 
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due to the high density of alternating positive and negatively charged residues promoting 
strong electrostatic interactions as evident from the high probability of on-diagonal salt 
bridges (Fig. 3.5A). Such NTR ordering is also consistent with experiments showing  high 
accessibility of NTR inside cells, suggesting limited or weak interactions with the other 
aS domains.85 Structurally, our simulations show that a stable, but extended, helical NTR 
is favoured, as short range electrostatic repulsion (Fig. C8B) between the ends of the 
fluctuating CTR and NTR screens long-range electrostatic attraction between the Lys 
residues on the NTR imperfect repeats and the acidic CTR. An intra-NTR K34–E46 salt 
bridge between the second and third imperfect repeat regions might also contribute to the 
helical stability of the NTR (Fig. 3.5A). Other NTR – NTR salt bridges formed with the 
F states are E20 – K43/K45 (C36/Ew), and D2–K21 and K12–E20 (C36m/mTIP3), all 
contributing to some extent to the overall NTR helical stability. The interplay between 
the salt bridges of different repeat regions has been shown to be a major factor in 
stabilizing the five-fold morphology of αS fibril structures.354 
 By contrast, the NTR interactions in the U states (Fig. 3.5B) of aS involve mainly 
the proximal part of the NTR, except C36/D which does not show any discernible 
interaction. Hydrophobic interactions between residues F4 and L8 in the NTR and 
hydrophobic residues in the distal NTR region promote a collapse of the NTR onto itself. 
The proximal hydrophobic residues have been shown to promote membrane penetration 
and subsequent oligomerization, through their interaction with distant NAC regions.355 
Our simulations show however that these proximal hydrophobic residues interact with 
regions closer than the NAC, but still promote unfolding of helices in the U states (Fig. 
3.5B). This suggests that hydrophobic interactions in the NTR do not contribute 
significantly to the overall helical stability of aS. Moreover, the stretch of initial 
hydrophobes in the NTR that interacts with distal NTR, NAC and proximal CTR (in 
model A03/D) are due to b-strand – b-strand interactions (discussed in the main text) that 
bind the NAC and CTR with a short helical segment in the NTR. Most importantly, the 
absence of intra-NTR salt bridge interactions (except K23 – E35, in model C36/2005) 
within the U states supports the hypothesis that salt bridges stabilize NTR helices in the 
F states. A few hydrogen bonds form between NTR and NTR/NAC with C36/TIP4 and 
C36/Ew in the F states (Fig. 3.5A), but their absence in the other F states and the P state 
 - 75 - 
(and their very minor presence along with the hydrophobic nodes in the U states (Fig. 
3.5B)) suggests that hydrogen bonds to NTR are not important for aS helicity. 
 It should be noted that interactions with the NTR does not contribute to the overall 
helical stability of aS. Unlike the NTR, the CTR does contribute significantly to the 
overall helical stability of aS (Fig. 3.5). We note however, that significant differences 
between the folded and the unfolding states stem from CTR interactions with the other 
domains, as identified by contact probabilities (Fig. C10B). The most obvious is the 
cluster of hydrophobic interactions between NAC and a collapsed CTR (V74 – 
I112/L113, V77 – P108/I112 and A78/I112 in model C36/mTIP3, Fig. 3.5A). These 
contacts stabilize the NAC helices, and, by contrast, there are virtually zero NTR – CTR 
interactions. A few short-range hydrophobic interactions such as A91/F94 – L100 also 
form. The NAC – CTR hydrophobic interactions are quite prominent within the other 
models in the F states: A69/V70 – P117, A76/V77 – L113 and A90 – M127/P128 with 
C36/TIP4, V63 – L113/M116, V66– M116/P117/P120/P128, A69–M116 and V77–I112, 
F94–I112 with C36/Ew, and L113/M116, V66 – M116/P117/P120/P128, A69–M116, 
V77–I112 and F94–I112 with C36m/mTIP3. We note the repeated involvement of the 
Ala and Val residues belonging to the hydrophobic core region of the NAC (G68 – V82) 
comprised of two overlapping segments, which is involved in fibrillation and 
cytotoxicity.356,357 Moreover, direct NAC – CTR interactions are completely absent in the 
P states (C36m/sTIP3).  
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Fig. 3.5. Interaction maps of aS for the (A) Folded (F) and the Partially folded/unfolded 
(P, C36m/sTIP3), and the (B) Unfolding (U) states. Maps were computed from 200 ns of 
dynamics for each state using the CONAN345 tool using a threshold of 50 % contact 
lifetimes. Specific interactions in the maps are coloured: orange – hydrophobic, green – 
hydrogen bond, and purple – salt bridge. The hydrophobic interaction areas are circled 
by broken black lines, while salt bridges areas are circled by broken red lines. The green 
rectangle on the map marks the boundaries of CTR interactions with other domains. 
Representative conformations are shown alongside the map and coloured by domain (red 
– NTR, green – CTR, grey – NAC). 
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 In the CTR, the most common hub of hydrophobic interactions (with either NAC 
or NTR) are residues I112 and L113, while all Pro residues participate to different extents, 
except P138 near the CTR tail. Residue F94 frequently interacts with I112 and forms the 
interior hydrophobic pocket in the Greek-key fibril topology along with other 
neighbouring aromatic residues.14 Recent studies show that F94, along with other 
aromatic residues F4 and Y39, can bind a small molecule that “switches off” the αS 
monomer to inhibit amyloid formation.358 The hydrophobic interactions of the NTR with 
the CTR in the F states (other than C36/mTIP3) involve residues V3–I112, F4 – 
I112/L113, L8–L113 and A11–M116 with C36/TIP4, M5–P108 with C36/Ew, and L38 
– M116/P117, V40 – P117/P120, V49 – P117/V118/P120 and V52/A53/A56 – M116 
with C36m/mTIP3. In the P states, such interactions are manifested by M5/L8 – A107 
and V52/V55 – M127. The simulations do not predict extensive salt bridge formation 
between NAC and CTR in P states, despite sub-5 Å E83–K96 contacts in C36/TIP4 and 
K80–E110 in C36/mTIP3. No salt bridges were identified with C36/Ew, even though this 
physical model gives the highest population of NAC – CTR hydrophobic contacts (Fig. 
3.5A). 
 By contrast, a number of persistent NTR – CTR salt bridges are observed for all 
the F states with C36/TIP4 which help stabilize the overall three-helix structure: K6 – 
D119/D121, K10–D119, K12–E121, K23 – D135/E137, K43 - D135/E137 and K45–
E137. This is reflected in its most favourable electrostatic energy amongst all the 
CHARMM variants of FF/WMs (Fig. C8). NTR – CTR salt bridges formed by the other 
F states include K43–D119 with C36m/mTIP3, and K10 – E104/E105 and K12–D119 
(C36m/sTIP3). The higher density of CTR salt bridges with the NTR than with NAC 
reflects the higher population of the imperfect repeats with variable hexameric motif 
KT(A)K(V)E(Q)GV(A) (five on NTR vs. one on NAC). The intra-domain hydrogen bond 
population in CTR is not significant in either the F or the P states as most of the hydrogen 
bonds are used in stabilizing helical structures of the NTR and the NAC. 
 The data shows a clear drop in NAC – CTR interactions on moving from the F to 
the P states, coupled with a small reduction in hydrophobic interactions in the P states. A 
further drop in CTR interactions occurs on transitioning to U states. For example, model 
C36/2005 samples only two CTR – NTR interactions: hydrophobic contact between V52 
and L100 and a D2–K102 salt bridge (Fig. 3.5B). Three of the other four U states (C36/D, 
C22*/D and A03Ws/2005) show zero CTR interactions. For the remaining A03/D, a 
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stretch of hydrophobic interactions between the very proximal NTR (especially F4) and 
distal NTR, NAC and proximal CTR stabilizes an atypical short helix-b-strand-b-strand 
structure. We observe that such a conformation involving interactions between 
NTR/NAC and CTR is due to two adjacent hydrophobes in the CTR: I112 and L113, 
which shows that these residues in the CTR are very much accessible. However, the 
structure persists for only 70 ns due to the very short b-strands (90 – 95 and 110 – 114) 
and short a-helix, with the final event of unfolding being the extension of disordered CTR 
away from the rest of the domains.  
 
3.3.4. Simple interaction energies capture the strong helix stabilizing effects of N-
terminus of Ab42 and C-terminus of aS  
 To quantify the relative contributions of the domain-domain interactions, Pearson 
Correlation Coefficients (PCC) were computed between interaction energies (Table C3) 
and conformational energies (EMM/PBSA), for the F and the P states, and the U states 
separately. A positive correlation is recorded for all the F and the P states of Ab42 (Fig. 
3.6), with the interaction energies between NTR and amyloidogenic CHC showing the 
highest PCC of 0.6 (marked in red) with the conformational energies, which is in line 
with our estimated relative populations in interaction maps (Fig. 4A). This is followed by 
modest correlations among amyloidogenic CHC – turn (P.C.C. = 0.4) and NTR – turn 
(P.C.C. = 0.4) indicating a competition between NTR and amyloidogenic CHC to interact 
with the turn region. The shift in population of the amyloidogenic CHC – CTR 
interactions towards CHC – NTR interactions is confirmed by the negligible CHC – CTR 
correlation coefficient (0.1). Similarly, there is no significant correlation (P.C.C. = 0.1) 
between interaction energies of the termini (NTR – CTR) and the conformational 
energies. In summary, the decreasing order of correlation for the folded F and partially 
folded P states of Ab42 is [NTR – CHC] > [CHC – turn] > [NTR – turn] > [turn – CTR] 
> [CHC – CTR] > [NTR – CTR]. By contrast, the interaction energies between the NTR 
and amyloidogenic CHC for the U states show only a weak correlation of 0.2 with the 
conformational energies, and all the interactions with the CTR show a negative 
correlation. Amyloidogenic CHC – CTR and NTR – CTR are highly anti-correlated, 
indicating that these interactions have no positive effect on the overall structure, which is 
in part due to an extension of conformation during unfolding. The highest correlation 
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among the U states for NTR – turn (0.3) is one of the weakest compared to the F and the 
P states, the order decreasing as [NTR – turn] > [NTR – CHC] > [CHC – turn] >> [turn 
– CTR] > [CHC – CTR] > [NTR – CTR].  
 
 
Fig. 3.6. Pearson Correlation Coefficient (P.C.C.) between conformational energy and 
(A) NTR-CHC, CHC-Turn, Turn-CTR, NTR-Turn, CHC-CTR and NTR-CTR 
interaction energy in Ab42, and (B) NTR-NAC, NAC-CTR and NTR-CTR interaction 
energy in αS. The standard error bars were estimated using block averages. 
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 On the other hand, for αS, a stronger segregation of the folded from the unfolding 
states could be observed with respect to the correlations between the interaction and the 
conformational energies (Fig. 3.6B). A high correlation (P.C.C. = 0.7) for the NAC – 
CTR interactions surpasses the weakly correlated NTR – NAC and NTR – CTR 
interactions for the F or the P states, reflecting the high frequency of NAC interactions 
with a predominantly collapsed CTR. This is in accordance with the prominent existence 
of hydrophobic interactions between NAC and CTR in the F states. However, the distant 
NTR – CTR interactions are slightly more favorable for αS (P.C.C. = 0.3) than A 42 
(P.C.C. = 0.1). The decreasing order or PCC for the F or the P states is [NAC – CTR] >> 
[NTR – CTR] > [NTR – NAC]. In the U states, the NAC – CTR interactions are 
negatively correlated (P.C.C. = -0.1) with the conformational energies showing that such 
interactions do not contribute towards overall helical unfolding of αS.  
 In summary, the strongest interactions are noted between the NTR and CHC in 
Ab42, and NAC and CTR in aS. These contacts show the highest Pearson Correlation 
Coefficients (P.C.C.) of 0.6 and 0.7, respectively, amongst all other domain-domain 
interactions. 
 
3.3.5. Predicting the effects of terminal deletion  
In order to further test the prediction that the termini modulate helical stabilities, we 
conducted simulations with N-terminal deleted Ab42 (16–42, Ab42NDEL) and C-terminal 
deleted aS (1–95, aSCDEL). Several NTR-truncated species of Ab42 and CTR-truncated 
variants of aS have shown faster aggregation and stronger neurotoxicity than their full-
length counterparts,317,319,359-361 with the magnitudes varying across different 
experimental conditions. In order to test if deletion of the termini had significant impact 
on overall helical fold propensities compared to full-length proteins, we selected four 
different models: two that unfolded helices completely for Ab42 and aS (C22*/D, 
A03Ws/2005), one that preserved the helically folded conformation (C36/mTIP3) and 
one that completely unfolded helices in Ab42 but stabilized helical conformations in aS 
(C36m/mTIP3). The first 15 residues were deleted in Ab42, and the last 45 residues were 
deleted in aS. CTR-deleted aS does not lose any helical regions compared with the full-
length peptide, but NTR-deleted Ab42 loses an eight-residue helical region S8–Q15. The 
overall hydrophobicity is enhanced for the deleted variants of both proteins compared 
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with their full-length counterparts, as the NTR of Ab42 is mostly polar and the CTR of 
aS is acidic. A total of ~3.2 µs of dynamics was sampled with terminally deleted Ab42 
and aS (Table 3.2). We used the same criteria of fraction of native contacts (Q) to assess 
the foldedness of Ab42NDEL and aSCDEL.  
 
Table 3.2. Details of the MD simulations for the terminal deleted peptides (A) Ab42NDEL 
and (B) aSCDEL showing the force field/water (FF/WM) model combinations used, total 
simulation times, complete unfolding times, average helical content and average number 
of residues in helical conformation. 
 
A 





Average Helical content 
(%mean±SD) 





a-helix p-helix 310-helix  
C36/mTIP3NDEL 438 328 28±7 0±0 3±1 8 
C22*/DNDEL 96 53 10±4 1±1 4±2 4 
C36m/mTIP3NDEL 492 454 25±3 1±1 1±1 7 
A03Ws/2005NDEL 76 69 27±5 0±0 7±2 9 
 
B 





Average Helical content 
(%mean±SD) 





a-helix p-helix 310-helix  
C36/mTIP3CDEL 736 734 39±18 0±0 2±2 38 
C22*/DCDEL 174 174 22±13 1±1 7±4 28 
C36m/mTIP3CDEL 836 772 59±9 0±0 1±1 56 
A03Ws/2005CDEL 424 408 27±11 0±0 3±3 28 
 
 
 All four physical models unfold the helices completely (Q<0.1, Fig. C12). Much 
faster unfolding was observed for both C22*/D (at ~53 ns for Ab42NDEL and ~174 ns for 
aSCDEL) and A03Ws/2005 (~69 ns for Ab42NDEL and ~408 ns for aSCDEL) than for their 
corresponding full-length U states (Table 3.1 and Table 3.2). Deletion of NTR makes 
Helix 1 slightly shorter than Helix 2 (by one residue) in Ab42NDEL, allowing it to unfold 
first, except for A03Ws/2005. For aSCDEL, we observe more concerted unfolding of the 
two helices than was calculated for the full-length protein. There is an overall tendency 
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to elongate the structures in the course of unfolding Ab42NDEL with primarily disordered 
amyloidogenic CHC and CTR, while the turn (22 – 29) transform into a more helical 
structure (Fig. 3.7A). aSCDEL remains fairly compact throughout the course of unfolding 
as was observed for full-length protein (except for CTR elongation during final 
unfolding). In addition, there is a tendency to retain the NTR helices (C36/mTIP3, Fig. 
3.7B). Overall, it is clear that the terminal deletions indeed lead to an enhanced helix 
unfolding for Ab42 and aS, and a shorter time to reach the disordered states. 
 To assess the impact of terminal deletions on the overall stability of Ab42 and aS, 
we calculated the Gibbs free energies by combing MM/PBSA (see 3.2. Methods) with 
entropy (TS) estimates from normal mode analysis (Table C2 under Appendix C). For 
Ab42NDEL, the conformational energy becomes unfavourable for three out of four models 
(Fig. 3.7B), indicating the overall instability of Ab42NDEL helical states. For aSCDEL, we 
observe a similar destabilization as for Ab42NDEL (Fig. 3.7C), which supports the 
prediction of a protective role of these distinct terminals in stabilizing helical structures. 
 We also validated our conformational ensembles generated by the above four 
models for the full-length peptides with in vitro experimental NMR 
measurements61,157,362-365 (see Appendix C, Figs. C13-16). The chemical shifts, 3JHNHa 
coupling constants and residual dipolar coupling constants were predicted from 
simulations by SHIFTX2,123 MDTraj290 library and PALES125 respectively (see 3.2. 
Methods). Tables 3.3-3.6 show the PCCs and the root mean squared deviations (RMSDs) 
between the simulated ensembles from different states and the experimental values 
obtained from two different parameters – one from the folded helical structures, and the 
other from the predominantly disordered ensemble. The general trend that we see for both 
Ab42 and aS is that the F states show a high PCC and low RMSD with the experimental 
helically folded structures, and vice versa with the disordered ensemble experimental 
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Figure 3.7. (A) The most populated conformations sampled by the four chosen physical 
models with Ab42NDEL and aSCDEL computed by the clustering method of Daura et al.366 
(B) Comparison of normalized (per residue number) conformational (Conformational 
energyNorm), TS (TSNorm) and total free energies (GTotal-Norm) between the full-length Ab42 
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Table 3.3. Pearson Correlation Coefficient (PCC) and Root Mean Squared Deviation 
(RMSD) of (A) Ca, (B) Cb, (C) Ha, and (D) N chemical shifts between simulations 
(back-calculated with SHIFTX2123) and experiments for the F and the U states of Ab42 
which show maximum difference. Two experimental values were chosen to compare: the 
full helically folded PDB structure 1IYT,89 and the predominantly disordered ensemble 
obtained by Hou et al 2004.61 The RMSD values showing maximum distinction between 
states are shown in bold. 
 
A 
dCa (ppm) 1IYT (Exp.) Hou et al 2004 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.98 1.33 0.96 2.13 
C36m/mTIP3 (U) 0.97 2.20 0.98 1.09 
C22*/D (U) 0.98 2.49 0.99 0.59 
A03Ws/2005 (U) 0.96 2.25 0.97 1.24 
B 
dCb (ppm) 1IYT (Exp.) Hou et al 2004 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 1.00 0.94 1.00 1.24 
C36m/mTIP3 (U) 1.00 0.94 1.00 0.66 
C22*/D (U) 1.00 0.95 1.00 0.43 
A03Ws/2005 (U) 1.00 1.02 1.00 0.66 
C 
dHa (ppm) 1IYT (Exp.) Hou et al 2004 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.89 0.15 0.72 0.24 
C36m/mTIP3 (U) 0.79 0.15 0.83 0.15 
C22*/D (U) 0.84 0.15 0.89 0.13 
A03Ws/2005 (U) 0.81 0.16 0.88 0.13 
D 
dN (ppm) 1IYT (Exp.) Hou et al 2004 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.88 2.57 0.91 3.86 
C36m/mTIP3 (U) 0.89 2.88 0.93 2.60 
C22*/D (U) 0.94 2.67 0.96 1.90 
A03Ws/2005 (U) 0.92 2.86 0.93 2.38 
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Table 3.4. PCC and RMSD of (A) Ca, (B) Cb, (C) Ha, and (D) N chemical shifts from 
simulations with SHIFTX2123 and experiments for the selected F and the U states of aS. 
Two experimental values chosen to compare are the helically folded micelle-bound PDB 
structure 1XQ8,90 and the predominantly disordered ensemble obtained from the study 
by Porcari et al 2015.362 The RMSD values showing maximum distinction between states 
are shown in bold. 
 
A 
dCa (ppm) 1XQ8 (Exp.) Porcari et al 2015 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.98 1.53 0.97 1.53 
C36m/mTIP3 (F) 0.98 1.35 0.97 1.75 
C22*/D (U) 0.97 2.07 0.99 0.82 
A03Ws/2005 (U) 0.96 2.48 1.00 0.60 
B 
dCb (ppm) 1XQ8 (Exp.) Porcari et al 2015 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 1.00 0.51 1.00 0.65 
C36m/mTIP3 (F) 1.00 0.37 1.00 0.60 
C22*/D (U) 1.00 0.67 1.00 0.60 
A03Ws/2005 (U) 1.00 1.00 1.00 0.49 
C 
dHa (ppm) 1XQ8 (Exp.) Porcari et al 2015 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.95 0.08 0.85 0.16 
C36m/mTIP3 (F) 0.92 0.10 0.80 0.18 
C22*/D (U) 0.67 0.18 0.75 0.17 
A03Ws/2005 (U) 0.83 0.19 0.90 0.07 
D 
dN (ppm) 1XQ8 (Exp.) Porcari et al 2015 (Exp.) 
 
PCC RMSD (ppm) PCC RMSD (ppm) 
C36/mTIP3 (F) 0.94 1.83 0.93 3.01 
C36m/mTIP3 (F) 0.92 1.97 0.90 3.32 
C22*/D (U) 0.84 3.18 0.92 2.30 
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Table 3.5. PCC and RMSD between back-calculated (with MDTraj290) three-bond H-N-
Ha scalar J-coupling constants from simulations and experimental values of (A) Ab42, 
and (B) aS chemical shifts. Like chemical shifts, the J-couplings obtained from 
simulations were compared with two different experimental values: the fully folded PDB 
structure and experimentally obtained predominantly disordered ensemble from 
Rosenman et al 2013157 for Ab42 and Schwalbe et al 2014363 for aS. The RMSD values 
showing maximum distinction between states are shown in bold. 
A 
3JHNHa (Hz) 1IYT (Exp.) Rosenman et al 2013 (Exp.) 
 
PCC RMSD (Hz) PCC RMSD (Hz) 
C36/mTIP3 (F) 0.26 1.87 0.12 2.35 
C36m/mTIP3 (U) -0.05 2.69 0.22 1.36 
C22*/D (U) -0.22 2.87 0.53 1.10 
A03Ws/2005 (U) 0.07 2.65 0.31 1.25 
B 
3JHNHa (Hz) 1XQ8 (Exp.) Schwalbe et al 2014 (Exp.) 
 
PCC RMSD (Hz) PCC RMSD (Hz) 
C36/mTIP3 (F) 0.31 1.80 0.06 2.37 
C36m/mTIP3 (F) 0.19 2.49 -0.03 2.04 
C22*/D (U) 0.05 2.56 0.19 1.66 
A03Ws/2005 (U) 0.01 2.57 0.12 1.27 
 
Table 3.6. PCC between Residual Dipolar Coupling (RDC) constants back-calculated 
with the PALES125 software and experiments. The experimentally determined RDCs for 
disordered ensemble was only used for validation, as the alignment tensor for RDC 
calculations depend heavily on the experimental conditions used. Experimental RDC 
values for (A) Ab42 were obtained from Yan et al 2008364 and for (B) aS from Narayanan 
et al365 2012. The highest P.C.C. value (for U states) is shown in bold. 
 
A 
1DNH (Hz) Yan et al 2008 (Exp.) 
 
PCC 
C36/mTIP3 (F) 0.22 
C36m/mTIP3 (U) 0.33 
C22*/D (U) 0.30 
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B 
1DNH (Hz) Narayanan et al 2012 (Exp.) 
 
PCC 
C36/mTIP3 (F) 0.20 
C36m/mTIP3 (F) 0.33 
C22*/D (U) 0.72 




Our data helps pinpoint the molecular signatures of helix stabilization in both Ab42 and 
aS in a membrane-free physiological environment. Such events are challenging to 
characterize in the free, unbound state of the peptides using spectroscopy alone due to the 
short helix lifetimes in a predominantly disordered conformational space.335,336  
 Evaluation of the tertiary structures reveal that the predominantly disordered 
termini (C-terminal in aS and N-terminal in Ab42) are frequently involved in short-range 
(≤ 5 Å) contacts with the central hydrophobic domain (amyloidogenic CHC in Ab42 and 
NAC in aS) in helically folded states, which are removed in unfolding states. The 
computed contacts are primarily hydrophobic, stabilized by secondary salt bridges. These 
frequent contacts render the charged terminals more collapsed and rigid than during 
complete unfolding.  
 In particular, we show that the helix protective effect of the N-terminal (NTR) on 
the amyloidogenic CHC in the folded states of Ab42 relies on frequent hydrophobic 
contacts involving aromatic F4 (F4 – L17/F19/20/A21) and Y10 (Y10 – F19/F20), and 
V12–F20 in the partially folded states. Hydrophobic interactions between the F4 phenyl 
ring and the side chains of V18 and A21 have previously been shown to promote a 
compact helical fold in Ab40.87 On the other hand, F19 in the amyloidogenic CHC of 
folded states specifically interacts with the NTR residues only, which implies a 
destabilizing effect on F19–L34 tertiary contacts shown to be present at all stages of fibril 
assembly.63 In addition, salt bridges formed between NTR (E3/R5) and turn region 
(E22/D23/K28), contribute to overall favourable electrostatic networks in folded states. 
 In aS, the C-terminal (CTR) preserves the NAC helices in folded states through 
hydrophobic contacts. The hydrophobic side chains of V63/V66/A69/V70/V74/A76/V77 
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in the NAC frequently interact with I112/L113/M116/P117/P120/P128 in the CTR. The 
fact that most of the interacting NAC residues are part of the toxic and aggregation-prone 
hydrophobic core (G68 – V82)356,357 implies that stabilizing (and physically blocking) the 
core region through tertiary interactions with the CTR, would potentially delay 
aggregation.367 In this context, we note that the CTR tertiary contacts are often identified 
as being off-pathway to pathogenic fibril formation.158 Moreover, there is evidence from 
kinetic binding assays that the C-terminal might play a critical role in suppressing αS 
aggregation.315,368 Our simulations show that the NAC helical stability is protected by the 
CTR through direct hydrophobic interactions that prevent its undesired exposure to the 
solvent, further strengthened by secondary electrostatic interaction between NTR and the 
CTR (Lys residues in the imperfect repeat regions of the NTR are involved in salt bridge 
with either Glu or Asp in the CTR). During the course of complete unfolding, strong 
electrostatic repulsions between NTR and CTR become dominant. 
 The significance of the terminal interactions with the central hydrophobic 
domains in the folded states is supported by high calculated correlations between the 
conformational energy and the interaction energy (highest amongst all other 
domain−domain interactions). In addition, simulations with terminal-deleted variants 
show a higher propensity to attain unfolded states than the full-length peptides. This is 
accompanied by more unfavourable free energies per residue with the N-terminal deleted 
Ab42 and C-terminal deleted aS than their full-length counterparts, confirming that the 
helices are destabilized by terminal deletions, in line with previous studies on NTR-
truncated Ab42359-361 and CTR-truncated aS317,319,369 that showed enhanced aggregation 
and cytotoxicity.  
 In conclusion, we show that terminal group mediated interaction persists in the 
freely soluble monomeric forms, where the helical structures predominate, which may 
further protect against nascent spontaneous aggregation to helical oligomers.292,302 It was 
recently reported that folding of prion protein to its neuroprotective native a-helical 
conformation (PrPC or cellular prion) was induced by interaction of the octarepeat region 
in the disordered N-terminus with (in the case of prion) globular helical C-terminus 
domains.370,371 Moreover, deletion of a short fragment of positively charged residues in 
the N-terminus interfered with the native helical folding of PrPC.372,373 Our study 
highlights similar mechanisms of modulation of helically folded states by flexible 
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terminal groups in both amyloid-b42 and a-synuclein. We propose this mechanism may 
be common among amyloidogenic proteins and could potentially be amplified by rational 
re-engineering of the terminal sequence. Our data suggests that such experiments aimed 
at reshaping aggregation-prone helical intermediates into aggregation resistant non-
canonical helical monomers could be useful in the fight against neurodegeneration. 
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Chapter 4. Allosteric Regulation of Partially Folded Helical 




In Chapter 3, we have provided a rationale for the experimentally observed aggregation-
resistant helical stabilities of amyloid-b42 (Ab42) and a-synuclein (aS). In this Chapter, 
we will reveal how the partially folded helical states may promote earliest aggregation, 
as also suggested by experimental evidences (see below). Although low molecular weight 
soluble oligomers are thought to be the most toxic species in the amyloidogenic 
pathway,96 the early stage amyloid self-assembly of IDPs such as Ab (implicated in 
Alzheimer’s disease or AD) and aS (in Parkinson’s disease or PD) are thought to proceed 
via a-helical oligomeric intermediates.292,296,299 In turn, partially folded helical 
conformers (monomers) have been reported to be on-pathway to fibril formation.300,374 
Consequently, the tendency to form helical oligomers (through helix-helix associations) 
may be imprinted within the minor populations of aggregation-prone partially folded 
helical monomers292,295,300,374 that both Ab and aS display in membrane-free aqueous 
solution,87,164 and which arise via conformational exchanges between non-aggregating 
helically folded and disordered states. Moreover, formation of partially folded 
intermediates has long been correlated with aggregation and is a key step in 
fibrillation.375,376 
 The energy landscape concept of protein folding and binding have been well 
documented.377 Especially, the ruggedness and ‘frustrations’ of an IDP energy landscape 
have to a large extent been attributed to fluctuated allosteric transitions.378 Allostery,379 
or regulation at a distance, plays a central role in mediating protein recognition, signal 
transduction and promiscuous interactions of intrinsically disordered proteins 
(IDPs).380,381 NMR relaxation measurements demonstrate correlated collective internal 
dynamics within IDP ensembles,382-385 a potential signature of allosteric coupling,386 and 
most IDPs exhibit allostery dynamically, where perturbation (such as folding or ligand-
binding) within one effector domain results in a regulatory effect on a distant, but 
energetically coupled, domain.387,388 As disorder is a functional advantage for regulation 
by allostery,389 conformational shifts may accommodate molecular recognition of IDPs 
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through hydrophobic interactions31 and promote folding-induced binding or 
conformational selections390 during self-assembly in many neurodegenerative 
diseases.64,391   
 It is extremely challenging to identify and measure the subtle variations in the 
degree of helicity and thus the difference between the helical intermediates using 
spectroscopy measurements,295 due to the very short-lived states of the monomer helices. 
Thus, little is known about what causes partially folded helical Ab42 and aS to be so 
aggregation-prone, compared to the fully folded or unfolded conformations (RQ2). In 
this study, we comprehensively map internal allosteric communications across helically 
folded, partially folded and unfolded states of Ab42 and aS peptides by computing free 
energy landscapes and dynamic cross-correlation networks from extensive microseconds-
scale molecular dynamics (MD) simulation data. We identify functionally relevant sub-
domains involving the charged termini ends that are distant from the hydrophobic 
domains, yet play a critical role in modulating their helical folds, through long-range 
allosteric coupling. Starting from solved helix-turn-helix structures,89,90 we employed a 
range of physical models with diverse helix-coil transition propensities to generate a 
broad distribution of conformational states (see 4.2 Methods). No single physical model 
has been able to produce consistent results for both the folded and the disordered states 
of IDPs (or the transitions in-between),64,212,213,215,222, and so we take advantage of model 
inhomogeneity to sample extensively in the rich IDP conformational sub-spaces. We 
recently used a similar strategy to characterise the a-helical ‘foldedness’ of Ab42 and 
aS.392 In detail, CHARMM36205 protein model (C36) with CHARMM-modified TIP3P 
water202 (mTIP3) and C36 with TIP4P340 (TIP4), gave predominantly fully-helical folded 
states while CHARMM22*204 (C22*) with TIP4P-D214 (D) and Amber ff03ws213 
(A03Ws) with the scaled TIP4P/2005213 (2005), gave partial helical folded states together 
with some completely unfolded (disordered) states (see 4.2. Methods). 
 
4.2. Methods 
The initial structures for equilibrium atomistic MD simulations were obtained from the 
NMR-derived helix-kink-helix structures of Ab42 solved in 20% water/80% deuterated 
hexafluoroisopropanol (PDB code 1IYT89) and micelle bound human αS solved in 
aqueous solution with sodium dodecyl sulfate (PDB code 1XQ890). As I have discussed 
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under Methods in Chapter 3, we wanted to start from a predominantly helical 
conformation to monitor the unfolding of helices, so we chose the aforementioned 
experimental models as our starting geometry. The two helices for Ab42 span Ser8 – 
Gly25 (helix 1) and Lys28 – Gly38 (helix 2), while for aS they span Val3 – Val37 (helix 
1) and Lys45 – Tyr92 (helix 2). All MD simulations were performed using the Gromacs 
5.1.4227 package. The starting structures were represented by three different protein force 
fields – CHARMM36205 (C36), CHARMM22*204 (C22*) and Amber ff03ws213 (A03Ws), 
and solvated in boxes containing four different water models – CHARMM-modified 
TIP3P202 (mTIP3), TIP4P (TIP4), protein-water interaction scaled TIP4P/2005213 (2005) 
and TIP4P-D214 (D) resulting in four distinct combinations of force fields and water 
models: C36/mTIP3, C36/TIP4P, C22*/D and A03Ws/2005. The details of these 
simulations are laid out in Table D1 under Appendix D. Additionally, we performed 
3.4µs of Hamiltonian replica exchange (70 ns * 48 replicas simulated at different 
Hamiltonians). These simulations used solute tempering (scaling)240,393 (H-REST) with 
C22*/D (aS) starting from a completely disordered state (for details on this enhanced 
sampling method, refer to Chapter 2). The steady states of the equilibrium MD (EMD) 
and H-REST simulations were assessed by the convergence of temporal cumulative 
average helix percentages (Fig. D1 under Appendix D). The converged helical content 
for C22*/D with aS for both EMD and H-REST show steady state populations of ~20%, 
indicating similar helical subspace sampling for the two different methods. The last 200ns 
was used for analysis of the EMD simulations of different states (folded, partially folded 
and unfolded), while the last 20 ns (out of the 70 ns/replica) was used for analysis of the 
H-REMD simulation. We show using free energy maps of percent helicity and radius of 
gyration, that the conformational spaces explored for the partially folded helical states in 
our EMD simulations matches up with H-REST simulations. H-REST sampled 
conformational spaces of transiently formed helices that are refolded from a completely 
disordered state, confirming that our sampling of helical subspaces is statistically robust 
(Fig. D2). 
 Physiological concentrations (0.15 M) of NaCl were added as counter-ions to 
neutralize the additional formal charge on the proteins. The minimum distance between 
a protein atom and the boundary of the boxes was set at 20 Å. The protein and water 
molecule bond lengths to hydrogen were constrained using the LINCS343 and the 
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SETTLE344 algorithms, respectively. An integration step of 2 fs was chosen for running 
the simulations employing the velocity Verlet integrator,234 and coordinates were saved 
every 20 ps. Long-range electrostatics were treated by the Particle mesh Ewald (PME) 
method.246 All systems were minimized for 50000 steps, and equilibrated for 1 ns in NVT 
ensemble followed by another 1 ns of NPT equilibration with the reference pressure at 1 
bar and a time constant of 4 ps using the Berendsen barostat.247 Protein and non-protein 
(water and ions) molecules were coupled separately to an external heat bath with the 
coupling time constant of 1 ps using the velocity rescaling method.248 The production 
runs were carried out in the constant pressure and temperature NPT ensemble. 
 Simulations were run for ~2 µs for Ab42 and ~1.5 µs for aS with each of the four 
combinations of protein force fields and waters models, amounting to a total run time of 
~14 µs. For simulations using C36/mTIP3 and C36/TIP4, complete unfolding of the 
helices does not occur within the simulation time, with both Ab42 and aS, retaining ~⅓ 
helicity (a-helix + p-helix + 310-helix, Fig. S1). These states are hence regarded as folded 
states. For C22*/D, fast and complete unfolding occurred by ~0.2 µs for Ab42 and ~0.6 
µs for aS, while for A03Ws/2005 a slower complete unfolding occurred by ~1.5 µs for 
Ab42 and ~ 1.2 µs for aS. Hence the last 200 ns before complete unfolding of C22*/D 
and A03Ws/2005 are regarded as partially folded states, and the final 200 ns of the 
trajectories with C22*/D and A03Ws/2005 are regarded as completely unfolded states. 
All analyses were carried out using the Gromacs 5.1.4 analysis tools. Contact probability 
maps were generated using the CONAN345 contact analysis tool and water dynamics was 
monitored using VMD16 software. 
 The values for the free energy (measured in kcal/mol) surface map using two 
different order parameters (used to distinguish between two different states: order and 
disorder here. Percentage of helical population and radius of gyration are two different 
order parameters) were obtained using the equation: 
∆𝐺 = −𝑘. 𝑇. (𝑙𝑛𝑃9 − 𝑙𝑛𝑃QgJ)                                  (4.1) 
where Pi is the probability distribution for pairs of order parameters, and Pmax is its 
maximum, such that lnPi – lnPmax identifies the lowest free energy point at DG = 0, kB is 
the Boltzmann constant and T is the absolute temperature.  
  Dynamic network analyses of cross-correlated motions were performed using the 
Bio3D R package.276,277 Correlated residue pairs were identified using linear Ca atomic 
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displacements, as opposed to linear mutual information.394 Consensus networks were 
generated for each of the designated folded, partially folded, and unfolded states of WT 
Ab42 and aS, using the method similar to Luthey-Schulten,275 but with network edges 
weighted based on the Ca-Ca cross-correlation values to include long-range interactions 
between residues that are not in direct contact. In a mass-weighted network graph, the 
residues represent nodes i and j, and the weights represent the edges with Pearson cross-
correlated (PCC) values278 cij connecting the nodes.  
 A community is defined as a cluster of nodes (residues) that are highly intra-
connected through correlated motions. The value of cij ranges between -1 and 1. cij is 
closer to -1 when the two coupled residues are negatively correlated or anti-correlated, is 
0 when they uncorrelated, and closer to 1 when they are positively correlated. All 
networks were constructed with a |cij| ≥ 0.4 (the modulus represents absolute value taken 
for both positive and negative correlations) based on the following criteria: (1) False 
positives or false negatives using a too low or high values of |cij|, respectively, could be 
circumvented by using a near-midpoint value of cross-correlated PCC (see Figs. S9A-
14A where the network graphs lose connections (edges) between nodes as the threshold 
|cij| is increased, identifying how flexible these IDP systems are). (2) The network 
structure remains consistent between 0.35, 0.4 and 0.45 allowing similar community 
partitioning. Dynamic cross-correlation maps (DCCMs) were further plotted at a PCC 
threshold of 0.4, from matrices representing |cij| ≥ 0.4.  
 Network path analyses (method of path analyses is described under Chapter 2) 
were carried out by considering four different combinations of ‘source’ and ‘sink’ residue 
pairs (start and end nodes) in both Ab42 and aS: (1) N-terminal end and C-terminal end, 
(2) Start of initial helical regions (in the original PDB) and end of helix, (3) Start of helix 
1 and end of helix 1, and (4) Start of helix 2 and end of helix 2. Consequently, the optimal 
path (shortest path) and sub-optimal paths were deduced out of a total 500 distinct paths 
constructed for each source and sink pair, using the shortest loopless path algorithm280 
implemented in Bio3D. Path length (summation over the weights of traversed edges and 
not representative of an actual geometrical length) distributions with their probability 
density were compared, which measures the coupling strength between residue pairs. 
Calculated non-normalized node degeneracies quantify the number of paths traversing 
each node, highlighting densely connected nodes. In addition, frequently crossed ‘hub’ 
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nodes were identified from measured betweenness centrality (or node centrality) of the 
number of unique shortest paths crossing each node. For details on the dynamic cross-
correlation network analysis method, see Chapter 2.  
 
4.3. Result and Discussion 
4.3.1. Free energy maps reveal the population distribution and densities of helical 
states 
Here we compute the helix (a-helix + p-helix + 310-helix) unfolding patterns (see Fig. 
D3 under Appendix D for the temporal evolution of helical content in different states) 
and the corresponding population distributions of Ab42 and aS from 2D free energy maps 
using residual helical percentages and radii of gyration (Rg) as order parameters. The 
complete helically folded states in our EMD simulations record a high percentage of 
helices. While such high helical content events might be extremely rare under 
physiological conditions in water, we reiterate that the idea here is to magnify these rare 
events to accurately delineate the features of otherwise experimentally imperceptible 
helical stability.  
 Ab42 display dense minima for the helically folded states (Fig. 4.1A, top panels) 
in the left high-helicity/small-radius region of the energy basin. A sharp energy barrier 
separates conformations with less than ~50% helical content sampled at low Rg, which 
reflects the difficulty in initiating helical unfolding from a predominantly compact state. 
The secondary structure (Fig. D4A) shows helix-rich (>80%) distal N-terminal (NTR, 
spanning residues 1 – 16), central hydrophobic cluster (CHC, 17 – 21) and proximal C-
terminal (CTR, 30 – 42) regions for the folded states; the remaining residues form the 
designated turn region (22 – 29).395 
 The partially folded helical states populate the minima of low-helicity/large-
radius basins (Fig. 4.1A, bottom panels) as Ab42 forms a more open structure and the 
significantly lowered helix population of partial folds in the distal NTR, CHC and CTR 
is compensated by turn regions, demonstrating the conformational plasticity of IDP 
structures (Fig. D4A). More extended structures (b-strand + b-bridge) are extremely rare 
and transient (Figs. D4A, D5A), with helices being the predominant structural motif. 
Helices can reform in the turn region from completely disordered states (Fig. D5A) and 
bear resemblance to partially folded helices (Fig. D4A). However, for the models 
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favouring disordered structures, in particular C22*/D, helices are extremely transient 
(<10%). This feature is underlined by the free energy maps, where transient helices arise 
at a broad range of compact and elongated conformations but are separated by high energy 
barriers (Fig. D8A). 
 
 
Fig. 4.1. Free energy surfaces of helical population and radius of gyration (Rg) for (A) 
Ab42 and (B) aS displaying folded and partially folded conformations, with 
representative helical conformations shown at different energy minima. The N- and the 
C-terminus are represented as red and green spheres, respectively. 
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 While the solvent-accessible surface area (SASA) scales as expected with Rg for 
Ab42 in both folded and partially folded states (Fig. D6A), a broad end-to-end distance 
(Re) is sampled within the narrow Rg of the folded states (Fig. D6A). This is because 
preservation of helices keeps Ab42 compact and globular, but divergent directionality of 
the N- and C-termini allows a comparatively large Re. Rg and Re are more correlated in 
the partially folded states due to overall extension but diverge again in conformations 
forming from completely disordered states (Fig. D7A). 
 For aS, model C36/TIP4 samples stable compact folded helices in an area of high 
helicity and low Rg basins (Fig. 4.1B). By contrast, C36/mTIP3 retains elongated helices, 
covering a narrow range of large Rg and 35 – 60% helices. Significant barriers identify 
distinct helical breaks at Gly residues leading to transition from a higher helicity (smaller 
Rg) to a lower helicity (larger Rg) minima. Persistent helices in the NTR (1 – 60) and 
hydrophobic non-amyloid-b component (NAC, 61 – 95) can be seen in the folded states 
of aS (Fig. D4B), which are by contrast extremely transient in the charged disordered 
CTR (96 – 140).  
 The partially folded states (Fig. 4.1B) sit mainly in the lower-left quadrant of the 
free energy landscape. The Rg distribution is densely populated between 15 – 35 Å, which 
identifies a heterogeneous population, but at the same time fairly compact given the 
length of aS. Sparsely populated large Rg basins demonstrate that formation of extended 
helical states might be a minor event during complete unfolding, and not necessarily a 
requirement for unfolding helices as was seen for Ab42. Transient helices can reform 
from disordered states (Fig. D5B) with significantly more extended configurations 
observed in the NTR and NAC. Despite tendencies to reform helices from disordered 
states in both Ab42 and aS (Fig. D5), the unfolded states offer significantly high energy 
barriers to refolding helices (Fig. S6B) confirming their negligible tendency to (re)sample 
helices than partial folds. The distributions of protein expansiveness and solvation (Figs. 
D6B, D7B and D8B) space fill larger areas as the conformations shift from helically 
compact to partially folded to completely unfolded states. Overall, the unfolding pattern 
of aS involves a more compact helix unravelling than Ab42, with low occurrence of 
helical refolding. Conformational heterogeneity is most prevalent in the partially folded 
states for both peptides. 
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Fig. 4.2. Computed contact maps (frequency, %) between residues in (A) Ab42, and (B) 
aS in folded, partially folded, and unfolded states. A contact occurs if the minimum 
average distance between heavy atoms (upper left triangle) or Ca atoms (lower right 
triangle) of each residue is within 5 Å in the last 200 ns of simulation. 
 
4.3.2. Charged terminal tips do not contact the hydrophobic hotspots in partially 
folded helical states 
We have previously demonstrated that the stability of helices in both Ab42 and aS are 
governed predominantly by terminal-mediated short range contacts with the central 
hydrophobic domains.392 We wanted to further identify the predominant short-range 
contacts in both partially folded helical and unfolded states. Calculated short-range 
(within 5 Å) contact probabilities between heavy atoms across all residue pairs (Fig. 
4.2A) show anti-diagonal contacts (left triangle) for Ab42 involving the CHC and CTR, 
corresponding to a helical hairpin-like conformation (Fig. 4.2A). In addition, more 
frequent contacts (>60%) between the distal NTR (R5 – V12) and the CHC are found in 
the folded states than in partially folded or unfolded states. The first four NTR residues 
are disordered, and do not interact with CHC, but instead with the turn region in the folded 
state. These contacts are not seen in the Ca contact maps (right triangle), indicating that 
the interactions are mostly between side chains. aS also exhibits anti-diagonal contacts 
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between NAC and the proximal CTR (K96 – Q134 away from the CTR tip) in the folded 
states (Fig. 4.2B), which are sparse (<20%) or totally absent in the partially folded and 
unfolded states. For C36/TIP4 model, the CTR end (135 – 140) interactions with NTR, 
in addition to NTR-NTR and NTR-NAC contacts, stabilize the folded state. By contrast, 
strong contacts (>70%) between NTR and NAC form in the unfolded states, with the CTR 
mostly extended into solution. 
 
Fig. 4.3. Consensus networks of Ab42 using a |cij| filter of 0.4, showing sub-optimal paths 
for propagation of disorder from (A) folded and (B) unfolded states, for full-length 
(source D1 – sink V42) and initial helical regions (source S8 – sink G38) in the folded 
structure. Network structures are overlaid on representative folded and disordered 
conformations with domains colored by region: red = NTR, grey = CHC, blue = turn, and 
green = CTR. Path thickness reflects inter-residue (intra-domain) coupling strengths. 
Optimal paths are shown below each network, with residues colored by hydropathy: white 
= hydrophobic, green = polar, red = negatively charged, and blue = positively charged. 
Broken lines between two nodes represent coupling including all residues in between. 
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4.3.3. Anti-correlated sub-domains during helix unfolding are separated by long 
distances 
 To characterize the partially folded states and probe the origin of their higher 
conformational heterogeneity compared with unfolded states, we performed cross-
correlated network analyses of Ca atomic fluctuations using the R package, Bio3D276,277 
(see 4.2. Methods) across all states of Ab42 and aS. Dynamic cross-correlation maps 
(DCCMs) of Ab42 filtered at Pearson correlation coefficient (PCC or |cij|) ≥0.4 (see 4.2. 
Methods for selection of this threshold value based on network graphs: Figs. D9-14 under 
Appendix D) identify positive correlation (red) in the folded states between the closely 
interacting (Fig. 4.2A) proximal (D1 – R5) NTR (N-terminal region, residues 1 – 16) and 
the turn region (22 – 29), and between the distal NTR and M35 in the CTR (C-terminal 
region, 30 – 42) (Fig. D9B). However, the overall tendency to unfold the helices comes 
from dominant off-diagonal anti-correlated sub-domains (cluster of residues within a 
domain) involving the NTR, turn region and CTR.   
 The sole cross-correlated regions are actually anti-correlated in the partially 
folded helical states of Ab42 involve communications between the sub-domains of NTR 
(D1 – E3) and central hydrophobic cluster (17 – 21): CHC (L17 – V18), turn (E22 – V24) 
and CTR (V36 – G38), and to a small extent NTR (H14 – K16) and A30 in CTR (Fig. 
D10B). DCCM from completely unfolded states of Ab42 is further reduced to intra-NTR 
and CHC-CTR negative correlations (Fig. D11B). No discernible cross-correlations is 
observed with the CHC in both folded and disordered states.  
 Similar to Ab42, the folded states of aS retain positively correlated areas at |cij| ≥ 
0.4 involving close-range (Fig. 4.2B) couplings between NTR (N-terminal region, 1 – 
60) and CTR (C-terminal region, 96 – 140), and NAC (non-amyloid-b component, 61 – 
95) and CTR sub-domains (Fig. D12B), while a larger number of anti-correlated sub-
domains ensure general propensity to unfold helices. As such, the partial folds only retain 
anti-correlated sub-domains (Fig. D13B) encompassing NTR (V15 – A27 and V52 – 
K60) and NAC (E61 – T64), NAC (F94 – K96) and CTR (Y133 – D135), and intra-CTR 
(E104 – E110 and S129 – A140). Due to the short-range NTR-NAC contacts (Fig. 4.2B) 
in the disordered states, intra-NTR positive correlations are revealed (Fig. D14B), which 
are further counteracted by NTR-NAC and NTR-CTR anti-correlations. 
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4.3.4. The helically folded and unfolded states propagate disorder without involving 
the central hydrophobic domains 
Concerted residue fluctuations were modelled by consensus correlation networks with 
four chosen source-sink residue pairs denoting regions encompassing the full-length, 
initial helices, helix 1 and helix 2 for both Ab42 and aS (see 4.2. Methods) at |cij| ≥ 0.4. 
The path length distributions for the helically folded states of Ab42 (Fig. D9C under 
Appendix D) show that the overall path of helix 1 is relatively short, while helix 2 path 
is nearly as long as the initial helical regions. Cooperativity between helices in unfolding 
is observed as the shortest path of helix 2 (Fig. D9E) from source K28 traces back to S26 
(adjacent to end of helix 1) before reaching M35 in the CTR, providing a potential 
explanation for the high energy barriers faced in unfolding the initial helices of the folded 
states (Fig. 4.1A). 
 The optimal path in full-length folded Ab42 (Fig. 4.3A) shows that disorder 
propagates through direct coupling of the NTR tip D1 and site M35 of CTR without 
populating other (sub)domain-specific nodes, which may confer a protective effect on the 
core helices. A similar trend (path from E11 in NTR to M35 in CTR) is seen when the 
initial helical regions are considered. Node degeneracy maps (Fig. D9D) reveal M35 
forming a centralized hub (Fig. D9F). The completely disordered states show non-
overlapping path-length distributions, with helix 2 paths being the shortest, but the helix 
1 paths are less dense than full-length or initial helical region paths (Fig. D11C). The 
ideal path on helix 1 skips the CHC region (Fig. D11E, see also minor paths in Fig. D11D 
and network hubs in Fig. D11F), as do the optimal paths of full-length helices (Fig. 4.3B, 
showing direct coupling between NTR Q15 and CTR A30). However, helix 1 does not 
include the CTR, which contributes significantly to the path density of the full-length 
Ab42 (Fig. 4.3B).  
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Fig. 4.4. Consensus correlation networks of aS using a |cij| filter of 0.4. Network paths 
for the (A) folded, and the (B) unfolded states. Legend is as for Fig. 2, except domains 
are colored as red = NTR, grey = NAC and green = CTR, with different source-sink 
residue pairs annotating the full-length (source M1 – sink A140) and the initial helical 
regions (source S8 – sink G38). 
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 In contrast to the Ab42 CHC region, DCCM of aS shows that sub-domains of 
NAC are correlated with other regions in folded and unfolded states. However, the 
optimal paths of disorder propagation in these states (Fig. 4.4) generally avoid the NAC 
sub-domains, with only G84 of the NAC falling on the ideal path traversing the NTR (M1 
– G14) and CTR for the full-length folded states (Fig. 4.4A). This is because nodes within 
the NAC that could potentially act as hubs are isolated by long non-populated sequences 
(Fig. D12F and D14F). The shortest path on helix 1 travels until S42 (close to the start 
of helix 2) and traces back to the end of helix 1, while for helix 2 it travels all the way 
back to A18 (belonging to helix 1) before ending with V95 – T92 (Fig. D12E). This 
indicates a prevalent inter-helical cooperative effect in unfolding the initial stable helices, 
as also seen in Ab42. The NTR shows the maximum number of paths (Fig. D12D). The 
shortest path along the full-length of the disordered states communicates between NTR 
(M1 – G7) and CTR (V118 – A140) (Fig. 4.4B), which for the initial helical regions do 
not involve any intermediary nodes (direct coupling between V3 and V92; see also Figs. 
D14C-E).  
 
4.3.5. Long-range dynamic coupling between terminal tips and central hydrophobic 
domains confers allosteric regulation of partially folded helical states  
Networks of partially folded Ab42 also sample distinct path-length distributions much 
like unfolded states, but helix 1 paths are densest (Fig. D10C). This is because the CHC 
region not only traces the shortest path on helix 1 (Fig. D10E), but also allows a greater 
number of paths to traverse than in the full-length or initial helical paths. The optimal 
path of disorder propagation from full-length partial folds involves couplings between the 
N-terminal tip (D1-A2) and transiently folded CHC (L17 – E22), before terminating at 
CTR (V36 – A42) (Fig. 4.5A).  
 In the initial helical region, the shortest path skips from the distal sub-domain of 
NTR (S8 – H14) to the CHC region. The paths identify extensive communication between 
sub-domains of NTR and CHC, which do not form short-range (<5 Å) geometrical 
contacts in the partially folded states. Thus, the CHC residues are extremely degenerate 
with all source-sink paired paths (except helix 2, which does not include the CHC region) 
(Figs. D10D, D10F). 
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Fig. 4.5. Consensus networks of the partially folded states of (A) Ab42, and (B) aS 
following the same scheme used in Figs. 2 and 3. (C) Schematic of proposed mechanism 
of long-range (up to 20 Å) allosteric coupling between the tip of the charged terminus 
(CT) and the central hydrophobic domain (CHD). This coupling is lost at distances >20 
Å for the folded and the unfolded states. 
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 In contrast to folded and unfolded states, the optimal path of partially folded states 
of aS reveal significant coupling between the full NAC domain (Q62 – V95) and CTR 
sub-domain (Y133 – A140) spanning the source-sink pair of full-length aS (Fig. 4.5B). 
The shortest path for helix 1 identifies similar node connectivity when calculated across 
full-length or initial helices in the NTR, which for helix 2 is continuous from K45 to V82 
mapping the imperfect repeats (Fig. D13E). The path lengths are distributed according to 
the size of the fragments and are very distinct (Fig. D13C). The dense population of 
several paths crossing the NAC residues (Fig. D13D) clearly distinguishes partially 
folded states from the node degeneracy of folded or unfolded states with large gaps on 
NAC nodes. Finally, the NAC domain is the most prominent network hub, followed by 
the CTR (Fig. D13F). 
 
Fig. 4.6. Probability distribution of distances from the (A) center of mass (COM) of D1 
– A2 in the NTR to the COM of the hydrophobic CHC (L17 – A21) for Ab42, and (B) 
from the COM of the hydrophobic NAC (Q62 – V95) to the COM of Y133 – A140 in the 
CTR, for folded, partially folded and unfolded states. These regions are shown to be 
highly correlated in the partially folded states (Fig. 4.5).  
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 We calculated separations between sub-domains involved in disordering partially 
folded helical states, by monitoring the distribution of distances from the centre of mass 
(COM) of the N-terminal end (D1 – A2) of Ab42 to the COM of CHC (L17 – A21), and 
the COM of C-terminal end (Y133 – A140) of aS to the COM of NAC (Q62 – V95) (Fig. 
4.6). For Ab42 (Fig. 4.6A), concerted fluctuations peak at separations of ~15–18 Å in 
partially folded states, and for aS at ~18–20 Å (Fig. 4.6B). By contrast, all folded and 
disordered states sample longer and/or broader distributions, which indicates that partially 
folded states are allosterically modulated by the (predominantly disordered) termini 
through long-range couplings up to a distance of 20 Å, beyond which the allosteric effect 
fades out. It was previously shown that the b-hairpin formed by the Aβ(17–34) fragment 
is allosterically stabilized by the N-terminal around 10 Å from the centre of the fragment, 
by the release of entropy to the surrounding water 159. Our analyses of water dynamics 
within 10 Å of the most hydrophobic CHC (Fig. D15A) and the fibril-forming core of 
NAC (68 – 78)357 (Fig. D15B) show subtle differences in temporal water retention 
between states. Evidently, the cores of the partially folded structures retain more water 
molecules than either of the disordered or the folded states for both IDPs, which supports 
the hypothesis that entropically favourable release of retained water may drive inter-
molecular oligomeric associations.396 
 
4.4. Conclusion 
In summary, we have derived an analytical insight into the regulation of aggregation-
competent Ab42 and aS partial helical folds via dynamic control of long-range intra-
peptide allosteric signalling between two distal sub-domains encompassing the flexible 
hydrophilic termini (C-terminus in aS and N-terminus in Ab42) and the hydrophobic 
hotspots of amyloidogenesis. Partially folded helices (intermediary between folded and 
unfolded) display a relatively flat energy surface that samples heterogeneously 
interconverting states. Computed dynamic cross-correlation networks suggest that 
susceptibility to form locally ordered (partial) helices in the central hydrophobic domains 
is upregulated by allosteric coupling with charged residues in predominantly disordered 
terminal ends. This allostery manifests across a long distance of up to 20 Å and might 
play a major role in promoting helix-helix associations. Our predictive model of allostery 
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is consistent with hydrophobic protein self-assembly397 modulated by immobilized 
ions.398 Hydrophobic interactions can be switched on or off according to spatial 
arrangements of charged groups,399 as indicated also from our analyses, providing a 
potential explanation for why partial helices may be more prone to 
oligomerization300,302,374,400 than predominantly folded or unfolded states (Fig. 4.5C). We 
envisage that our modelling strategy could be applied to study monomeric helical 
intermediates of other IDPs401 and help rationally re-engineer their tendency to initiate 
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a-synuclein (aS) is the primary component of Lewy bodies and neurites, the insoluble 
aggregates that are the pathological hallmark of Parkinson’s disease (PD),402 as I have 
introduced in Chapter 1 of this thesis. Few recent experimental evidences suggest that a 
helically folded tetramer of aS resists further aggregation and fibril formation under 
physiological conditions.83,166 These observations are against the long-standing view that 
aS exists natively as an unfolded monomer (hence the name, IDPs) that is prone to 
aggregation,82,186 and more recently from in vivo NMR and EPR experiments showing 
that the intrinsic disorder is preserved in crowded mammalian cell environment.85 Some 
have attributed the existence of aS folded helical tetramers to stabilizing cofactors in 
neurons such as small lipids, which is destabilized during protein purification leading to 
monomers.184 Other studies show that PD-causing familial pathogenic missense 
mutations (such as E46K, H50Q, G51D and A53T) decrease the tetramer:monomer 
ratios, thus destabilizing the helical tetramers, and inducing neurotoxicity and Lewy body 
inclusions.187 These studies point towards a dynamic equilibrium between disordered 
monomers and helical tetramers under cellular conditions.84,165 On the other hand, 
missense mutations in the conserved consensus repeat motifs, KTKEGV have been 
shown to block the formation of aggregation-impeding tetramers and induce PD-like 
neurotoxicity,403 an intriguing observation that aS tetramers may play a crucial role in 
maintaining cell viability.404 In addition, homologous E→K mutations of aS (E35K, 
E46K, and E61K) could individually (familial PD causing E46K) or collectively obstruct 
aS tetramers/multimers and encourage aggregation of monomers at membranes to 
facilitate vesicle-rich inclusions.185,188 
 Monomers of aS are predominantly IDPs in water,64 but can adopt multitude of 
helical conformations in organic solvents or when bound to membranes,94 including both 
broken90,91 (two anti-parallel helices separated by a linker) and extended helices when 
vesicle-bound.311,405 Interestingly, a number of studies have also reported on the 
membrane-associated aS monomer structure with a helical periodicity of 11/3 (11 
residues complete three turns) as opposed to a 18/5 (18 residues completing 5 full turns) 
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periodicity of a ‘true’ a-helix.406-408 Especially, site-directed spin labelling with an EPR-
based approach showed that membrane-bound monomeric aS can form an extended, 
curved helical structure with a super-helical twist having 11/3 periodicity.409 
Furthermore, the authors proposed that such 11/3-helical architecture may be conducive 
to assemble into a 11/3-helical aS tetramer (as opposed to an a-helical tetramer) akin to 
tetrabrachion, a right-handed coiled coil tetramer protein having 11-residue repeats that 
exists naturally.410 This is in contrast to a proposed broken a-helical aS tetramer model 
(in a membrane-free environment) with the missense pathogenic point mutations located 
around a putative loop (linker) region separating the two a-helices.411 Recently, possible 
existence of an extended soluble helical monomer of aS in water was underscored 
facilitated by transient interactions with the lipid membrane, thus proposing that the lipid 
environment might act as a chaperone favouring helical refolding just like crowded 
cellular environment.164  
 In line with the above experimental evidences, there have been few attempts to 
computationally model and rationalize the existence of aS helical tetramers 
assembly,140,189-191 but they have been speculative to a large extent. I have discussed these 
molecular dynamics (MD) studies under section 1.8.1. a-synuclein helical tetramers in 
Chapter 1. Given that hydrophobic packing plays an important role in folding and 
stabilization of globular proteins,412 for IDPs like aS which display a broad distribution 
of conformational substates under physiological environment,64 hydrophobic interactions 
have been suggested to be a major driving force governing their self-assembly into 
oligomers,413 as ‘hydrophobes’ also pack along the fibril growth axis.414 We note that 
most homomers have high structural symmetry,415 and cyclic symmetries are thought to 
be the basic building blocks for de novo design of self-assembling proteins such as water 
soluble a-helical barrels416 and helical bundles with high thermodynamic stability.417 
This preliminary knowledge may potentially make modelling and design of homomeric 
assemblies (like aS tetramer) less complex than heteromeric assemblies.418 
 In this work, we utilize the above knowledge to rationally design predictive 
models of helical aS tetramers, also incorporating available information from 
experimental data. In turn, our modelling rationale attempts to answer these several 
unresolved questions (RQ 3): (1) Could the same a-helical regions (Val3–Val37 and 
Lys45–Thr9) that form curved helices in the micelle-bound aS broken a-helical 
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monomer (PDB code 1XQ890), persist in a a-helical folded tetramer in membrane-free 
water, and does the hydrophobic non-amyloid-β component region (NAC, Glu61–Val95, 
forms the second a-helix fragment and is an essential molecular signature for aS 
aggregation and fold preference419) play a role in forming a stable a-helical tetramer 
assembly by packing those hydrophobic residues, or do the charged N-terminal (Met1–
Lys60) and C-terminal (Lys96–Ala140) also contribute to the stability of aS tetramer? 
(2) How do PD-causing missense familial mutations such as E46K, H50Q, G51D, and 
A53T187 destabilize the a-helical aS tetramer? (3) In line with the observation of 
membrane-bound 11/3-helical extended aS monomers,409 could the same helical 
periodicity of monomers and tetramers sustain in the membrane-free aqueous 
environment, how does the continuity (extended Vs. broken) and periodicity (11/3-helix 
Vs. a-helix) of helices control the stability of aS tetramer assembly, and how does E→K 
mutations (E35K, E35K+E46K, and E35K+E46K+E61K) affect the tetrameric 
assembly? (4) Why are helical aS in tetrameric assembly so ubiquitous compared to other 
low molecular weight helical multimers of different monomeric sizes? We employ 
extensive atomistic MD simulations to answer the aforementioned questions. 
  To address the first two questions above, we probe the free energy landscape of 
αS tetramerization from four alternatively designed broken a-helical constructs and 
identify the active state corresponding to the conformation attained by a monomer when 
bound in a stable tetramer. In the process, we design a most stable de novo broken a-
helical tetramer with a reconstructed loop motif using available experimental data.411 Our 
results highlight that optimization of inter-monomeric hydrophobic packing in NAC 
regions facilitate assembly to a stable broken a-helical tetrameric construct, with 
secondary roles of the termini in regulating stability. Moreover, we show that PD-causing 
familial mutations may create a much higher energy barrier for association of a-helical 
monomers into the aggregation resistant a-helical tetramer, shifting tetramer–monomer 
equilibrium back towards aggregation-prone disordered monomers. Next, we investigate 
on the possible existence of an extended 11/3-helical tetramer in water by reconstructing 
tetramer models utilizing the curvature geometry of experimental membrane-bound 
monomer structures,409 and compare their thermodynamic stabilities with broken a-
helical tetramer model. Our findings reveal that while the relative stabilities of different 
extended 11/3-helical tetramer constructs are heavily determined by their inter-
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monomeric electrostatic interactions, the wild type (WT) extended 11/3-helical tetrameric 
assembly is in general less stable than our designed de novo broken a-helical tetramer 
model, but more stable than tetramer formed by micelle-bound aS,90 thus underscoring 
the importance of a plausible intermediary extended 11/3-helical tetramer conformation 
while transitions between membrane-associated and membrane-free broken a-helical 
tetramers. Furthermore, both broken and extended tetramer helix destabilizations due to 
the collective hierarchical homologous E→K mutations predict that their NAC regions 
are more exposed to water, which may facilitate imminent dissociations. Finally, we 
characterize the thermodynamic and kinetic properties of both WT and quadruple mutated 
(E46K + H50Q + G51D + A53T) a-helical tetramers from a re-designed more stable 
(than the previous de novo model) de novo a-helical tetramer assembly in order to 
elucidate the phenomenon of tetramer ubiquity compared to aS oligomers of different 
sizes from dimer to octamer. We show that although the conformational stability of aS 
oligomers increases linearly with the number of monomers, assembly of aS multimers 
proceed via multiple energy barriers, for which the tetramer shows the lowest activation 
energy, which may explain its ubiquity. 
  
5.2. Methods 
The design strategies used in this study can be further divided into three parts: 
 
5.2.1. Predictive modelling of broken a-helical tetramers 
 The initial structures of broken a-helical αS tetramers T1, T2, T3 and T4 (see Fig. 5.1 
showing different hydrophobic packing in the NAC) were designed as follows: T1 was 
constructed by packing the membrane-bound αS structure (PDB ID: 1XQ890); T2 was 
taken from previous simulation results of αS multimers;140 T3 deduced from electron 
microscopy in combination with nuclear magnetic resonance and circular dichroism was 
generously provided by Prof. Thomas Pochapsky;166 and T4 was designed in terms of 
available experimental evidence about the loop region connecting a1 and a2 segments in 
helical aS tetramers.411 Except T2, the other three tetramers are homogeneous tetramers. 
M1, M3, and M4 are the monomers used to construct T1, T3, and T4, and directly used 
in the control monomer simulations; whereas T2 is a heterogeneous tetramer, and only 
one of its monomers was used in simulations of M2. The starting tetramer structures 
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formed by NAC are taken from the corresponding full-length tetramers (see Fig. E1; Figs. 
E2-E14 are discussed under 5.3. Result and Discussion). The initial structures of βS 
monomer and tetramer were constructed based on M4 and T4. A set of mutations (E46K, 
H50Q, G51D and A53T) were introduced simultaneously in each monomer, resulting in 
four mutant monomers M1_M, M2_M, M3_M and M4_M, and four mutant tetramers 
T1_M, T2_M, T3_M, and T4_M. Note that the wild type αS monomer has a negative 
charge of -9e. The quadruple mutant (E46K + H50Q + G51D + A53T) in the loop motif 
has a net charge of -8e. The change of the protein charge (-4e) in the tetramer could lead 
to considerable change in the electrostatic interactions and polar contribution to the 
solvation energy (see Table E1 under Appendix E). All initial tetramer structures were 
modelled using the ZDOCK server (http://zdock.umassmed.edu/).420  
 All protein structures were represented by the CHARMM36m215 protein force 
field, and the corresponding modified TIP3P water model was used to solvate the protein 
structure. MD simulations were performed using GROMACS-5.0.4 software.229 Each 
structure was solvated in a water box, with any protein atom at least 15 Å from the box 
edge, and salt ions were added to neutralize formal charge with an additional 0.15 M 
NaCl to represent physiological ionic strength. MD simulations were conducted at 310 K 
and 1 atm. The temperature was maintained using a velocity rescaling thermostat,248 and 
the pressure was controlled by the Parrinello-Rahman coupling method.249 The short-
range van der Waals and electrostatic interactions were truncated using a cut-off of 12 Å, 
and the long-range electrostatics treated using the particle mesh Ewald (PME) method. 
Each system was first subjected to energy minimization, followed by two stages of 
equilibration with positional restraints on the heavy atoms of the protein structure: 100 ps 
at constant volume followed by 100 ps at constant pressure at 310 K. A time step of 2 fs 
was applied with the LINCS algorithm. Production dynamics were then performed at 
constant pressure without any positional restraints, with the trajectory saved every 10 ps. 
 The conformational energy was calculated using the Generalized Born using 
Molecular Volume (GBMV) implicit solvent model implemented in the CHARMM 
(v40b2) program.193 The single point energy was calculated after 200-step minimization 
of each conformation using the GBMV II algorithm.255-257 Other energy terms including 
bonded energy, van der Waals energy, electrostatic energy, and solvation energy were 
also obtained with the GB implicit solvent model. The block average method was used to 
estimate the mean value and standard deviations. 
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5.2.2. Predictive modelling of extended 11/3-helical tetramers 
The initial structures for an extended 11/3-helical model was obtained from 
experimentally determined membrane-bound structures of aS with super-helical 
twists,409 generously provided by Prof. Ralf Langen. Out of the ten available monomer 
models, model 3 gave best structural fit with a monomer of tetrabrachion410 (see section 
5.1. Introduction). WT tetramer models were designed starting from available residues 
Ser9 – Ala89 of this 11/3 helical structure, containing all the seven 11-residue repeat 
regions (refer to Fig. E15 under Appendix E). We designed at least four tetramer 
complex variants (complexes I-IV) utilizing the curvature geometry of 11/3 helices, and 
employing the following design strategies: 
 I. Separated and optimized in which the hydrophobic core of NAC (71 – 82) is optimized 
for intermolecular contact between hydrophobes of monomers, while the rest of the 
monomer helices are separated from each other. 
II. Intertwined and optimized in which the hydrophobic core contacts are optimized but 
the rest of the monomer helices are intertwined with each other. 
III. Intertwined and not optimized in which the core contacts are not optimized but focus 
is given on intertwining the helices so that it may form maximum contacts in other 
regions. This could be taken as a control to see if the hydrophobic residues play a role in 
stabilizing the extended helical tetramers as well. 
IV. Aligned and optimized in which the hydrophobic core of NAC region of each 
monomer was aligned to each other to optimize the tetramer structure containing a C4 
symmetry axis. 
 All complexes were generated preserving the original curvature of model 3 with 
the sidechains of Lys residue facing outwards.409 Complexes I-III were designed by using 
the ZDOCK server,420 while complex IV was constructed using the M-DOCK server 
(http://zdock.umassmed.edu/m-zdock/)421 for symmetrical docking with Cn symmetry. 
 An initial sanity check on extended 11/3 helical tetramer stabilities were 
performed by running short MD simulations (50 ns by following the same simulation 
parameter as preceding sub-section 5.2.1; see Fig. E16) on the NAC region (Glu61-
Ala89) of aS(9-89) tetramers. Complexes I and IV present very similar topologies in the 
NAC region with the optimized hydrophobic core contacts. However, the NAC helices 
are apparently more stable with complex IV than I. We thus do not consider complex I 
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for further analyses. On the other hand, the initial NAC helical topology in complex II is 
also mostly preserved after 50 ns, while for complex III (not optimized with core 
hydrophobic contacts), the NAC helices come closer to each other. To account for any 
impact of the C- (and/or the N-) terminal (especially the intertwined N-terminal regions 
in complexes II and III) on the overall inter-helical hydrophobic contacts and stabilities, 
we selected complexes II, III and IV to further design full-length WT helical tetramers. 
These 11/3-helical full-length tetramers of complexes II, III and IV were re-constructed 
by adding disordered loop to N-terminal (1-8) and C-terminal (90-140) of the aS(9-89) 
tetramer. 100 ns MD simulations were performed on these complexes for further model 
elimination. The initial and the final structures of these models are shown in Fig. E17 
(Fig. E18 is discussed under 5.3. Result and Discussion). We assessed the 
conformational energies by using the GBMV method implemented in the CHARMM 
193(v40b2) program using the GBMV II method255-257 for the three complexes to account 
for their relative stabilities (Table E2). From the conformational energies, the overall 
stabilities of the complexes are in the order: III > IV > II, with very close values between 
III and IV (in bold). The differences are majorly contributed from the electrostatic 
energies (in bold) which for II and III are appreciably higher than IV, meaning more 
charge-charge attractions in IV. However, this is highly compensated in III by their most 
favourable vdW energy (in bold). Finally, we selected complexes III and IV for further 
comparison with the WT and E→K mutations on the broken a-helical model. The MD 
simulation protocols for WT and E→K mutated complexes III and IV, including force 
field/water model parameters are same as that of the previous sub-section. The production 
run for each system was 100 ns and the last 20 ns was used for analyses. 
 
5.2.3. Predictive modelling of broken a-helical multimers (oligomers) 
Following our designed de novo broken a-helical aS tetramer assembly described in 
section 5.2.1 with residues Val3–Val44 and Lys51–Thr92 forming two a-helices, we 
further designed a more stable aS broken a-helical tetramer construct using the same aS 
helical monomer as the building unit. Additionally, oligomers/multimers from dimers to 
octamers were constructed using the same designed broken a-helical monomer structure. 
The initial helical multimeric structures containing NAC regions with Cn symmetry was 
obtained using the M-DOCK server.421 We randomly chose one structure from the top 
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ten near-degenerate predicted structures. Each full-length helical oligomer was modelled 
by adding an unstructured C-terminal. Four familial mutations (E46K, H50Q, G51D and 
A53T) were introduced simultaneously in each monomer, resulting in different mutated 
helical oligomers. The packing of NAC in each multimer before and after simulations is 
shown in Fig. 5.6 and Fig. E19 under Appendix E. The initial conformations of all helical 
oligomers are shown in Fig. E20. 
 The MD simulation parameters and force field/water model used are the same as 
that used in preceding sub-sections. The production run for each system is 200 ns, and 
the convergence of each simulation was assessed by the temporal fraction of native 
contacts (Fig. E27), number of water molecules, SASA, and water excluded volume (Fig. 
E31). The conformational energy was calculated via the GBMV II255-257 algorithm as 
before.  
 We constructed different aS oligomers using the design rule of direct NAC 
contacts with Cn symmetry in the starting structures. To test if oligomers generated in 
this way could be more stable than alternative geometries, we first compared the relative 
stabilities of aS tetramer without initial perfect C4 symmetry designed previously329 and 
the C4 tetramer designed in this work. Note that both tetramers have direct NAC contacts 
between neighbouring monomers, and the symmetry was not preserved during 
simulations (Fig. 5.6B). We found overlapping conformational energies of -11115 ± 11 
and -11122 ± 3 kcal/mol, respectively (Fig. E23). Next, we designed an alternative 
octamer structure containing one pentamer with C5 symmetry and one trimer with C3 
symmetry, but no direct NAC interactions between them (Figs. E24 and E25). We found 
that both octamers reach equilibrium during 200-ns MD simulations (Fig. E26). The 
octamer without initial NAC contacts is penalized by +61 ± 19 kcal/mol, indicating that 
initial NAC contacts between neighbouring monomers are important to stabilize aS 
octamers. Hence, cyclic symmetry and hydrophobic contacts between adjacent NAC 
regions provides a convenient way to rapidly generate stable aS structures. 
 
5.3. Result and Discussion 
5.3.1. Hydrophobic packing in the NAC region determines the stability of broken a-
helical tetramer assembly 
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We initially compared the stability of four WT NAC tetramers under physiological 
conditions (Fig. 5.1) by MD simulations. It is seen that T1 and T3 NAC tetramers are not 
stable due to unfavourable hydrophobic packing (Fig. E1 under Appendix E) Within 1ns 
of simulation time, T1 quickly dissociates into two dimers; and one NAC monomer 
moves away from the core of T3. In contrast, T2 NAC tetramer remains stable during 
50ns of dynamics, indicating that the initial hydrophobic packing pattern is critical for 
stability of the helically folded NAC tetramer. To avoid the curved helix in T1, and 
increase initial packing of T2, we designed the de novo model T4 with nearly linear 
helices and high symmetry, which remains stable during 50 ns simulation (see Fig. E1). 
The hydrophobic stretch (Val71–Val82) within the NAC region was previously found to 
be essential for aS assembly.422 To explore the role of NAC in supramolecular packing, 
we constructed another variant of T4 NAC tetramer with these 12 residues deleted (Fig. 
E2). This shorter NAC tetramer did not dissociate within 50 ns, but one NAC monomer 
moved away from the core, implying that this 12-residue hydrophobic stretch is 
imperative to the helical NAC tetramer stability. Note that a-helix structure in monomer 
conformations were largely preserved in all simulations (Fig. E1 and Fig. E2 under 
Appendix E). 
 Comparison of computed NAC and WT full-length aS tetramers (Fig. 5.2, using 
the same notations T1 to T4 for the corresponding NAC tetramers) also highlights the 
role of N- and C-terminal tails in tetramer assembly. In addition to full-length T2 and T3 
tetramers, T1 was constructed by addition of the other part of micelle-bound aS; and T4 
was constructed using experimental data on the arrangement of the two a-helix regions 
(a1 and a2) and the linking loop that is thought to host disease-causing mutations.411 In 
each monomer of T4 tetramer, a1 and a2 span Met1–Thr44 and Gly51–Phe94, 
respectively. Similar to its NAC tetramer, T3 is not able to form a stable tetramer as one 
of the monomers separates from the core of the structure during a 60 ns MD simulation 
(see Fig. E3 under Appendix E). Thus, no further analysis was performed on this model. 
The other tetramers remain well packed during 200 ns of dynamics (Fig. 5.3). 
Dissociation was not observed for T1, T2 and T4, but structural rearrangements occurred 
during the first few tens of nanoseconds after which contacts did not change significantly 
(as seen from fraction of native contacts in Fig. E4). Consistent with a recent simulation 
study of T3 using the CHARMM27 force field,191 the helix structures of T1, T2, and T4 
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were well conserved during simulations, resulting in ~50% populations (sum of a-, 310, 
and p-helix, Fig. E5). The stabilities of the tetramers were compared according to their 
conformational energies calculated from the GBMV255-257 solvation model as described 
in 5.2. Methods. It was found that T4 is the most stable tetramer studied here (Fig. 5.3); 
T1 is more stable than T2, but the distributions of their conformational energies overlap, 
suggesting plausible conformational transition and population shifts between T1 and T2 
tetramers (Fig. E6). 
 
 
Fig. 5.1. (A) The sequence of the NAC segment with hydrophobic residues Ala, Ile, Val 
and Phenylalanine underlined; Alternative packing modes between two NAC monomers. 
(B) Hydrophobic packing patterns in four different helical aS NAC tetramer structures 
(T1–T4, design strategies described under 5.2. Methods). For clarity, not all hydrophobic 
residues are labelled in the side view. In the top view, the heavy atoms of residues 71–82 
are represented as van der Waals spheres with hydrophobic, acidic, basic, and polar 
residues coloured white, red, blue, and green, respectively.   
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5.3.2. Secondary role of termini in modulating the broken a-helical tetrameric 
assembly  
Molecular interaction maps were generated by contact analysis using the CONAN tool.345 
A contact occurs if the distance between any two heavy atoms is within 5 Å, and the 
various tetramer structures show different contact frequencies among the NAC, N- and 
C- termini regions (Fig. E8 under Appendix E). Note that the initial T1 NAC tetramer 
dissociates very quickly (~1 ns simulation, Fig. E1), but the full-length T1 (with N- and 
C-termini) is more stable than T2. To investigate how other regions of aS modulate 
hydrophobic packing among NAC regions, we took the NAC tetramer from the last 
conformation sampled by full-length aS tetramer and carried out a 50 ns simulation for 
each isolated NAC tetramer. All NAC tetramers remained associated during 50 ns (Fig. 
E9), indicating specific molecular interactions that could optimize hydrophobic packing 
of NAC regions within full-length αS tetramers. To further rationalize the source of these 
interactions, we calculated interaction energies between different parts of αS tetramers 
(Fig. E10). A modest correlation was found between conformational energy and 
interaction energy between N- and C-terminals, indicating that the termini could have a 
mild effect in modulating the inter-monomeric hydrophobic interactions in NAC regions 
(Fig. E10) due to the presence of long-range tertiary interactions, as also reported 
previously.320,423 In T3, poor hydrophobic packing in NAC is not compensated by N- and 
C- terminal interactions, and so full-length T3 remains an unstable tetramer (Fig. E3). 
 
5.3.3. PD-causing familial mutations require a higher activation energy to a-helical 
tetramerization than WT aS  
To investigate the effects of missense familial mutations on the structure and 
thermodynamic stability of aS, we designed quadruple mutants (E46K + H50Q + G51D 
+ A53T) of each monomer. Previous experimental evidences suggest that this engineered 
mutant dramatically decreases aS tetramer:monomer ratios.424 Three tetramer mutants 
(denoted T1_M, T2_M, and T4_M here) were constructed from T1, T2, and T4, and 
each conformation was simulated under the same simulation conditions as WT. Similar 
to the WT tetramers, no significant structural alteration was observed in their native 
contacts after the first 50 ns of dynamics, indicating that equilibrium was obtained for 
each (Fig. E4 under Appendix E) with ~50% calculated helix structures (Fig. E5). Their 
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relative stabilities follow the same trend as WT tetramers (Fig. 5.3). T4_M has the lowest 
conformational energy compared with T1_M and T2_M; and a large overlap of the 
distribution of conformational energy was found between T1_M and T2_M (Fig. E6). 
Finally, the corresponding homologue β-synuclein (βS) shares ~62% sequence identity 
with αS,425, 426 and our computed structures show that the βS tetramer constructed with 
the same packing as T4 remains stable during 200 ns of dynamics (Fig. E7), providing a 
plausible structural model for βS tetramers.427  
 
 
Fig. 5.2. Initial conformations of four full-length a-helical aS tetramers (T1–T4) in both 
side and top views. The first and last residues of the loop that connects a1 and a2 
segments are labelled. 
 
 Membrane-bound aS monomers form a-helices, but are expected to unfold and 
lose helicity in water.64 Our MD simulations of aS monomer (M1, one monomer of T1) 
show that a2 unfolds during 200 ns in water (Fig. E11). This conformational change may 
impede initial aggregation of aS monomers as they do not have time to associate as 
extended helices and optimize supramolecular interactions. This hypothesis is consistent 
with the reconfiguration rate model of aS aggregation in which intra-molecular 
rearrangement of the monomer determines the rate of biomolecular association and 
subsequent aggregation steps,428 meaning aS may escape oligomerization by rapid 
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reconfiguration. As shown in Fig. 5.3, even though oligomerization into T1 helps to 
stabilize M1 by hydrophobic interactions between NAC regions, three a1 helices 
partially unfold. Similarly, T2 shows partial dissociation (Fig. 5.3) and M2 (one 
monomer of T2) also unfolds from its initial helical conformation over 200 ns (Fig. E11). 
In contrast, both a helices were largely maintained in M4 (one monomer of T4, Fig. 
E11), and M4 and T4 exhibited similar helicity to within a few percent. The above results 
indicate that helical monomers that could form relatively stable helical tetramers may 
exhibit a different loop linking a1 and a2 segments in solution (Fig. E11), hence 
providing structural insights into the soluble helical aS conformer with a long lifetime 
proposed in a recent experimental study.164 The finding that the most stable helical aS 
monomer and tetramer are M4 and T4 suggests that the early association of helical aS 
monomers into a tetramer by hydrophobic interactions likely occurs via conformational 
selection.429,430  
 
Fig. 5.3. Final structures of different helical aS tetramer conformations (T1, T2, and T4 
for wild type, T1_M, T2_M, and T4_M for mutant) computed following 200 ns 
simulations, shown in side and top views. The tetramer T3 is not stable and not included 
here. The corresponding conformational energy (in 103 kcal/mol) averaged over the final 
20 ns of dynamics is shown for each tetramer. The standard deviations and energy terms 
contributing to conformational energy are given in Table E1 under Appendix E.  
 
 By contrast, in the quadruple mutant, all monomers (M1_M, M2_M, and M4_M) 
display significantly restructured a1, whereas a2 is well preserved over 200 ns (Fig. 
E11). The difference in helicity is less than 5% between mutated monomers and 
tetramers. Similar to WT (Fig. 5.3), M4_M display the most negative conformational 
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energy amongst the mutated monomers. M4 and M4_M show persistent a-helix 
structures in solution (Fig. E11), suggesting that these monomer conformations initiate 
early aggregation of aS by stabilizing hydrophobic interactions (see our proposed 
mechanism in Fig. 5.4). The heterogeneity in hydration shell is similar to random coil 
aS.396 The NAC domain forms less hydrogen bond with solvent, and the hydration water 
seems more sluggish near it (Figs. E12 and E13).  
 The average conformational energies of the four monomers in T4 and T4_M are 
-2623.1±2.1 kcal/mol and -2696.7±10.8 kcal/mol, respectively, which are less stable than 
the free a-helical monomers (Table E1 under Appendix E), analogous to a hidden state 
during protein-protein recognition. Thus, in the process of M4 self-assembling to form 
T4, the energy barrier that needs to be overcome is about 25 kcal/mol; whereas the barrier 
to T4_M is about 55 kcal/mol, which will impede the formation of a helical tetramer. In 
this regard, the experimentally measured decreased tetramer:monomer ratios187 caused 
by these mutations is consistent with our calculated larger barrier to self-assembly in the 
mutant, but not with dissociation of tetramers back into monomers (Fig. 5.4). For the 
other monomers (M1, M2, M1_M, and M2_M), large conformational shifts were 
calculated with corresponding significant changes in conformational energies, indicating 
formation of unstable tetramers. We estimate energy barriers to transition from the free 
monomer to its activated state of approximately 21 kcal/mol, 57 kcal/mol, 58 kcal/mol, 
and 58 kcal/mol for M1, M2, M1_M, and M2_M, respectively. It is to be noted that since 
all mutated monomers could maintain helical structures for at least 200 ns, the energy 
barriers for association of M1_M, M2_M, and M4_M are quite similar to each other (55-
58 kcal/mol), although the stability of the resulting tetramers (T1_M, T2_M, and T4_M) 
differ. In addition, based on our 200 ns simulations of bS monomer and tetramer (Fig. E7 
and Fig. E11), we found that the energy barrier needed for bS to reach active 
conformations that readily form a stable a-helical tetramer is about 49 kcal/mol (Table 
E1). This barrier is twice that of the corresponding aS tetramer T4 (~25 kcal/mol), 
suggesting that formation of bS tetramer is energetically less favourable than aS tetramer, 
consistent with the barrier to tetramerization of the aS mutant. This could be ascribed to 
the lack of 12 hydrophobic residues in the bS NAC region (Fig. E2).  
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Fig. 5.4. (A) Role of helical tetramer in the pathological aggregation of αS. The 
hydrophobic NAC is also represented as surface. (B) The proposed molecular pathways 
to decreased tetramer:monomer ratios in the mutant. Energy levels are estimated 
according to the calculated conformational energy of disordered αS monomers, helical 
αS monomers and tetramers. 
 
 We also probed the differences in the 3JHNHα coupling constants, and 1Ha and 15N 
chemical shifts between experimental micelle-bound broken a-helical monomer 
structure90 and our de novo designed aS monomers (Tables 5.1-5.5 and Fig. E14). The 
chemical shifts were calculated using SHIFTX2123 program for conformations from the 
last 20 ns MD trajectories. The NMR J-coupling constants were calculated using the 
Karplus equation128 (g_chi tool in Gromacs software). 
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Table 5.1. Pearson Correlation Coefficient (P.C.C.) of J-coupling constants between 
residue indices of different aS systems. 1XQ8 (sim.) refers to the calculated J-coupling 
constant for micelle-bound aS (PDB ID: 1XQ890); and 1XQ8 (exp.) refers to the 
experimental chemical shift for the same micelle-bound αS (PDB ID: 1XQ8). M4, 
M4_M, <M4>T4, and <M4_M>T4_M refer to the systems shown in Table E1. Compared 
to experimental structure 1XQ8, the designed helical aS (M4) has the biggest difference 
in 3J-coupling constant; and the mutant (M4_M) has the biggest difference in Hα and N 
chemical shifts (shown in Fig. E14). 
 
3JHNHα 1XQ8 (sim.) M4 M4_M <M4>T4 <M4_M>T4 
1XQ8 (sim.) 1.00 0.05 0.22 0.10 0.21 
M4 0.05 1.00 0.35 0.55 0.55 
M4_M 0.22 0.35 1.00 0.65 0.60 
<M4>T4 0.10 0.55 0.65 1.00 0.68 
<M4_M>T4_M 0.21 0.55 0.60 0.68 1.00 
 
 
Table 5.2. Pearson Correlation Coefficient (PCC) of Cα chemical shifts between different 
systems. The chemical shifts were calculated using SHIFTX2 program123 for 
conformations from the last 20-ns MD trajectories.  
 
δCa 1XQ8 (exp.) M4 M4_M <M4>T4 <M4_M>T4 
1XQ8 (exp.) 1.00 0.99 0.97 0.98 0.97 
M4 0.99 1.00 0.98 0.99 0.97 
M4_M 0.97 0.98 1.00 0.97 0.99 
<M4>T4 0.98 0.99 0.97 1.00 0.97 
<M4_M>T4_M 0.97 0.97 0.99 0.97 1.00 
 
 
Table 5.3. Pearson Correlation Coefficient (PCC) of Hα chemical shifts between 
different systems. 
 
δHα 1XQ8 (exp.) M4 M4_M <M4>T4 <M4_M>T4 
1XQ8 (exp.) 1.00 0.98 0.79 0.82 0.84 
M4 0.98 1.00 0.81 0.84 0.87 
M4_M 0.79 0.81 1.00 0.86 0.84 
<M4>T4 0.82 0.84 0.86 1.00 0.89 
<M4_M>T4_M 0.84 0.87 0.84 0.89 1.00 
 
 
Table 5.4. Pearson Correlation Coefficient (PCC) of N chemical shifts between different 
systems. 
 
δN 1XQ8 (exp.) M4 M4_M <M4>T4 <M4_M>T4 
1XQ8 (exp.) 1.00 0.90 0.83 0.89 0.85 
M4 0.90 1.00 0.91 0.95 0.91 
M4_M 0.83 0.91 1.00 0.90 0.95 
<M4>T4 0.89 0.95 0.90 1.00 0.92 
<M4_M>T4_M 0.85 0.91 0.95 0.92 1.00 
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5.3.4. Designed extended 11/3-helical tetramers are less stable than designed broken 
a-helical tetramers  
Following the final model selections (complexes III and IV; see section 5.2.2) of 
extended 11/3-helical aS tetramers, we performed 100 ns MD simulations on the 
complexes III and IV. The initial and final structures of the simulations with WT and 
homologous E→1K, 2K and 3K mutations (E35K, E35K/E46K, and E35K/E46K/E61K) 
are shown in Fig. E18 under Appendix E with the conformational energies alongside. 
As identified in section 5.2.2, the extended helical 11/3-tetramers are sensitive to inter-
monomer electrostatic interactions, which for complex III is more repulsive than IV. The 
N-terminal intertwined geometry in III might promote Lys-Lys electrostatic repulsions 
in the repeat (consensus KTKEGV) regions, but this unfavourable electrostatic in III is 
compensated by favourable vdW energy producing an overall more favourable 
conformational energy than IV (Table E2). The hydrophobic packing is otherwise not 
optimized initially in the NAC region of complex III.  
 
 
Fig. 5.5. Comparison of extended 11/3-helical and de novo designed broken a-helical 
monomer structures of WT and homologous E→K mutants. Mutable Glu residue (E35, 
E46 and E61) sidechains are represented as red licorice, while mutated Lys residue 
(K35, K46 and K61) sidechains are represented as blue licorice. 
 
 
 We further performed 100 ns simulations on the extended 11/3-helical monomer 
structures of WT and E→K mutants in order to compare with our previously designed 
broken a-helical monomer model. The final structures of these simulated models (Fig. 
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5.5) show that the extended monomer 11/3-helices are fairly stable in WT aS, and 1K 
and 2K mutants, while being destabilized for 3K mutant. Comparatively, the monomer 
broken a-helices are distorted for both WT and 1K mutant, but relatively more stable for 
2K and 3K mutants. A closer look at the conformational energies (calculated by 
GBMV255-257  method) reveal that broken a-helical aS monomers are in general more 
stable than the extended 11/3-helical monomers (Table 5.5), with energy barriers that 
promote ease of transition from WT extended to broken helices (26 kcal/mol), but 
becoming difficult (energy barriers of 89 kcal/mol, 89 kcal/mol and 70 kcal/mol for the 
1K, 2K and 3K mutants respectively) to transit with the hierarchical E→K homologous 
mutations. Interestingly, the WT 11/3-helical monomer model is more stable (Table 5.5) 
than the micelle-bound broken a-helical monomer90 (also see data for M1 in Table E1), 
suggesting that extended 11/3-helices may be initially favoured and may have to undergo 
significant conformational re-arrangements before a-helical membrane associations 
under physiological conditions. 
 
Table 5.5. Comparison of extended 11/3-helical and broken a-helical monomer 
conformational energies with the energy barrier (DE) of their transition. Structure 1XQ8 
is the micelle-bound broken a-helical monomer.  
  
Extended 11/3-helix Broken a-helix 
 
 
helicity % Conformational 
energy 
(kcal/mol) 





WT 54 ± 1 -2622 ± 0 60 ± 2 -2648 ± 16 26 
1K 50 ± 1 -2548 ± 3 58 ± 1 -2637 ± 0 89 
2K 54 ± 0 -2534 ± 8 67 ± 0 -2618 ± 2 84 




49 ± 1 -2607 ± 7 
 
 
 Comparison of the simulated final structures of aS tetramers reveal that one of 
the monomers in the 2K and 3K mutants in the complex IV (Fig. 5.6B) has the propensity 
to dissociate from the extended 11/3-helical tetramer assembly compared to these mutants 
in complex III (Fig. 5.6A). Overall the conformational energies reveal that the broken a-
helical tetramer is more stable than either complex III or IV (Fig. 5.6). 
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Fig. 5.6. Comparison of final structures (100 ns) of WT and E→K mutants of (A) 
extended 11/3-helical complex III, (B) extended 11/3-helical complex IV, and (C) 
broken a-helical de novo tetramer models of aS with their corresponding conformational 
energies (kcal/mol) and standard deviations (in parentheses) thereof. Mutable Glu residue 
(E35, E46 and E61) sidechains are represented as red licorice, while mutated Lys residue 
(K35, K46 and K61) sidechains are represented as blue licorice. 
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 Further, the energy barriers of transition from broken a-helix to extended 11/3-
helix and vice versa (Table 5.6)  reveals that it is easier to form the broken helical stable 
WT tetramer from complex III than from IV, but it becomes an increasingly difficult 
transition with each additional E→K mutation in III. This observation is in line with 
recent experimental evidences suggesting that mutations in the conserved repeat regions 
may block aS helical tetramer assembly.403 
 
Table 5.6. Comparison of extended 11/3-helical and broken a-helical tetramers’ 
conformational energies Structure 1XQ8 is the micelle-bound broken a-helical tetramer. 
DE1 = energy barrier between complex III and broken a-helix, and ΔE2 = energy barrier 
between complex IV and broken a-helix. 
  






















WT 57 ± 0 -11045 ± 62 55 ± 1 -10907 ± 0 61 ± 1 -11122 ± 3 77 215 
1K 56 ± 0 -10716 ± 51 56 ± 0 -10723 ± 10 59 ± 0 -10821 ± 23 105 98 
2K 56 ± 0 -10510 ± 39 57 ± 1 -10472± 1 61 ± 0 -10639 ± 9 129 167 
3K 55 ± 0 -10242 ± 26 56 ± 1 -10250 ± 5 57 ± 1 -10322 ± 17 80 72 
         
1XQ8 
(WT) 
    




5.3.5. Broken a-helical multimers with initial symmetric NAC contacts are more 
stable  
As described under section 5.2.3, we constructed different aS oligomers using the design 
rule of direct NAC contacts with Cn symmetry in the starting structures. The aS NAC 
region is crucial for determination of fibril fold,419 and formation of stable helical 
tetramers.329 To test if oligomers generated in this way could be more stable than 
alternative geometries, we first compared the relative stabilities of αS tetramer without 
initial perfect C4 symmetry designed in previously329 and the C4 tetramer designed in 
this work. It is to be noted that both tetramers have direct NAC contacts between 
neighbouring monomers, and the symmetry was not preserved during simulations (Fig. 
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5.7B). We found overlapping conformational energies of -11115 ± 11 and -11122 ± 3 
kcal/mol, respectively (see Fig. E23 under Appendix E). Next, we designed an 
alternative octamer structure containing one pentamer with C5 symmetry and one trimer 
with C3 symmetry but no direct NAC interactions between them (Figs. E24 and E25). 
We found that both octamers reach equilibrium during 200-ns MD simulations (Fig. 
E26). The octamer without initial NAC contacts is penalized by +61 ± 19 kcal/mol, 
indicating that initial NAC contacts between neighbouring monomers are important to 
stabilize aS octamers. Hence, cyclic symmetry and hydrophobic contacts between 
adjacent NAC regions provides a convenient way to rapidly generate stable αS multimers.  
 
5.3.6. Linear dependence of conformational energy and binding energy with the 
number of monomers in aS oligomers 
The temporal evolution of fraction of native contacts286 assessed the convergence of the 
MD simulations (Fig. E27). Note that both WT and mutant aS tetramers maintain a 
relatively high fraction of native contacts compared to other a-helical oligomers. Most 
oligomers kept >90% of their initial helicity, except the WT a-helical dimer that lost 20% 
helicity during simulations (Fig. E28), consistent with the finding that multimerization 
can stabilize aS helical structures.191,329 Based on the calculated conformational energies, 
a linear relationship was formed between the conformational energy of the oligomer and 
its number of monomers (Fig. 5.8A), indicating that self-assembly to aS multimers 
should be thermodynamically favourable, and may increase proportionally to the 
concentration of monomer.  
 Linear stabilization of the growing oligomers is supported by the binding energy 
calculated using the single and separate trajectory methods (Fig. 5.8B and Fig. E29). In 
the single trajectory method, only the oligomer trajectory was used to calculate the 
binding energy, which is the energy difference between the oligomer and its multiple 
building monomers. The binding affinity linearly increases from dimer to octamer in 
general (Fig. 5.8B), confirming that assembly of helical aS oligomers is 
thermodynamically favourable. We also calculated the binding free energy using the 
separate trajectory approach, to map alternative routes to formation of an oligomer. For 
instance, an octamer could be formed by assembly of eight monomers simultaneously or 
by assembly of a preformed pentamer and a trimer. As discussed above, assembly of eight 
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monomers through tight supramolecular packing of their hydrophobic NAC regions leads 
to a more stable octamer. Consistent with this result, we found that the strongest binding 
affinity was obtained for the energy difference between the oligomer and free monomers. 
The binding affinity also increases linearly from dimer to octamer (Fig. E29, see also 
Tables E3-E4) and no significant alterations were observed in the helical structures of 
the assembling monomers. The above results collectively suggest that the formation of 
aS multimers are more likely to follow the conformational selection mechanism than the 
induced fit model.429 
 
 
Fig. 5.7. Designed aS NAC oligomers from dimer to octamer in side and top views (A) 
at the start of the simulations (after minimization and equilibration) and (B) after 200 ns 
of unconstrained dynamics in water. Computed conformations of NAC in mutants are 
shown in Appendix E, Fig. E19. The corresponding conformations of full-length aS 
oligomers before and after MD simulations are shown in Figs. E20-E22.  
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Fig. 5.8. (A) Conformational energy, (B) binding energy calculated using single 
trajectory, and (C) activation energy. Horizontal axis number n 1 to 8 indicates growth 
from monomer to octamer. The linear fit is shown for conformational and binding energy 
and the lines connecting activation energy values in (C) are guides to the eye. Binding 
energy calculated using separate trajectories is shown in Fig. E29 under Appendix E. 
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5.3.7. aS broken a-helical tetramers have the lowest activation energy amongst all 
multimers 
As discussed above, the thermodynamic predictions, by themselves, indicate that 
assembly of a-helical aS oligomers ought to proceed smoothly, and should not stall at a-
helical tetramers as suggested by experimental data.83,166 To reconcile this apparent 
contradiction, we estimated the activation energy at each stage by computing the largest 
energy difference between the conformational energy of monomer in bound and free 
states. In this way, the activation energy not only reflects the average energy barrier for 
assembly,329 but specifically highlights the largest energy barrier that is rate-limiting for 
assembly. Although there is no direct experimental data to compare, activation energy 
values for αS nucleation and fibril elongation have been reported in the range of 17 to 20 
kcal/mol.329,400 The activation energy of lipid-induced nucleation and elongation has also 
been reported at about 27 kcal/mol.329 A smaller activation energy is expected for 
oligomerization since it does not involve significant conformational transition as occurs 
in fibril elongation when an unfolded monomer transforms into an aggregation-competent 
folded intermediate. 
 The maximum change in activation energy with number of monomers is shown 
in Fig. 5.8C (see also Fig. E30 for the averaged activation energies329). The a-helical 
tetramer has the lowest, on average, activation energy amongst all other multimers 
investigated in this study, which provides an explanation for why the tetramers are the 
most populated species observed experimentally. Pentamers, hexamers, heptamers, and 
octamers are thermodynamically stable, but the higher energy barriers indicate that their 
assembly may be kinetically unfavourable. The finding that helical dimers and trimers 
have higher energy barriers than tetramers suggests that formation of a helical nucleus is 
kinetically unfavourable, but once assembly of a dimer succeeds, the assembly should 
proceed to tetramer.  
 
5.3.8. Assembly of aS tetramers proceeds via multiple energy barriers 
The spread of activation energies for each monomer within a specific oligomer suggests 
that aS assembly may proceed through multiple energy barriers (Fig. 5.9). The 
conformational energy of individual monomers within different oligomers is shown, and 
the conformational energy of free monomer is also included for comparison. For example, 
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there are five and four monomers that have different activation energies higher than the 
average activation energy in the WT and mutated octamer, respectively (Fig. 5.9). The 
existence of many energy barriers and thus many rate-limiting steps has also been 
observed for the assembly of 30S ribosomal subunit.431 The largest energy barrier shown 
in Fig. 5.8C indicates the maximum energy (rate-limiting process) required to form the 
relatively stable helical oligomers.  
 
 
Fig. 5.9. Conformational energy of individual monomers (marked as Monomer 1 to 8) in 
different (A) WT and (B) mutated oligomers. The conformational energy for the free 
monomer is shown for comparison. 
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 The finding that the quadruple mutated tetramer mutant has maximum activation 
energy comparable with that of the WT tetramer is consistent with experimental evidence 
of the formation of both the WT and mutated tetramers.187 However, the calculated 
stability of the mutant is much more sensitive to the supramolecular packing modes by 
which the monomers interlock. The mutant with our previously designed tetramer 
structure329 is much less stable than the present high-symmetry structure (-11424 kcal/mol 
± 13 vs. -11526 ± 12 kcal/mol, Table 5.7), indicating that conformational change could 
have a significant effect on the thermodynamic stability of the tetrameric mutant under 
the same experimental conditions (the WT structures do not show this sensitivity, see 
Table 5.7). We also found that the largest activation energy in the pentamer, hexamer, 
and heptamer mutants is higher than their corresponding WT oligomers (Fig. 5.8C), 
implying that these mutations could also decrease the amount of helical pentamers, 
hexamers and heptamers. 
 
Table 5.7. Conformational energy (in kcal/mol) with the standard deviations (in 
parentheses) for all αS multimers. 
 
System WT Mutants 
1 Monomer -2647.8 (15.7) -2751.1  (2.9)  
2 Dimer -5365.9 (9.8) -5634.2  (15.0)  
3 Trimer -8228.2 (11.7) -8541.6  (15.1)  
4 Tetramer -11121.6 (3.3) -11526.2  (12.0)  
5 Pentamer -14071.8 (1.4) -14448.6  (18.7)  
6 Hexamer -16999.5 (10.4) -17430.1  (27.4)  
7 Heptamer -19855.6 (2.6) -20558.8  (11.7)  
8 Octamer -22939.2 (13.4) -23677.8  (2.8)  
 
 
5.3.9. Helical tetramers have more balanced protein-protein and protein-water 
interactions 
Assembly of helical aS proteins involves interplay of protein-protein and protein-water 
interactions. Water molecules need to be expelled from the core of hydrophobic NAC 
regions, along with the rearrangement of peptides to minimize the energy of the resulting 
oligomer structures. The calculated number of water molecules, solvent accessible 
surface area (SASA), and water excluded volume all show that oligomerization expels 
water molecules from the NAC regions (Fig. E31 under Appendix E). For example, the 
number of water molecules within 3.5 Å of oligomeric NAC regions quickly decreases 
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during the first 100 ns of molecular dynamics. Similar behaviour was also found in the 
calculated SASA and water excluded volume. Helical dimers and trimers generally have 
more hydrated water and surface area exposed to solvent, resulting in a larger solvent 
excluded volume than other oligomers. On the other hand, helical pentamers to octamers 
have less or comparable hydrated water, SASA, and water excluded volume compared 
with helical tetramers (Fig. E31). At equilibrium, pentamers and octamers have less 
hydrated water molecules near each NAC region than tetramer (Fig. E32). A few dynamic 
water molecules were found near residues 77–95 of the NAC regions, but few water 
molecules were trapped near residues 67–76 of the NAC regions, indicating that no water 
channel was formed in the whole NAC regions of all oligomers (Fig. E33). 
 The trapped water molecules may affect inter-peptide interactions. Too much 
exposure to the solvent in the cases of dimers and trimers would lead to large structural 
fluctuation driven by water dynamics432,433 whereas less hydrating water suggests 
stronger inter-peptide interactions as the driving force for assembly of helical pentamers 
to octamers. To test if pentamers to octamers have enhanced inter-peptide interactions, 
we calculated the pair interaction energies among all NAC regions and full-length 
monomers within each oligomer (the solvent effect was modelled with constant 
dielectric), and results are shown in Fig. 5.10 and Fig. E34 under Appendix E for the 
WT and mutated oligomers, respectively.  
 Compared with the pair interactions in dimer (Fig. 5.10A), tetramer has one 
stronger pair interaction, pentamer and hexamer have four each, heptamer has six, and 
octamer has eight pair interactions stronger than in dimer, confirming that pentamers to 
octamers have stronger inter-peptide interactions than tetramers. Thus, in order to form 
stable helical oligomers, pentamers to octamers need to rearrange in such a way that the 
pair interactions between neighbouring monomers could be enhanced by maximizing 
their hydrophobic interactions, which requires expulsion of water molecules from the 
NAC regions. Another feature of these pair interactions is the large fluctuation in their 
strength, which is more pronounced in large oligomers including pentamer to octamer. 
For example, the pair interaction energies vary from -17 kcal/mol to -69 kcal/mol in the 
helical octamer. The effect of these interactions on the shape of a-helical oligomers 
before and after simulations is shown in Fig. 5.7. 
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Fig. 5.10. Pair interaction energies (in kcal/mol) among (A) all NAC regions and (B) all 
full-length monomers in different WT multimers. Interaction energies (absolute values) 
less than 7 kcal/mol in (A) and 94 kcal/mol in (B) are not shown. The pair interactions 
between monomers that are stronger or comparable than dimer is also highlighted in 
shaded rectangles (B).  
 
  
 The presence of both terminal regions modulates the pair interactions between 
different monomers of a-helical multimers (Fig. 5.10B). Compared to the pair 
interactions in dimer, except for tetramer, all the other oligomers show at least one 
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enhanced pair interaction between adjacent monomers. Specifically, trimer and pentamer 
each has one, and hexamer to octamer each has two stronger pair interactions. Interactions 
involving both termini also shift the relative interaction strength between different 
monomers. In the absence of both termini, for example, NAC monomers A and D display 
the strongest pair interactions in the tetramer (Fig. 5.10A), whereas in the presence of 
both termini, monomers B and C show the strongest pair interactions in the same tetramer 
(Fig. 5.10B). In addition, more weak interactions between non-adjacent monomers are 
induced primarily by the fluctuating C-termini (residues 96–140) because residues 3–44 
of each N-terminus (residue 1–60) form one a-helix segment. However, interactions 
involving both termini do not reduce the significant fluctuations of the pair interaction 
energies in all a-helical oligomers, suggesting that multimers could not maintain specific 
shapes. Similar results are also obtained for the a-helical mutants (Fig. E34). This 




First, we use data from available experimental evidences to rationally design the location 
of the loop motif linking the two a-helices of aS helical monomers and designed a new 
a-helical aS monomer (M4) and their corresponding tetramer (T4). Our results indicate 
that tetramer T1 formed by association of membrane-bound helical aS is less stable than 
T4, but more stable than tetramers (T2 and T3) generated from previous studies.140,166 
This suggests that hydrophobic packing is the primary factor that controls stability of αS 
tetramers, which in turn allows aS to display different a-helical conformations when 
environment varies. The activation energy between the unbound and bound state is much 
larger for the familial PD-associated mutant than for WT aS, indicating a much higher 
energy barrier along the tetramerization pathway. Thus mutation could shift the 
monomer–tetramer equilibrium to favour monomers, providing a plausible molecular 
mechanism for decreased tetramer:monomer ratios observed experimentally.187  
 Next, we used available membrane-bound monomeric experimental model409 to 
rationally design models of extended helical tetramers having 11/3 periodicity, and 
compared them with our previously designed broken a-helical tetramer model. Our 
findings suggest that monomeric aS with 11/3 helices is less stable than the de novo 
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broken a-helical model proposed in our previous work,329 but more stable than the WT 
micelle-bound aS (PDB ID: 1XQ890), suggesting that the extended 11/3-helical 
conformation could be more favourable than the broken a-helical conformation under 
physiological conditions (310K and 0.15 M NaCl), and may further undergo 
conformational change to reach a relatively stable state (for example, the de novo broken 
a-helical model we proposed). Furthermore, E→K mutated helical tetramers in both 
broken a-helical and extended 11/3-helical (proposed models III and IV) conformations 
undergo significant conformational change; the movement of the N-terminal regions 
makes the NAC regions more  exposed to the solvent, and thus they become less stable 
(dissociation could be expected but was not observable at the ~0.1 µs simulation 
timescale). This observation is consistent with recent experimental results suggesting that 
abolishing aS helical tetramers by 3K mutations leads to excess aggregation-prone 
monomers in vivo.188 In addition, our results also underlines a possible intermediary 
extended 11/3-helical tetramer conformation while transitions between membrane-
associated and membrane-free broken a-helical tetramers. 
 Finally, we attempt to identify the molecular assembly landscape of a-helical aS 
multimers. Given the conformational flexibility of aS peptides,94,189 we delineate design 
rules for relatively stable helical αS oligomers via optimal packing of the NAC regions. 
For example, to further test the effect of initial symmetry on the stability of helical 
oligomers, we carried out MD simulations on the WT helical tetramer and hexamer with 
slight warping of their initial symmetry. After 200 ns simulations, less stable tetramer (-
11047 ± 22 kcal/mol) and hexamer (-16934 ± 25 kcal/mol) with higher activation energy 
(101 ± 11 kcal/mol for tetramer and 89 ± 3 kcal/mol for hexamer) were obtained, 
confirming that the initial cyclic symmetries could lead to more stable helical multimers 
with lower activation energies. Helical αS oligomers constructed in this way could also 
be valuable for the study of other polypeptides that form helical intermediates during 
amyloid formation and their interactions with membranes. 
 In addition to tetramers, the formation of oligomers of other sizes are confirmed 
by their thermodynamic stability and binding affinity, but their assembly might be 
kinetically unfavourable due to the presence of multiple high energy barriers. Although 
the largest activation energy obtained for the tetramer (~25 kcal/mol) is very close to the 
activation energy for the nucleation and elongation of αS fibril formation under different 
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conditions (17–27 kcal/mol),400,435,436 we could not exclude the presence of other helical 
tetramer geometries with lower activation energies by further optimization of the 
arrangement of helical monomers.  
 By characterization of protein-protein and protein-water interactions, our data 
predict that assembly of soluble oligomers occurs by expelling water molecules to 
maximize hydrophobic contacts between monomers, which works most efficiently for the 
helical tetramer. Helical dimers and trimers are too hydrated whereas pentamers to 
octamers exhibit large fluctuations in their monomer packing modes. These two types of 
interactions mean helical oligomers could not maintain specific morphologies. Both WT 
and mutant helical tetramers display the lowest activation energy, providing a rationale 
for the experimental observation that the helical tetramers are the most populated 
oligomers83,166. We also find that slight change in the hydrophobic packing of helical 
structures could greatly destabilize mutated tetramers and create much higher energy 
barriers for tetramerization, which is a possible (and potentially drug-targettable) route 
by which mutations destabilize tetramers.83,187  
 The design strategies we present for modelling aS tetrameric assembly could be 
applied to investigate other factors responsible for stability of aS tetramers,185,437 and 
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Chapter 6. ‘Profibrillar’ Oligomers Illuminate the 
Differences in Amyloid-b40 and Amyloid-b42 Aggregation 
Profiles on Graphene-Water Interface 
 
6.1. Introduction 
In the preceding Chapters, we have deciphered the molecular signatures of self-assembly 
within monomeric precursors of amyloids and designed predictive models of the 
assembly of non-aggregating low molecular weight oligomers. In this Chapter, we 
identify potential molecular signatures of a ‘profibrillar’ (prone to fibril formation) 
oligomer of amyloid-b (Ab), in order to investigate the differences in the aggregation 
profiles of its two alloforms – Ab40 and Ab42 at a graphene-water interface, and 
benchmark our findings against Atomic Force Microscopy (AFM) experimental data 
provided by collaborator Dr. Peter N. Nirmalraj of Adolphe Merkle Institute at the 
University of Fribourg in Switzerland.  
 As discussed in Chapter 1, the observation that low molecular weight oligomers 
of Ab are the primary toxic agents in the pathophysiology of Alzheimer’s disease (AD), 
has shifted the focus of amyloid research to characterizing these oligomers formed early 
in the amyloidogenic cascade. On the other hand, the observed polymorphisms439 or 
multiple shapes and folds within Ab fibrils are speculated to originate from 
conformational polymorphism within the oligomers themselves. In particular, aggregated 
oligomers of a critical size can adopt a certain fold that helps them pack into a fibrillar 
cross-b architecture by further addition of monomers.440,441 This forms the “seed” for 
elongation and growth of fibrils.  
 Ab exists in its two most common alloforms, the more populated Ab40 (~80-
90%) and the less populated, but more hydrophobic, aggregation-prone and pathogenic 
Ab42 (~5-10%), the latter also being the principal species found in brain lysates of AD 
patients.442,443 The observed faster aggregation kinetics (and pathogenicity) of Ab42 
compared with Ab40 has been attributed to differing morphologies in the two additional 
C-terminal residues (I41 and A42) of Ab42,444-446 heterogeneity in Ab42 size 
distribution,443,447 and persistent soluble Ab42 oligomeric species (dimers, trimers and 
small oligomeric aggregates but not monomers448) that are more neurotoxic and 
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pathogenic.449 However, the knowledge gained so far have not been properly translated 
into potential therapeutics, due to lack of a high resolution Ab oligomer model structures 
in an extended cellular environment.450 
Several experiments have highlighted the population distribution of Ab42 
oligomers to be a heterogeneous mix of variable sizes and shapes.10,451 However, 
experiments alone are inadequate to provide spatial tracking of the size and shape changes 
that the Aβ peptides undergo in a physiological environment. Visualising the 
morphological changes directly at a nanoscopic level will be of immense value in 
precisely quantifying the Aβ aggregated forms, to verify and complement the 
experimental findings from techniques that lack real-space analytics. Interestingly, earlier 
studies have highlighted that Ab42 dodecamers are one of the primary toxic and dominant 
species in AD pathogenesis,452-454 and Ab40 does not form these structures. 
Ab42 pentamers/hexamers can also self-assemble into decamers/dodecamers.455 Most 
recently, intriguing possibilities have emerged regarding the involvement of Ab42 
dodecamers in AD pathogenicity. Firstly, it was shown that dodecamers seed fibril 
formation only in case of Ab42, but not Ab40456 (this study observed tetramers of Ab40 
as the maximum sized oligomers, but no long protofibrillar structures). They referred to 
the dodecamers of Ab42 as pre-protofibrillar structures. Secondly, propagation of an 
Ab42 dodecamer called large fatty acid-derived oligomers (LFAOs) derived from 
synthetic Ab42 leads to morphologically distinct fibrils and selectively induces cerebral 
amyloid angiopathy.457  
Here with the aid of MD computer simulations, we have assessed the 
conformational preferences and stabilities of preformed dodecamers of Ab40 and Ab42 
on single layer graphene to map the formation of pro-aggregating oligomeric signatures 
under experimentally inaccessible sub-100 ns timescales. We wanted to understand the 
molecular determinants of the differences in aggregation profiles between Ab40 and 
Ab42 from the perspective of a preformed, profibrillar oligomer, such as a dodecamer 
(RQ4). Structures of Ab40 fibrils have been shown to attain both U-shaped two-fold and 
three-fold symmetries,458 but full-length Ab42 fibrils may attain polymorphic folds with 
varying degree of order in their N-terminal.11-13 The N-terminal was previously shown to 
be mostly disordered in Ab fibrils and not part of the fibril core.11,305 However, recent 
ssNMR and cryo-EM experiments revealed that the N-terminal of some fibril polymorphs 
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form structured b-strand motifs,12,13 consistent with earlier inferences from experiments 
and molecular dynamics (MD) simulations that the NTR in monomeric Ab42 has a high 
propensity to sample b-sheet structures and is more compact than the NTR of Ab40.306,307 
In line with these experimental evidences, we used the recently solved ‘LS’ shaped Ab42 
fibrils13 having structured b-sheet in N-terminal as a starting morphology to build a pro-
aggregating dodecamer of Ab42 (two symmetric folds of hexamers packed laterally and 
intertwined, see Fig. 6.1A) and Ab40 (by deleting the last two residues; see 6.2. 
Methods). We compared our calculated structures, dynamics and energetics with 
experimental AFM data collected at the graphene-water interface by our collaborator Dr. 
Peter N. Nirmalraj. The motivation behind use of graphene as an imaging platform in this 
study stems from its enormous applications ranging from disrupting protein aggregation 
to nanotechnology-based diagnostic and therapy in neurodegeneration.459 
Our results show that both Ab40 and Ab42 profibrillar dodecamers align 
favourably in an orientation that may facilitate single layer growth along the graphene 
surface, and that Ab42 dodecamers present a more closed conformation in the growth 
direction of (pro)fibril elongation. Further, from difference in hydrogen bonds at the two 
ends of the dodecamer, we show possibilities of unidirectional growth in Ab40, but not 
in Ab42. Finally, oligomer height profiles on the graphene surface reveal that dodecamers 
of Ab42, but not Ab40, may remain after fully mature fibrils have formed. 
 
6.2. Methods 
The atomic structure of single layer graphene was parametrized as a neutral sheet with no 
partial charges on carbon atoms. The infinite graphene sheet was obtained by applying 
periodic boundary conditions, and the graphene carbon atoms were held fixed throughout 
the simulations. The dodecamers (12-mers) of Ab42 were built using the ‘LS’ shaped 
topological fold in the recently solved cryo-EM structure (PDB code: 5OQV13) of Ab42 
with two layers of hexamers side by side. To build models of Ab40 in the same 
morphology and fold, the last two residues were deleted. Initial orientations of the 
dodecamers on the graphene sheet led to three different possibilities (see Fig. 6.1B): 
orientation I in which the xy plane (green) of the fibrils is perpendicular to the fibril 
growth axis and exposed to graphene; orientation II in which the yz plane (grey) of the 
fibril is parallel to the fibril growth axis and exposed to graphene; and orientation III in 
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which the xz plane (blue; also parallel to the fibril growth axis) is exposed to graphene. 
The structures were placed at a starting distance of at least 6Å above the graphene sheet. 
The protein and the graphene were represented by the CHARMM 36m215 force field, and 
solvated with CHARMM-modified TIP3P215 explicit water. MD simulations were carried 
out using the Gromacs 2018.3228,460 package with a time step of 2 fs using the leapfrog 
integrator.461 Bond lengths to hydrogen were constrained using the LINCS462 (protein) 
and the SETTLE344 (water) algorithms. Background ions were added to neutralize protein 
formal charges. Long-range electrostatics were treated by the Particle mesh Ewald (PME) 
method.246 Protein and non-protein molecules (graphene, water and ions) were coupled 
separately to an external heat bath (310 K) with the coupling time constant of 1 ps using 
the velocity rescaling method.248 All systems were minimized for 100 ps, and equilibrated 
for 1 ns in constant volume NVT ensemble followed by another 1 ns of NPT equilibration 
with the reference pressure at 1 bar and a time constant of 4 ps using the Parrinello-
Rahman barostat.463 The production runs were carried out for 100 ns in constant pressure 
NPT ensemble. Structures were saved every 20 ps.  
 The convergence of simulations was assessed using the fraction of native contacts 
(Q) by Best, Hummer and Eaton286 (Fig. F1 under Appendix F, see Chapter 2 for details). 
 The binding energies (DEbinding) between the pre-fibrillar oligomers and graphene 
sheet were calculated using the molecular mechanics energies combined with Poisson–
Boltzmann continuum solvation (MM/PBSA)252 method implemented in Gromacs 
(g_mmpbsa).254 The binding energies include the solvation effect of interfacial water 
(DEpolar + DEnonpolar) in addition to the non-covalent vdW and electrostatic interaction 
energies (DEMM). For details see Chapter 2. 
 The protein (dodecamer) only conformational energies were also calculated by 
MM/PBSA method as: 
Conformational energy = EMM + Solvation energy                                                                                (6.1) 
where Solvation energy = protein only solvation free energy, and EMM is the molecular 
mechanics potential energy in vacuum comprised of the non-bonded energies due to vdW 
and electrostatics. 
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Fig. 6.1. (A) Cryo-EM solved ‘LS’-shaped structures of Ab (PDB code 5OQV13) with 
hexamers on each of the two folds or layers presenting a dodecamer. The structure of 
Ab40 was constructed by deleting the last two C-terminal residues from Ab42. (B) Three 
different starting orientations of dodecamers on graphene – I, II and III as described under 
6.2. Methods. 
 
6.3. Result and discussion 
6.3.1. Preformed Ab dodecamers preferably undergo profibrillar growth as a single 
layer along the graphene-water interface 
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To probe the different properties of dodecamers on the graphene surface and validate 
them based on the AFM aggregation experiments (unpublished) at the graphene-water 
interface, our designed dodecamers (12-mer) of Ab40 and Ab42 were modelled in three 
different orientations – I, II and III (for further details on these orientations, see 6.2. 
Methods and Fig. 6.1B). The initial (0 ns) and final (100 ns) snapshots from MD 
simulations are represented in Fig. F2 under Appendix F for all three orientations. 
Further details on model building, MD simulations and other related analyses are given 
in 6.2. Methods. The Aβ40 and Ab42 12-mer structures are predicted to retain their 
conformations and are stable in all three different orientations examined in the current 
simulations study. The temporal evolution of fraction of native contacts (Q) confirms the 
overall stabilities of these alloforms in the three orientations and confirms that 
convergence is reached after the first 50 ns of free dynamics (see Fig. F1). Therefore, we 
used the last 50 ns for analysis.  
 In order to identify the preferred orientation of the dodecamers at the graphene-
water interface, we calculated the dodecamer-graphene binding energies (Fig. 6.2A). We 
find that the computed binding energies (DEbinding) show a preference for orientation III 
(Fig. 6.2A, top panels) for both Ab40 and Ab42 (the large error bar for Ab40 represents 
that structures with orientation III samples the most favourable binding energy) over 
either orientation I or II. This points towards the propensity of the dodecamers to grow 
along the graphene sheet with the two folds lying adjacent to each other (showing a single 
layer), which is conducive to fibril growth or elongation. Further decomposition of the 
DEbinding values into their respective components (bottom insets in Fig. 6.2A) show that 
the differences originate from DEpolar (polar solvation binding energies, see 6.2. 
Methods), which is negative for III, but positive for orientations I and II in both Ab40 
and Ab42. Thus, we posit that the oligomer-graphene interfacial water plays a crucial role 
in stabilizing this adsorption mode of a preformed dodecamer which may in turn seed 
fibril growth. In order to assess the relative binding affinities of Ab40 and Ab42 
dodecamer on graphene, we calculated the number of atomic contacts within 0.35 nm 
between the dodecamers and graphene for orientation III. Fig. 6.3C shows that residue 
Tyr10 in both Ab40 and Ab42 dodecamers samples stable contacts with graphene (top 
inset) with no participation from the two additional C-terminal residues in Ab42. 
However, the computed number of contacts (bottom inset) show that Ab42 is only 
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marginally better than Ab40 at making contacts with graphene with subtle difference in 
their orientation. This finding from the simulations clarifies the high-resolution AFM 
images (unpublished) of Ab40 (Fig. F3A) and Ab42 (Fig. F3B) protofibrils on graphene, 
where no major differences were observed for fibril-surface alignment or for morphology 
of the two species of protofibrils. Fig. F4 shows representative conformations of Ab40 
and Ab42 12-mer structures at the graphene-water interface in the three orientations, and 
Fig. 6.2C shows representative structures in orientation III. 
 
Fig.6.2. (A) The average binding energies (DEbinding) of Ab40 and Ab42 with graphene 
(top insets), and the decomposition of the binding energies showing their respective 
components (DEMM, DEpolar and DEnonpolar) for both the dodecamers (bottom insets). (B) 
Average number of oligomer (dodecamer)-graphene heavy atom contacts within a cut-
off distance of 0.35 nm in orientation III. Top insets show that residue Tyr10 in the 
dodecamer makes persistent direct contacts with graphene for both Ab-40 and Ab-42. 
(C) Representative structures of the most populated Ab40 and Ab42 oligomer in 
orientation III with side and top views. 
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6.3.2. Ab42 dodecamers are more stable and present a closed structure 
In order to assess the stabilities of the dodecamers in the growth-favourable orientation 
for the LS-type fold, we calculated the conformational energies (Fig. 6.3A, left inset) by 
MM/PBSA252 method. Computed energies predict that Ab42 dodecamers are more 
favourable than Ab40 on graphene, which signifies that profibrillar Ab42 are 
significantly more stable than Ab40 in the orientation of fibril elongation. This computed 
preference is consistent with the faster aggregation of Ab42 observed in the AFM study 
(unpublished) and in previous investigations of Ab42 aggregation, coupled with the 
existence of higher order oligomers (like dodecamers) for Ab42, but not for Ab40.456 
Furthermore, the computed solvation energies (Fig. 6.3A, right inset) are more favourable 
for Ab40 than Ab42, confirming the propensity for Ab40 to lose their b-sheet structure 
and become unstable. Also, the number of computed in-register hydrogen bonds (H-
bonds) from our simulations show more structural integrity for Ab42 than Ab40 (Fig. 
6.3B) presenting a more closed structure. 
 
Fig. 6.3. (A) Calculated solvation free energies of Aβ-40 and Aβ-42 dodecamers. (B) 
Computed number of in-register hydrogen bonds occurring between the two monomers 
at each end of the dodecamers (E1 and E2; blue) of Ab40 and Ab42, and between the two 
central monomers (C; black). Both folds were considered for this calculation. 
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6.3.3. Ab42 dodecamers potentially favour bidirectional growth, while Ab40 favours 
unidirectional growth 
A potentially interesting finding from our simulations is the persistence of ‘profibrillar’ 
in-register H-bonds on both ends of the dodecamer of Ab2, but not Ab40 (see Fig. 6.3B). 
Some previous experiments have reported that Ab fibril growth is unidirectional,464,465 
while others have highlighted bidirectional growth.466,467 Unidirectional fibril growth has 
been attributed to differences in H-bonding between the two fibril ends exposed to the 
solvent (one end being less fluctuating and stable or more closed than the other) for both 
Ab40 and Ab42, from previous MD simulation studies.468 Simulations have shown that 
the closed ends may extend faster than the open ends469 but it is not known which end 
actually favours the addition of monomers on fibrils. From our analysis of the dimers at 
the two ends (designated E1 and E2) exposed to water and the bulk central dimers 
(denoted as C) of dodecamer, we find that the number of in-register H-bonds at one end 
(E1) is significantly less than that of the other end (E2) (Fig. 6.3B) for Ab40 but  not 
Ab42. A difference of 5% (Table 6.1) is recorded for the strongest (≥90%) H-bonds 
(shown in bold) between E2 and E1 for Ab42, while a difference of 10% is recorded for 
Ab40, implying Ab40 dodecamers are more open (twice more than for Ab42) at the 
fluctuating end (We did not take into consideration transient H-bonds <50% occupancy). 
The increased similarity of the two ends of Ab42 dodecamer compared with those in 
Ab40 may promote monomer addition on the E1 end in addition to the E2 end for Ab42, 
and so potentially bidirectional fibril growth, a possible reason why Ab42 fibrils appear 
so closely packed and aligned from the AFM images (Fig. F3B), whereas Ab40 appear 
more as random networks (Fig. F3A). 
 
6.3.4. Oligomer height distributions predict the potential position of dodecamers in 
the aggregation pathway 
We calculated the distribution of maximum dodecamer heights on top of the graphene 
layer.  Fig. 6.4 shows a range of ~7–8 nm for Ab42, commensurate with the oligomer 
sizes (~7-9 nm) co-existing with the fully formed aligned matured fibrils at the longest 
times from incubation as seen from the high-resolution height and phase-contrast AFM 
images (unpublished). We tentatively posit that the oligomers that remain post mature 
fibril formation in the AFM experiments may form a single layer of preformed 
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dodecameric oligomers with the designated LS-shaped fold (orientation III in our 
simulations), which could further seed fibril elongation as identified from a previous 
study.456 Further, the absence of Ab40 oligomers post fibril formation coupled with the 
dodecamer height range of ~6.5-7.6 nm from our simulations (Fig. 6.4) confirms that 
Ab40 does not present primarily as dodecamers,454,456 but as a mixture of differently sized 
small oligomers as also found from the unpublished AFM data.  
 
 
Fig. 6.4. Distribution of maximum heights of dodecamers of Ab40 and Ab42 above the 
graphene surface, computed the along the axis normal to the graphene. 
 
 
Table 6.1. The percentage existence of in-register hydrogen bonds (H-bonds) in the 
dodecamers of Ab40 and Ab42 at the two edges or ends (E1 and E2), and the center (C). 
The % existence was calculated by % occupancy of H-bonds at different ranges (50-70% 




E1 (%) C (%) E2 (%) 
Ab40 50-70 70-90 ≥90 50-70 70-90 ≥90 50-70 70-90 ≥90 
10 13 13 5 24 31 4 19 23 
Ab42 50-70 70-90 ≥90 50-70 70-90 ≥90 50-70 70-90 ≥90 
 




In this Chapter, I have presented a precise evaluation of the profibrillar molecular 
determinants in preformed oligomers of Ab on a graphene sheet, which could potentially 
help rationalize the experimentally observed difference in aggregation profiles between 
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Ab40 and Ab42. We use experimentally inaccessible sub-100 ns MD simulations on 
computationally reconstructed models of Ab dodecamers and correlate our findings with 
AFM data collected by collaborators at the graphene-water interface. These dodecamer 
structures were designed with the view that on one hand, they identify with a disease-
relevant fibril morphology (like LS-shaped fold with structured N-terminal in our case), 
but on the other hand, they retain the number of monomers in a dodecamer. This allowed 
us to characterize the profibrillar or fibril-prone features more readily from the 
perspective of a preformed oligomer.  
 Our findings suggest a number of possible aggregability features that 
distinguishes Ab40 from Ab42. Firstly, we identify that the preferred orientation 
conducive to fibril growth or elongation is along the graphene surface in a single layer, 
with this adsorption mode potentially stabilized by ordering of oligomer-graphene 
interfacial water. However, the last two residues in the C-terminal of Ab42 do not 
participate in direct dodecamer-graphene interactions. Secondly, Ab42 presents a more 
stable and closed morphology retaining most of its starting ‘fibrillar’ fold without 
significant disruption, which suggests that they are generally more profibrillar than Ab40. 
Thirdly, one end of Ab40 dodecamer is more open and fluctuating than the other, 
suggesting a unidirectional growth propensity, rather than bidirectional in case of Ab42, 
where both dodecamer ends are comparably stable. Finally, comparison with AFM height 
profiles (unpublished data) reveals that the preformed dodecamer of Ab42 in our 
simulations samples sizes that match oligomers persisting past mature fibril formation in 
the AFM experiments. By contrast, the poor matching with AFM height profile of Ab40 
dodecamer coupled with the observation of no oligomers post fibril formation confirms 
that Ab40 does not form dodecamers. 
 
Special acknowledgement for this research work: We thank Dr. Peter N. Nirmalraj for 
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Chapter 7. Conclusion and Future Work 
 
7.1. Overall summary of findings 
Aberrant self-assembly of natively unstructured peptides to highly structured amyloid 
fibrils are the foundation of many progressively pathological neurodegenerative disorders 
like Alzheimer’s, Parkinson’s, Huntington’s and Prion’s diseases, and type 2 diabetes. 
The driving forces behind aggregation are poorly understood and may involve several 
extrinsic and intrinsic factors. However, a consensus has recently emerged from 
experiments that posit soluble, low molecular weight oligomers to be the most pathogenic 
species in the amyloid aggregation pathway, and thus attractive targets for therapeutics. 
As simple as it may seem, the problem is that most of these oligomer species are still 
elusive to bulk experiments and may require artificial stabilization in order to be studied 
experimentally, which in turn precludes obtaining the real picture in an extended cellular 
environment. One way to tackle this problem is by using predictive modelling techniques 
through atomistic molecular dynamics (MD) simulations, which can provide significant 
insights into the assembly of these oligomers, and which provide leads for future 
experiments. For this thesis, two computational modelling approaches are employed to 
understand formation of oligomeric assemblies in amyloid-b (Ab) implicated in 
Alzheimer’s disease (AD) and a-synuclein (aS) implicated in Parkinson’s disease (PD) 
– first, from the perspective of identifying signature features of aggregation promotion 
and resistance in monomers and profibrillar oligomers, and second, predictive 
computational design of non-aggregating oligomer assemblies benchmarked against 
available experimental data. The key findings for the research presented in this thesis are 
summarized below: 
 
1. Aggregation-impeding helical stabilities of Ab42 and aS peptides can be 
optimized by facilitating specific terminal group mediated short-range 
interactions with central hydrophobic hotspots of aggregation in both peptides, 
given our discovered common intra-peptide route to helical stabilization in 
amyloidogenic monomers. 
2. Long-range allosteric modulation of partially folded helical regions (in 
hydrophobic hotspots of self-assembly) by charged terminal ends in both Ab42 
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and aS determines the aggregation behaviour in these peptides, and we propose 
that this allosteric effect could play a dominant role in promoting initial helical 
oligomerization of the partially folded states. 
3. A de novo stable broken a-helical aS tetramer can be designed by reconstruction 
of a loop motif that optimizes inter-monomer hydrophobic packing. Our 
simulations reveal that disordered monomers are pushed into a-helical active 
conformations during non-aggregating helical tetramer assembly (conformational 
selection). Familial PD-causing mutations double the energy barrier to a-helical 
tetramerization, restoring the ensemble to aggregation-prone disordered 
monomers. 
4. A computationally designed extended 11/3-helical aS tetramer is less stable than 
the previously designed broken a-helical tetramer, but more stable than the 
broken a-helical tetramer constructed from membrane-associated aS monomer. 
This suggests that 11/3-helical tetramers may co-exist as an intermediate 
assembly between membrane-bound and membrane-free a-helical tetramers. 
Homologous E→K mutations raise the energy barrier to transitions from extended 
11/3-helical to broken a-helical tetramers and destabilize helices in both showing 
a potential for dissociation. This provides a rationale for the experimental 
evidence that abrogating aggregation-impeding aS tetramer assembly by E→K 
mutations produces aggregation-prone monomers. 
5. Rational design of a-helical multimers shows that their stabilities increase 
linearly from dimers to octamers, but high activation energies are required for 
assembly of helical oligomers larger than tetramers. Tetramers show lowest 
activation energy with optimized hydrophobic packing, providing a rationale for 
the experimental observation that tetramers are the most populated oligomers. 
6. Computationally constructed profibrillar, preformed dodecamers of Ab grow as a 
single layer along the graphene-water interface and Ab42 dodecamers are more 
closed in structure than Ab40. There are indications of unidirectional elongation 
along the graphene surface in Ab40, and bidirectional growth in Ab42 which may 
explain the finding from microscopy experiments that dodecamer sized oligomers 
may co-exist with mature fibrils of Ab42, but not Ab40. All these findings provide 
a rationale for the observed difference in Ab40 and Ab42 aggregation profiles. 
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7.2. Answers to the research questions (RQs) and validation of the research 
hypotheses (RH) 
The four primary research questions have been addressed as follows: 
 
RQ1. Could the population of stable a-helical conformations of amyloidogenic 
monomers be optimized to make them more resistant to toxic oligomerization and if so, 
what are the molecular signatures that govern such stabilities? 
 
We probed the experimentally observed aggregation-impeding tendency of a-helical 
conformers of Ab42 and aS amyloidogenic peptides. The difficulty in characterizing the 
subtle differences in helical stabilization through experiments alone, means there is little 
information on their molecular origins. The models of helical plasticity were generated 
from multi-microsecond MD simulations across ten protein force field and water model 
combinations. Computed free energies and interaction maps revealed that the residues in 
the disordered N-terminus of Ab42 and the C-terminus of aS optimize the a-helical 
stabilities in both peptides via primary hydrophobic interactions with central hydrophobic 
domains (central hydrophobic cluster or CHC in amyloid-b42 and non-amyloid-b 
component or NAC in a-synuclein), and secondary salt bridges with other domains. 
These interactions screen the CHD from surrounding solvent and may potentially act as 
an impediment to aggregation. The absence of such short-range stabilizing interactions 
during the course of complete unfolding of helices, and a substantial drop in helical 
stabilities in terminal-deleted variants, emphasizes that terminal groups may play a 
critical role in protecting fully folded stable helices. These predicted models were further 
benchmarked against available experimental NMR averages. 
 
RQ2. What causes the partially folded a-helical amyloidogenic monomers to be so 
aggregation-prone, compared to the helically folded or unfolded states? 
 
We investigated the tendency of the partially folded helical Ab42 and aS amyloidogenic 
peptides to undergo early oligomerization, as experiments suggest that these locally 
folded helices are on-pathway to amyloid aggregation. The free energy maps and 
computed cross-correlation network analyses of the models generated by MD simulations 
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uncover a common feature of long-range concerted coupling between the partially folded 
helical central hydrophobic domains and the charged N-terminal end in Ab42 and C-
terminal end in aS. The absence of such internal intra-peptide modulation effects within 
the calculated helically folded and unfolded conformational spaces identified allosteric 
regulation of the central hydrophobic domains (such as the CHC in Ab42 and NAC in 
aS) by the termini. We posit that this long-range allosteric effect plays a crucial role in 
promoting initial helical oligomerization of the partially folded states.  
 
RQ3. What are the molecular determinants in the formation of non-aggregating a-
synuclein helical tetramers over the aggregation prone disordered monomers? In more 
detail, how does familial pathogenic mutations shift the equilibrium towards disordered 
monomers, how does helical periodicity (11/3-helix vs. a-helix) and continuity (extended 
vs. broken) govern the stabilities of a-synuclein tetramer, and why are the helical 
tetramers the most populated species amongst helical multimers of different monomeric 
sizes? 
 
We computationally re-designed a highly stable de novo broken a-helical tetramer of aS 
by reconstructing the loop motif (that connects the two a-helices) known to host familial 
pathogenic mutations. Preliminary scanning of the free energy landscapes of aS 
tetrameric assembly from four designed broken a-helical constructs (using available 
experimental data) helped us identify that optimization of inter-helical hydrophobic 
packing in the non-amyloid-b component (NAC) regions of associating monomers act as 
a major molecular determinant to stabilize the broken a-helical tetrameric construct, with 
secondary roles of the termini (both N- and C-terminus) in regulating stability. We also 
demonstrate that familial pathogenic missense mutations associated with PD such as the 
quadruple E46K, H50Q, G51D, and A53T collectively create a much higher energy 
barrier for self-assembly of a-helical monomers into the aggregation resistant a-helical 
tetramer, thus switching the tetramer–monomer equilibrium towards aggregation-prone 
monomeric aS IDPs. Our predicted models are validated against available experimental 
NMR data. 
 In addition to the broken a-helical aS tetramer (18 residues in 5 helical turns), we 
also probed the plausible existence of an extended 11/3-helical tetramer of aS (11 
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residues in 3 helical turns) in water. We designed 11/3-helical tetramer models by 
exploiting the curvature geometry of experimental membrane-bound 11/3-helical 
monomer conformations. The computed thermodynamic stabilities from four 
alternatively constructed extended 11/3-helical aS tetramer constructs show that their 
relative stability is driven by the inter-monomeric electrostatic interactions. However, 
two of our designed wild type (WT) extended 11/3-helical tetrameric assembly (of 
comparable stabilities, but different architectures) were overall less stable than our 
designed WT broken a-helical tetramer model, but more stable than the tetramer formed 
by micelle-bound aS. This suggests a possible intermediate 11/3-helical tetramer 
assembly while transiting from the membrane-associated to membrane-free broken a-
helical tetramers in water and vice versa. Moreover, homologous E→K mutated (E46K, 
E35K/E46K, and E35K/E46K/E61K) tetramers in both 11/3- and a-helical 
conformations undergo significant conformational change. It is easier to form broken a-
helical stable WT tetramer from WT extended 11/3-helical tetramer, but the transitions 
become increasingly difficult with each additional E→K mutation. The fluctuating N-
terminal makes NAC regions more exposed to solvent, and thus they become less stable 
pointing towards potential for dissociation at longer timescales. This observation is 
consistent with experimental observations that abolishing aS tetramer assembly by E→K 
mutations leads to excess aggregation-prone monomers in vivo.  
 Finally, our characterization of the thermodynamic and kinetic properties of both 
WT and quadruple mutated a-helical tetramers from a re-designed more stable (than the 
previous de novo model) de novo a-helical tetramer assembly reveal that assembly of aS 
multimers in general proceed via multiple energy barriers, despite the linear increase in 
conformational stability of aS multimers from dimer to octamer. The a-helical tetramer 
shows the lowest activation energy, giving a potential explanation of their high population 
amongst other multimers of different sizes. 
 
RQ4. What are the molecular determinants of the difference in aggregation profiles 
between amyloid-b40 and amyloid-b42 from the perspective of a preformed, profibrillar 
oligomer? 
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We explored the conformational orientations, preferences and stabilities of preformed 
Ab40 and Ab42 oligomers prone to fibrillation at the graphene-water interface. Using 
simulations from a starting model of dodecamer (suggested as one of the toxic species 
from experimental evidences) with two hexamers arranged laterally and benchmarking 
against AFM experiments, we identify possible molecular signatures that distinguishes 
the aggregation profiles of Ab40 from Ab42. We show that preformed Ab dodecamers 
preferably undergo profibrillar growth as a single layer on the graphene surface with 
Ab42 presenting a more stable and closed structure. One end of Ab40 dodecamer is more 
open and fluctuating than the other, whereas both dodecamer ends were comparably 
stable for Ab42, potentially pointing towards a unidirectional fibril growth in Ab40 and 
bidirectional growth in case of Ab42. This observation is further validated by AFM 
images in which fibrils appear closely packed and aligned for Ab42, whereas Ab40 fibrils 
form haphazard networks. Further, the preformed dodecamer of Ab42 in our simulations 
samples sizes commensurate with oligomers co-existing with mature fibrils as measured 
from AFM height profiles.  
 
The three research hypotheses have been validated as follows: 
 
RH1. Re-engineering terminal residues may control initial neurodegenerative 
aggregation of amyloidogenic monomers by optimizing their a-helical stabilities.  
 
The models of helical plasticity and design rules presented in Chapters 3 and 4 suggest 
new strategies to tackle neurodegeneration in both amyloid-b42 and a-synuclein by 
rationally re-engineering terminal groups to optimize their predicted ability to deactivate 
helically folded monomers (by stabilizing helices) and switch off the neurotoxic pathway 
(by abolishing partially folded helices), thus validating this research hypothesis. 
 
RH2. The native state of a-synuclein may exist as an aggregation resistant helical 
tetramer in addition to amyloidogenic disordered monomers which are in dynamic 
equilibrium with each other, and the shift in population from a potentially ubiquitous 
(amongst all helical multimers) tetramers to monomers determine pathogenicity. 
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The models and design strategies presented in Chapter 5 validates the existence of aS 
helical tetramers, which can be stabilized by optimizing the hydrophobic packing along 
the inter-monomer helical axis. The ubiquity of helical tetramers has been attributed to 
their lowest activation energy of formation amongst other helical multimers (oligomers). 
Pathogenic familial mutants shift the calculated activation barriers and so shift the 
population balance of helical tetramers and disordered monomers. 
 
RH3. Pro-aggregating properties of preformed dodecamers can potentially explain the 
differences between aggregation profiles of amyloid-b40 and amyloid-b42. 
 
Several pro-aggregating properties (including conformational preferences, 
thermodynamic stability, alignment and direction of growth, and ‘endedness’) of a 
potentially toxic dodecamer in the Ab aggregation pathway have been delineated in 
Chapter 6, which may help understand the more aggregation-prone behaviour of Ab42 
compared to Ab40, thus proving this hypothesis. 
 
7.3. Future work 
On the basis of the present conducted research, and myriad remaining unresolved 
questions in the field of amyloid research, the following research directions are being 
explored: 
 
A. We are currently exploring the possible monomeric signatures of non-standard 
(non-familial) mutations and comparing them with pathogenic familial mutations 
of Aβ40, Ab42 and the Microtubule-binding domain (MBD) of Tau. This work is 
carried out in collaboration with Prof. Mariano Carrión-Vázquez’s group in Spain, 
who are conducting AFM experiments to test the mechanical stabilities of these 
peptides. We have evaluated the conformational spaces of these peptides through 
extensive Hamiltonian Replica Exchange with Solute Tempering simulations. 
Preliminary results with Charmm36m force field produced excellent agreement 
with NMR-derived measurements, even replicating a b-hairpin structure in the 
exact regions obtained from experiments. This encouraged us to use Charmm36m 
for Ab40 and MBD of Tau as well. The free energy landscapes of our 8µs 
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simulations for each (total of 24 µs) of the WT and mutants (pathogenic Arctic 
E22G and non-standard I31E/E22G) of Aβ42 revealed a higher population b-
hairpin in E22G mutant compared to the WT and larger solvent exposure in the 
hydrophobic core, while the same was almost diminished by half in the double 
mutant I31E/E22G, indicating its lower aggregation propensity.  The simulations 
with Ab40 (total of 16 µs) displayed energy minima of b-sheet structures with a 
higher population for the E3R (non-standard) mutant than the WT. These two 
preliminary findings are in line with AFM data. The simulations with MBD 
domain of WT Tau and its pathogenic mutants K280D and P301L still need to 
attain convergence (5 µs each running – total of ~15 µs). In order to resolve the 
kinetically-relevant transitions, we will construct time-independent Markov State 
Models (MSMs) for all ensembles. Choosing a distance metric as contacts within 
5Å and a clustering method such as Hybrid k-Centers/k-Medoids may allow us to 
identify the rare events/conformations from the potential energy landscape. We 
will then test the mechanical stabilities through potential of mean force (PMF) 
simulations on the identified conformations. 
B. Since the 11/3-helical tetramer of aS (discussed in Chapter 5) designed from 
experimentally determined membrane-bound extended 11/3-helical monomer 
showed lower thermodynamic stability than the broken a-helical model tetramer, 
we are re-designing 11/3-helical coiled coil monomers from scratch by employing 
design rules for ideal right-handed coiled-coil helices. We will then design their 
corresponding helical tetramers, with the hope of getting a better stability than the 
experimentally determined model. These 11/3-helical extended models will be 
further simulated on surface of mixed membranes to compare with their broken a-
helical congeners, as membranes have been shown to promote oligomer 
aggregation. 
C. Following up on the work on profibrillar dodecamers (discussed in Chapter 6) of 
Ab40 and Ab42, we further plan on testing different dodecamer folds (to see if 
they have a fold preference) and their interactions with graphene, especially the 
impact of orderliness in the N-terminal (b-sheet or disordered). In this context, we 
have also simulated N-terminal point mutants of Ab40 and Ab42 including 
homozygous (pathogenic) and heterozygous (non-pathogenic) A2V, and A2T 
 - 158 - 
(non-pathogenic) on graphene-water interface and freely in solution. The distinct 
role of the N-terminus in modulating helical preference of monomeric Ab42 has 
been extensively studied in Chapters 3 and 4. We wish to evaluate their roles from 
the standpoint of the preformed dodecamer to deduce whether these N-terminal 
mutants scale pathogenicity with conformational and fold preferences. 
D. Certain mutations in human mitochondrial aminoacyl-tRNA synthetases (aaRS; 
the enzymes that match amino acids with their cognate tRNA in protein synthesis) 
are associated with neurodegenerative disorders. Especially, aspartyl-tRNA 
synthetse (AspRS) mutations have long been associated with 
leukoencephalopathies (degeneration of white matter). As a preliminary test of 
AspRS fidelity, we have simulated WT AspRS and its Q195A mutant with bound 
Asp in its two enantiomeric forms (L-Asp and D-Asp). The binding energies 
reveal that Q195A mutated AspRS may exhibit pro-D chiral selectivity. We 
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Table A1. Summary of protein force fields and water models used in recent benchmarking studies of 
IDPs. 
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Example R script for dynamic cross-correlation network analysis 
 
B1. Generating network model 
#!/usr/bin/R 
 





#READ ‘CONSENSUS’ TRAJECTORY FILES BY CREATING CHUNKS 
cat("loading dcd and pdb files...\n") 
files <- list.files('./','*.dcd') 
chunks <- lapply(files, read.dcd) 
 
#READ PDB FILE 
pdb <- read.pdb("protein.pdb") 
 
#CALCULATE CROSS-CORRELATION MATRIX FOR C-ALPHA ATOMS  
cat("generating dynamic cross-correlation matrix...\n") 
cij <- lapply(chunks, dccm) 
sse <- dssp(pdb) 
 
#CALCULATE CROSS-CORRELATION AT DIFFERENT THRESHOLD VALUES 
cat("calculating correlations for different thresholds...\n") 
cij_0 <- filter.dccm(cij, cutoff.cij=0) 
cij_0.3 <- filter.dccm(cij, cutoff.cij=0.3) 
cij_0.35 <- filter.dccm(cij, cutoff.cij=0.35) 
cij_0.4 <- filter.dccm(cij, cutoff.cij=0.4) 
cij_0.45 <- filter.dccm(cij, cutoff.cij=0.45) 
cij_0.5 <- filter.dccm(cij, cutoff.cij=0.5) 
cij_0.55 <- filter.dccm(cij, cutoff.cij=0.55) 
cij_0.6 <- filter.dccm(cij, cutoff.cij=0.6) 
cij_0.65 <- filter.dccm(cij, cutoff.cij=0.65) 
cij_0.7 <- filter.dccm(cij, cutoff.cij=0.7) 
cij_0.75 <- filter.dccm(cij, cutoff.cij=0.75) 
cij_0.8 <- filter.dccm(cij, cutoff.cij=0.8) 
cij_0.9 <- filter.dccm(cij, cutoff.cij=0.9) 
 
#GENERATE DCCM IMAGES AT DIFFERENT THRESHOLDS 
png("dynamic_corr_all.png", width=800, height=600) 
plot(cij_0, sse=sse, col.regions=bwr.colors(200), contour=FALSE, at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.3.png", width=800, height=600) 
plot(cij_0.3, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.35.png", width=800, height=600) 
plot(cij_0.35, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.4.png", width=800, height=600) 
plot(cij_0.4, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.45.png", width=800, height=600) 
plot(cij_0.45, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.5.png", width=800, height=600) 
plot(cij_0.5, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.55.png", width=800, height=600) 
plot(cij_0.55, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.6.png", width=800, height=600) 
plot(cij_0.6, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
png("corr_filter_0.65.png", width=800, height=600) 
plot(cij_0.65, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
 VII 
png("corr_filter_0.7.png", width=800, height=600) 
plot(cij_0.7, sse=sse, col.regions=bwr.colors(200), contour=FALSE,  at=seq(-1,1,0.01) ) 
dev.off() 
 
#CALCULATE AND PLOT NETWORK STRUCTURE (FOR ALL VALUES OF CIJ) 
net_0.3 <- cna(cij_0.3) 
grp.col <- list() 
for (i in 1:max(net_0.3$communities$membership)) { 
  grp.tmp <- which(net_0.3$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.3$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.3$communities$membership), alpha = 0.5) 
png("net_0.3.png", width=800, height=600) 
plot(net_0.3, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.35 <- cna(cij_0.35) 
grp.col <- list() 
for (i in 1:max(net_0.35$communities$membership)) { 
  grp.tmp <- which(net_0.35$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.35$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.35$communities$membership), alpha = 0.5) 
png("net_0.35.png", width=800, height=600) 
plot(net_0.35, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.4 <- cna(cij_0.4) 
grp.col <- list() 
for (i in 1:max(net_0.4$communities$membership)) { 
  grp.tmp <- which(net_0.4$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.4$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.4$communities$membership), alpha = 0.5) 
png("net_0.4.png", width=800, height=600) 
plot(net_0.4, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.45 <- cna(cij_0.45) 
grp.col <- list() 
for (i in 1:max(net_0.45$communities$membership)) { 
  grp.tmp <- which(net_0.45$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.45$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.45$communities$membership), alpha = 0.5) 
png("net_0.45.png", width=800, height=600) 
plot(net_0.45, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.5 <- cna(cij_0.5) 
grp.col <- list() 
for (i in 1:max(net_0.5$communities$membership)) { 
  grp.tmp <- which(net_0.5$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.5$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.5$communities$membership), alpha = 0.5) 
png("net_0.5.png", width=800, height=600) 
plot(net_0.5, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.55 <- cna(cij_0.55) 
grp.col <- list() 
for (i in 1:max(net_0.55$communities$membership)) { 
  grp.tmp <- which(net_0.55$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.55$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.55$communities$membership), alpha = 0.5) 
 VIII 
png("net_0.55.png", width=800, height=600) 
plot(net_0.55, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.6 <- cna(cij_0.6) 
grp.col <- list() 
for (i in 1:max(net_0.6$communities$membership)) { 
  grp.tmp <- which(net_0.6$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.6$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.6$communities$membership), alpha = 0.5) 
png("net_0.6.png", width=800, height=600) 
plot(net_0.6, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.65 <- cna(cij_0.65) 
grp.col <- list() 
for (i in 1:max(net_0.65$communities$membership)) { 
  grp.tmp <- which(net_0.65$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.65$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.65$communities$membership), alpha = 0.5) 
png("net_0.65.png", width=800, height=600) 
plot(net_0.65, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.7 <- cna(cij_0.7) 
grp.col <- list() 
for (i in 1:max(net_0.7$communities$membership)) { 
  grp.tmp <- which(net_0.7$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.7$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.7$communities$membership), alpha = 0.5) 
png("net_0.7.png", width=800, height=600) 
plot(net_0.7, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.75 <- cna(cij_0.75) 
grp.col <- list() 
for (i in 1:max(net_0.75$communities$membership)) { 
  grp.tmp <- which(net_0.75$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.75$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.75$communities$membership), alpha = 0.5) 
png("net_0.75.png", width=800, height=600) 
plot(net_0.75, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.8 <- cna(cij_0.8) 
grp.col <- list() 
for (i in 1:max(net_0.8$communities$membership)) { 
  grp.tmp <- which(net_0.8$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.8$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.8$communities$membership), alpha = 0.5) 
png("net_0.8.png", width=800, height=600) 
plot(net_0.8, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
net_0.9 <- cna(cij_0.9) 
grp.col <- list() 
for (i in 1:max(net_0.9$communities$membership)) { 
  grp.tmp <- which(net_0.9$communities$membership == i) 
  grp.col[[i]] <- grp.tmp 
} 
colbar.full <- vmd_colors()[net_0.9$communities$membership] 
colbar.comms <- vmd_colors(max(net_0.9$communities$membership), alpha = 0.5) 
png("net_0.9.png", width=800, height=600) 
 IX 
plot(net_0.9, pdb, full = TRUE, mark.groups = grp.col, mark.col = colbar.comms) 
dev.off() 
 
#PLOT AND REPRESENT MINIMAL (COARSE-GRAINED) NETWORK 
png("min_net_0.3.png", width=800, height=600) 
plot(net_0.3, pdb) 
dev.off() 
png("min_net_0.35.png", width=800, height=600) 
plot(net_0.35, pdb) 
dev.off() 
png("min_net_0.4.png", width=800, height=600) 
plot(net_0.4, pdb) 
dev.off() 
png("min_net_0.45.png", width=800, height=600) 
plot(net_0.45, pdb) 
dev.off() 
png("min_net_0.5.png", width=800, height=600) 
plot(net_0.5, pdb) 
dev.off() 
png("min_net_0.55.png", width=800, height=600) 
plot(net_0.55, pdb) 
dev.off() 
png("min_net_0.6.png", width=800, height=600) 
plot(net_0.6, pdb) 
dev.off() 
png("min_net_0.65.png", width=800, height=600) 
plot(net_0.65, pdb) 
dev.off() 
png("min_net_0.7.png", width=800, height=600) 
plot(net_0.7, pdb) 
dev.off() 
png("min_net_0.75.png", width=800, height=600) 
plot(net_0.75, pdb) 
dev.off() 
png("min_net_0.8.png", width=800, height=600) 
plot(net_0.8, pdb) 
dev.off() 




#WRITE NETWORK ATTRIBUTES TO FILE 
cat("printing network attributes to file...\n") 

















B2. Path analysis 
#!/usr/bin/R 
 





#LOAD CONSENSUS TRAJECTORY 
cat("loading dcd and pdb files...\n") 
files <- list.files('./','*.dcd') 




pdb <- read.pdb("disordered.pdb") 
 
#CALCULATE CROSS-CORRELATION MATRIX FOR C-ALPHA ATOMS 
cat("generating dynamic cross-correlation matrix...\n") 
cij <- lapply(chunks, dccm) 
sse <- dssp(pdb) 
 
#CALCULATE CROSS-CORRELATIONS ABOVE A CERTAIN THRESHOLD (0.4 HERE) 
cij_0.4 <- filter.dccm(cij, cutoff.cij=0.4) 
net_0.4 <- cna(cij_0.4) 
 
#CALCULATE AND PLOT NODE CENTRALITY 
node.betweenness <- betweenness(net_0.4$network) 
png("betweenness_0.4.png", width=800, height=600) 
plot(node.betweenness, xlab="Residue No", ylab="Centrality", type="h") 
dev.off() 
 
#COMPUTE SUB-OPTIMAL PATHS 
#for whole protein 
pa_whole <- cnapath(net_0.4, from=1, to=140, k=500, ncore=4) 
 
#for helix only 
pa_helix <- cnapath(net_0.4, from=3, to=92, k=500, ncore=4) 
 
#for helix1 only 
pa_helix1 <- cnapath(net_0.4, from=3, to=37, k=500, ncore=4) 
 
#for helix 2 only 
pa_helix2 <- cnapath(net_0.4, from=45, to=92, k=500, ncore=4) 
 
#for beta hairpin region 
pa_hairpin <- cnapath(net_0.4, from=37, to=54, k=500, ncore=4) 
 
#Group paths into list 
pas <- list(pa_whole, pa_helix, pa_helix1, pa_helix2, pa_hairpin) 
 
#WRITE PATHS TO FILE 




#PLOT PATH ANALYSES 
cat("printing paths...\n") 
names(pas) <- c("Full length","All helix","N-terminal helix","C-terminal helix","Beta hairpin region") 
png("all_together.png", width=800, height=600) 
print.cnapath(pas, pdb=pdb, col=c("black", "purple", "red", "darkgreen", "orange"), plot=TRUE) 
dev.off() 
 
png("pa_whole.png", width=800, height=600) 
print.cnapath(pa_whole, pdb=pdb, col =c("black"), label="Full length (1-140)", plot=TRUE) 
dev.off() 
 
png("pa_helix.png", width=800, height=600) 
print.cnapath(pa_helix, pdb=pdb, col=c("purple"), label="All helix (3-92)", plot=TRUE) 
dev.off() 
 
png("pa_helix1.png", width=800, height=600) 
print.cnapath(pa_helix1, pdb=pdb, col=c("red"), label="N-terminal helix (3-37)", plot=TRUE) 
dev.off() 
 
png("pa_helix2.png", width=800, height=600) 
print.cnapath(pa_helix2, pdb=pdb, col=c("darkgreen"), label="C-terminal helix (45-92)", plot=TRUE) 
dev.off() 
 
png("pa_hairpin.png", width=800, height=600) 
print.cnapath(pa_hairpin, pdb=pdb, col=c("orange"), label="Beta hairpin region (37-54)", plot=TRUE) 
dev.off() 
 
#VIEW PATHS IN VMD WITH DIFFERENT COLOURS 
vmd.cnapath(pa_whole, pdb=pdb, spline=FALSE, col=c('darkgreen', 'red'), launch=FALSE) 
system("mv vmd.cnapath.pdb pa_whole.pdb") 
 XI 
system("mv vmd.cnapath.vmd pa_whole.vmd") 
 
vmd.cnapath(pa_helix, pdb=pdb, spline=FALSE, col=c('darkgreen', 'red'), launch=FALSE) 
system("mv vmd.cnapath.pdb pa_helix.pdb") 
system("mv vmd.cnapath.vmd pa_helix.vmd") 
 
vmd.cnapath(pa_helix1, pdb=pdb, spline=FALSE, col=c('darkgreen', 'red'), launch=FALSE) 
system("mv vmd.cnapath.pdb pa_helix1.pdb") 
system("mv vmd.cnapath.vmd pa_helix1.vmd") 
 
vmd.cnapath(pa_helix2, pdb=pdb, spline=FALSE, col=c('darkgreen', 'red'), launch=FALSE) 
system("mv vmd.cnapath.pdb pa_helix2.pdb") 
system("mv vmd.cnapath.vmd pa_helix2.vmd") 
 
vmd.cnapath(pa_hairpin, pdb=pdb, spline=FALSE, col=c('darkgreen', 'red'), launch=FALSE) 
system("mv vmd.cnapath.pdb pa_hairpin.pdb") 
system("mv vmd.cnapath.vmd pa_hairpin.vmd") 
 
#PRINT SHORTTEST PATH(S) AND PATH DISTANCES 
cat("printing shortest paths...\n") 
sink("shortest_paths.txt", append=TRUE, split=FALSE) 






















































Appendix C  
Notes 
1. Physical models used in this study 
The combinations of force field and water model (FF/WM) used in this study are CHARMM361 (C36) 
with CHARMM-modified TIP3P2 (mTIP3), TIP4P3 (TIP4), TIP4P/20054 (2005), TIP4P-Ew5 (Ew) 
and TIP4P-D6 (D); CHARMM22*7 (C22*) with D; CHARMM36m8 (C36m) with mTIP3 and scaled 
mTIP38 (sTIP3); Amber ff039,10 (A03) with D; Amber ff03Ws11 (A03Ws) with scaled 2005. The 
combinations of FF/WM were carefully chosen. Previous benchmarking studies have shown that C22* 
better represented model IDPs compared to other force fields,12,13 including that of Ab42,14,15 and so 
here we have combined C22* with the TIP4P-D water model to favour extensive sampling of 
disordered states. On the other hand, we combine C36 (mainly developed for folded/globular proteins) 
with three-point and four-point water models and also TIP4P-D to sample more ordered states. The 
recently developed C36m, a flexible protein force field to simultaneously model ordered and 
disordered protein states, with the two three-point water models provides an additional useful model 
to sample transitions between quasi-ordered states. Similar rules apply for the Amber FF variants, with 
A03 parameterized for ordered states, and so we wanted to assess if combining it with TIP4P-D water 
model would expedite unfolding of helices. 
 
2. Secondary structure decomposition 
The helices of Ab42 in the F state are significantly structured in the distal part of the NTR (residues 
12-15), the amyloidogenic CHC region (16-20) and the beginning of the hydrophilic turn region (22-
25) with virtually zero random coils (Fig. C5A). The proximal part of CTR (30-38) also shows some 
helical propensity in the F state, which diminishes in the P state. By contrast, the helical probabilities 
for the U states show a much more unstructured NTR, with the remaining helicity localized in the 
amyloidogenic CHC and parts of the turn region. There is also increasing probability of forming 
extended (b-hairpin) structures in the CTR during late-stage unfolding, consistent with previous 
studies of disordered states.16,17 Persistent NTR helices still exist in the F states for aS (Fig. C5B). 
Previous experimental and simulation studies of N-terminal acetylation have shown the importance of 
this amphipathic NTR helicity (containing the consensus repeat sequences KTKEGV) for lipid binding 
and for resisting oligomer aggregation.18-22 Helices are also clearly visible in the NAC, except for a 
few cases (C36/Ew and C36m/mTIP3) where the side nearest the disordered CTR loses some helicity. 
The P states show a similar pattern only with loss of helices in the distal NAC. On the other hand, no 
persistent helices are seen in the NTR for the U states (except C36/D) but NAC retains some helicity 
despite losses near the CTR. In addition to the b-hairpins present in the CTR of the U states, transient 
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b-hairpin formations appear in the NTR including the region 35-54 which was captured 
experimentally by affibodies.23 
 
3. Conformational distribution of helical intermediates 
Fig. C6 shows the populations of the three most representative structures of helical intermediates 
sampled through different physical models for Ab42 and aS and computed by clustering (using cut-
off of 6 Å) based on the iterative method described by Daura et al.24 Ab42 (left panel) shows large 
population (~50%) of F states in the first cluster. By contrast, the population of P and U states in the 
first cluster are significantly reduced indicating a high conformational heterogeneity or polymorphism 
for these helical intermediates. This is further supported by similar distributions in the second cluster. 
While a compact structure is a prevalent feature in the F states of the helical conformation due to the 
proximity of the hydrophobic amyloidogenic CHC and CTR, such compactions are also observed for 
the U states initially, but are short-lived, suggesting that generally unfolding of Ab42 helices involves 
overall elongation of structures. Table C1A shows that the average radius of gyration (<Rg>) of Ab42 
displays a systematic increase from the F to the U states. However, even for the U states the <Rg> is 
much more compact than that measured in organic solvents.25 Compact helical conformations have 
also been calculated in previous REMD simulations.26-29 The broad probability distributions of Rg and 
end-to-end distances (Re) (Fig. C7A) for Ab42 reveal the overall elongation and conformational 
heterogeneity with the U (and the P) states. This is in contrast to the F states where calculated 
distributions are tighter and shifted towards lower values.  
The solvent accessible surface area (SASA) plots (Fig. C7B) show that the predominantly 
helical conformation in the amyloidogenic CHC helps shield hydrophobic side chains from water. The 
hydrophilic turn region (especially the charged residues Glu22, Asp23 and Lys28, and polar residue 
Arg27) are in general more solvent exposed in the F and the P states signifying the preservation of the 
distinctive turn characteristic with no discernible secondary structure formation. The most important 
distinction between the FF/WMs lie in the proximal NTR (residues Glu3-Asp7) which display notably 
higher SASA values for some of the U states than the F/P states. The more solvated NTR shows an 
extended conformation in the U states with a propensity for being unstructured, and a more collapsed 
and structured conformation in the F/P states that may help preserve the helical conformation. 
In contrast to Ab42, aS populates a diverse range of helical intermediates irrespective of the 
folding/unfolding state (Fig. C6, right insets). In particular, the noted high clustering of F states with 
Ab42 is not evident for aS, highlighting that conformational heterogeneity can prevail at the level of 
ordered helical states. This is partly due to the greater length of the peptide (more than three times that 
of Ab42) with a long (45 residues) fluctuating unstructured CTR. In order to be consistent with Ab42, 
we have used the same cut-off value of 6 Å for cluster computation of aS. The probability distributions 
of Rg (Fig. C7C) with different FF/WMs show no clear demarcation, as the U states display a slightly 
broader distribution over the F states with peaks between 15 – 30 Å. Although most of the F states 
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display a higher frequency of lower peak values with slightly narrower distribution, C36/mTIP3 
samples largely elongated/expanded helically folded conformations with no instance of compact 
states. Similar extended state features of folded proteins have been previously obtained with 
C36/mTIP3 over the standard TIP3P3 water model.30 There is also no general trend of increased <Rg> 
values with the U states (Table C1B) as observed with Ab42. Previous Small-angle X-ray scattering 
(SAXS) measurements (under in vitro conditions) of predominantly disordered states have indicated 
an expanded ensemble with <Rg> ranging around 40 – 41 Å,31-33 which is larger than what we have 
computed for the helical intermediates. It has also been noted that SAXS measurements are very 
sensitive to the more extended conformations.33 However, recent in-cell NMR experiments have 
revealed more compact disordered conformations than those measured by in vitro experiments.34 Also 
very recent high-speed Atomic force microscopy (AFM) experiments and Discrete MD (DMD) 
simulations showed a major state (~76%) of compact aS with several helical regions with a minor 
(~14 %) population of elongated conformations.35 The observed extended helical NTR35 resembles 
conformations sampled by C36/mTIP3 (Fig. C5) in terms of shape as well as population density (~15 
% of total population in the first cluster). This is further supported by the distribution of Re, where 
C36/mTIP3 shows a broader distribution mainly due to fluctuations between an extended and 
collapsed CTR (Fig. C7C).  
The residue-wise decomposition of SASA shows a slightly more solvent exposed NTR 
(especially from Ala30-Glu35, where the two Lysine residues at 32 and 34 are close to the kink region) 
in the U states than the F/P states mainly owing to the lack of stable helices in the NTR of U states 
(Fig. C7D). Additionally, Lys58 and Lys60 are notably more exposed from the distal NTR in the U 
states. However, a highly solvated NTR with an elongated helix is also observed for the F states with 
C36/mTIP3. Although the NAC region records overall lower SASA values than the rest of the peptide 
due mostly to the preservation of helicity (more for F than U), Lys80 in the NAC is comparably more 
solvent exposed for the U states. The residue Lys80 is shown to be extremely important for the stability 
of aS fibrils in the Greek-key topology by sharing a salt bridge with Glu46.36 We have shown 
previously that mutating it to a polar residue (K80Q) in a 5-fold topology of NAC fibrils invokes large 
changes in its overall dimensions and solvent exposure, through a hydrophobic collapse at a lower 
temperature (280 K) indicative of cold denaturation.37  
 
4. Free energies with AMBER parameters  
As far as the two AMBER variants of force fields are concerned, the U states with A03Ws/2005 
sample more favourable solvation free energy than the F states with A03/D in Ab42 (Fig. 3.3A). 
However, the combination of a less negative electrostatic energy, a less positive covalent energy and 
a slightly less negative vdW energy of A03Ws/2005 (Fig. C8A) lead to an almost equal Gvacuum with 
A03/D, thus leading to a more favourable total free-energy with A03Ws/2005. It is to be noted that 
the electrostatic energy term is sensitive to the differences in partial charges within the AMBER 
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variants.38 The trend of the two U states with the AMBER variants in aS is very similar to Ab42, 
except for the Gvacuum (Fig. C8B) in vacuum, which are very unfavorable due to the coulomb’s 
electrostatic energies as discussed before, but still more favourable than the CHARMM variants due 
to different charge considerations.  
 
5. Effect of the physical models on free energies  
The average polar solvation free energies for the CHARMM variants in the F states range from -853 
± 28 to -720 ± 12 kcal.mol-1 for Ab42 and from -4236 ± 7 to -2692 ± 31 kcal.mol-1 for aS, while for 
the U states they range from -897 ± 23 to -844 ± 15 kcal.mol-1 for Ab42 and between -4173 ± 62 to -
3439 ± 164 kcal.mol-1 for aS. Previous Replica Exchange MD (REMD) studies have estimated the 
Gsolvation of WT Ab42 to be -668 kcal.mol-1 (MM/GBSA)39 and for WT aS to be -16704 ± 170 kJ.mol-
1 » -3992 kcal.mol-1 (MM/PBSA).40 While this value for aS is well within the range of what we have 
calculated (Table C2B), for Ab42 our Gsolvation (Table C2A) range is slightly more favourable for the 
helical intermediates, possibly originating from the different implicit solvent model (PB vs. GB). 
There are two striking anomalies in the computed energies: firstly, the minimum polar 
solvation energy in the F states (C36/2005) is slightly lower than the maximum energy in the U states 
(C22*/D) for Ab42 and secondly, the minimum polar solvation value in the F states (C36/mTIP3) is 
the lowest amongst all the FF/WMs (including the U states) for aS. We have noted earlier that for 
Ab42, a prominent feature promoting helix unfolding is the sampling of extended conformations. 
Given this scenario, the more favourable electrostatic component of the solvation energy of the 
modestly compact helical conformations with C36/2005 (larger magnitude than C22*/D of the U 
states) is unexpected. Likewise, the most favourable polar solvation energy for the extended and folded 
helical intermediates (retaining the maximum average helical content amongst all FF/WMs (Table 3.1 
in Chapter 3) with C36/mTIP3 is difficult to rationalize for aS, given an overall compact helix 
unfolding for the U states. This brings us to the question whether the favourable (polar) solvation free 
energies are solely reflective of the helix unfolding or include a strong influence from overall 
elongation. Of course, the fast interchangeability between helical and disordered states involving small 
energy barriers for IDPs cannot be entirely ruled out.41  
We observe that for the predominantly hydrophobic (with a low net charge per residue) Ab42, 
the slightly favourable polar solvation energies with C36/2005 compared to C22*/D are not 
compensated by a higher electrostatic energy (which is not the case with the U states). Thus, we reason 
that a slightly stronger attraction between oppositely charged residues coupled with improved van der 
Waals (vdW) contacts (-89 ± 1 kcal.mol-1 as opposed to -70 ± 5 kcal.mol-1 with C22*/D) might 
contribute in preserving the compact conformations in C36/2005 despite having a more negative polar 






6. Conformational entropy 
The absolute average values of entropies (TS) do not show any significant gains while moving from 
the F to the U states for both Ab42 and aS (Fig. C8). Although mapping the entropies (S) as a function 
of simulation time (Fig. C9) shows that some of the U states evolve towards a slightly more positive 
entropy, the difference is small (~0.1 kcal.mol-1 for Ab42 and ~0.3 kcal.mol-1 for aS). Overall, the 
fluctuating crests and troughs in the S curves denote the uneven entropy gains and losses between 
transiently unfolded and reformed helices respectively. Similar entropy gains with loss of helical 
segments have also been observed in previous simulation studies.29,42 
 
7. Contact maps 
In order to have a thorough understanding of the differences between the specific interactions that 
preserve the helically folded states and that which promote unfolding, we performed tertiary structure 
analyses by computing the contact probabilities between all residues. Pairs of residues are in contact 
if the minimum average distance between the heavy atoms of the two residues is within 5 Å. We 
performed these analyses by using the CONAN43 contact map analysis tool, which utilizes the gmx 
mdmat tool in GROMACS.44  
We observe a high percentage of anti-diagonal residual contact lifetimes (Fig. C10A) 
throughout the full trajectory (i.e. from the start of simulation to the complete unfolding for the U 
states) of Ab42. Their magnitudes in the F and the P states (upper panel) suggest predominantly 
collapsed conformations. These contacts in the F or P states between the hydrophobic amyloidogenic 
CHC (16 – 21) and the CTR (30 – 42), and the proximal turn region (22 – 25) and CTR, decay in the 
U states (lower panel, < 50 % in A03Ws/2005) due to an overall elongation of structures. Such anti-
diagonal contacts have been shown to form anti-parallel b-hairpin motifs in monomers15,17 and have 
been linked to an increased aggregation propensity, comparable to the b-sheet rich horseshoe-shaped 
morphology of Ab42 protofibrils from solid-state NMR (ssNMR).45 While massive structural 
rearrangements (unfolding and refolding) are required to form b-sheets in these regions, capturing 
such similar morphology and contacts in the helically folded states suggests that stabilizing such 
helical structures with predominantly buried hydrophobic side-chains could make the peptide less 
aggregation-prone.  
In addition, the contact frequencies of the NTR (1-15) with the rest of the domains (marked 
by a red rectangle in Fig. C10A) shows clear contacts between the distal part of the NTR (10 – 15) 
and the CTR in the F and the P states, which either do not exist or become extremely sparse in the U 
states. The most interesting findings are the prominent contacts between proximal part of the NTR (1-
5) and the amyloidogenic CHC in the F states (with C36/TIP4 and A03/D) and between the distal NTR 
and the amyloidogenic CHC in the P states (with C36/D). These contacts are also present to some 
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extent in the other F states, but completely absent in the U states. These NTR contacts are more 
prominent in the last 200 ns of the simulations as shown for the F states with amyloidogenic CHC (red 
rectangle) but fades slightly for the P states as shown in Fig. C11A.  
Similar to that of Ab42, we characterized the tertiary structure using contact probability maps 
of aS residue pairs with heavy atoms within 5 Å (Fig. C10B). At the outset, the distribution of contacts 
seems quite diffuse with prevalent anti-diagonal contacts in the lower-left or the upper-right corners 
of the maps irrespective of either F or P or U states. These constitute the contacts of NTR (1 – 60) 
with NAC (61 – 95) or the contacts between NAC and CTR (96 – 140) respectively. Given the 
structural heterogeneity of aS with a long-disordered tail of CTR (45 residues), it is a challenge to 
segregate the dominant tertiary structural patterns with the fold propensities. However, two distinct 
patterns emerge that separate the F from the U states: firstly, the contact frequencies between CTR 
and the rest of the domains (marked by green rectangle) for C36m/mTIP3 of the F states are truly anti-
diagonal with densely-populated NAC – CTR contacts (> 60 % probability) and with no discernible 
NTR – NAC contacts. Secondly, a total absence of contacts between either NTR or NAC and CTR 
for C22*/D of the U states with a less dense NTR – NAC contact probabilities. The prominence of 
CTR contacts can be appreciated from the last 200 ns of the simulations, where frequent interactions 
with the NAC region (green rectangle) is seen for the F states (Fig. C11B). Moreover, the P states 
(C36m/sTIP3), which could be regarded as a transition between the F and the U states show the fading 
out of CTR contacts with the establishment of NTR contacts. Evidences from experiments and 
simulations suggest that the presence of long-range intramolecular contacts in the monomeric aS may 
prevent it from spontaneous aggregation.46-50 Contradictorily, pathogenic familial mutants was shown 
not to perturb these long-range contacts.51,52 However, their link (if any) to aggregation-resistant 























Fig. C1. The convergence of the MD simulations as monitored using the conformational matrices 
(atom coordinates) of (A) Ab42 and (B) aS by Bootstrapped Block Covariance Overlap Method 
(BBCOM). All the Folded (F), Partially folded (P) and Unfolding (U) states are shown. Initially 
conservative blocks of 10 ns were considered, with an iterative increment of 10 ns until half the 
simulation times (relative to the protein and sampling time).  Most systems start converging after the 


















Fig. C2. Temporal evolution of the (A) Fraction of native contacts (Q), (B) Percentage of helical 
content in different regions, and (C) corresponding helical hydrogen bond counts of Ab42 across the 
ten different force field/water model (FF/WM) combinations. The different states are abbreviated as 
F = folded, P = partially folded and U = unfolding. The percentage of helix in panel B is the sum of 
310-helix, a-helix, and p-helix according to the DSSP definition, and the hydrogen bond counts in 
panel C are shown separately for each one of them. In Ab42 the initial helical region spans residues 
Ser8-Gly38 with Helix 1 (Ser8 – Gly25) and Helix 2 (Lys28 – Gly38) including the two-residue linker 









Fig. C3. Analysis of contacts, secondary structures and hydrogen bonds (A – C) in aS with details in 
legend of Fig. S1. In aS the initial helical region spans residues Val3-Thr92 including the kink from 















Fig. C4. Typical MD snapshot of aS (sampled by A03Ws/2005) showing the initial helical breaks 
created by Gly and Val in Helix 2 NAC regions (Val66-Val77 or near-CTR Val82-Gly86), followed 
by breaks in the NTR of Helix 1 (Gly31-Gly37). The high population of glycine (helix-breaker) and 
valine (b-sheet promoter) residues in these regions creates kinks that destabilize the helices and 
facilitates the rest of the helices to unfold. Very similar patterns follow for rest of the FF/WMs 
favouring the U states. The N-terminal, C-terminal and the NAC regions are shown as red, green and 
grey cartoons, respectively. The Gly and Val residues are shown as sticks (polar = green, hydrophobic 
= white).  
 
Note: Breaks in helical structures have been reported in previous experimental measurements61,62 of 
aS on membrane and small unilamellar vesicles, and there is a well-documented broken helix in region 
















Fig. C5. Residue-wise secondary structure populations (%) for the last 200 ns of (A) Ab42, and (B) 
aS for ten different physical models. The different states are abbreviated as F = folded, P = partially 











Fig. C6. Three most representative structures of Ab42 (left) and aS (right) from F, P and U states of 
physical models obtained using the clustering method described in Daura et al.24 The percentage 




Fig. C7. Distributions of radii of gyration (Rg) and end-to-end distances (Re) of different helical states 
for (A) Ab42 and (C) aS. Solvent accessible surface area (SASA) as a function of residue index of 








Fig. C8. The average total free energies (Total) for the last 200 ns further decomposed into 
electrostatic, van der Waals (vdW), covalent or bonded, polar and apolar (non-polar) solvation free 
energies, and entropy times the temperature (TS) for all the F, P and U states of (A) Ab42 and (B) aS. 
All calculations were done by the MM/PBSA66 method employed in Amber 12.67 Average entropy 











Fig. C9. The time evolution of configurational entropy (S) for the last 200 ns shown for the F/P and 























Fig. C10. Intra-molecular contact frequencies. Contact probabilities (%) between amino acid residues 
in (A) Ab42, and (B) aS, for all the F, P, and U states. A contact occurs if the minimum average 
distance between heavy atoms is less than 5 Å. All N-terminal contacts of Ab42 are shown within red 
















Fig. C11. Contact probabilities (%) within 5Å between residues (heavy atoms) for the last 200 ns of 
the F and the P sates of (A) Ab42 and (B) aS showing the prominence of NTR-amyloidogenic CHC 
contacts in Ab42 and CTR-NAC contacts in aS. The contacts fade a little for the P states signifying 










Fig. C12. Time evolution of the fraction of native contacts (Q), Percentage of helical content in 
different regions, and helical hydrogen bond counts for (A) N-terminal deleted Ab42 (Ab42NDEL) and 
(B) C-terminal deleted aS (aSCDEL) of four chosen FF/WM combinations (see section 2.5 in the main 











Fig. C13. Comparison of secondary chemical shifts (CS; DdCa, DdHa and DdN) between simulated 
ensembles from four different physical model combinations used for N-terminal deletions of Ab42, 
1IYT folded experimental PDB and experimental secondary CS values obtained from a predominantly 



























Fig. C14. Comparison of Ca, Ha and N secondary chemical shifts (CS) between simulated ensembles 
from four different physical model combinations used for C-terminal deletions of aS, 1XQ8 folded 
experimental PDB and experimental secondary CS values obtained from a predominantly disordered 




Fig. C15. Comparison of 3JHNHa scalar coupling constants between ensembles generated from 
simulations with four different physical models (selected for terminal deletions) with their respective 
F or U states generated, the experimental PDB folded structures and experimental predominantly 
disordered ensemble obtained from Rosenman et al71 for (A) Ab42, and Schwalbe et al33 for (B) aS. 










Figure C16. Comparison of RDC constants between the ensembles generated from simulations with 
four different physical models (selected for terminal deletions) with their respective F or U states 
generated, and experimental predominantly disordered ensemble obtained from Yan et al72 for (A) 







Table C1. Average radius of gyration (Rg) of FF/WM combinations used in this study for (A) Ab42 
and (B) aS.  
 
A 
FF/WM Rg [Å] (Avg±SD) 
 C36/mTIP3 (F) 10.9±0.3 
C36/TIP4 (F) 10.1±0.1 
C36/2005 (F) 11.1±0.2 
C36/Ew (F) 11.8±1.2 
A03/D (F) 10.6±0.1 
C36/D (P) 12.4±0.3 
C22*/D (U) 12.5±0.3 
A03Ws/2005 (U) 13.3±0.4 
C36m/mTIP3 (U) 13.3±0.4 
C36m/sTIP3 (U) 13.5±0.3 
 
B 
FF/WM Rg [Å] (Avg±SD) 
C36/mTIP3 (F) 38.3±0.3 
C36/TIP4 (F) 18.1±1.2 
C36/Ew (F) 24.5±5.3 
C36m/mTIP3 (F) 25.2±1.7 
C36m/sTIP3 (P) 21.9±0.8 
C36/2005 (U) 24.1±2.4 
C36/D (U) 25.4±0.4 
C22*/D (U) 27.3±3.1 
A03/D (U) 21.6±0.9 







Table C2. Decomposition of MM/PBSA66,67,74 energies into their respective energy components for 
(A) Ab42 and Ab42NDEL, and (B) aS and aSCDEL. Elec = electrostatic energy, and vdW = van der 
Waals energy in vacuum, TS = absolute temperature times the entropy, Cov = covalent bonded energy, 
Gvacuum = free energy in vacuum = Elec + vdW + Cov – TS, Gsolvation = free energy of solvation = Gpolar 
+ Gapolar, Gtotal = total free energy = Gvacuum + Gsolvation, Gvacuum-Norm = free energy in vacuum normalized 
per residue = Gvacuum/number of residues (42 for Ab42, 140 for aS, 27 for Ab42NDEL, and 95 for 
aSCDEL), Gsolvation-Norm = normalized free energy of solvation, and Gtotal-Norm = total free energy 
normalized per residue. All of the Ab42NDEL or aSCDEL FF/WMs undergo complete unfolding. The 
standard errors are shown in parentheses and were calculated by a block averaging procedure. All 
units are in kcal.mol-1.  






C36/mTIP3 (F) -549 (15) -76 (1) 817 (2) 
-720 






(0) -8 (0) -17 (0) -25 (0) 
C36/TIP4 (F) -501 (33) -88 (3) 817 (1) 
-775 






(5) -7 (1) -18 (1) -25 (0) 
C36/2005 (F) -408 (27) -89 (1) 835 (4) 
-853 






(3) -4 (1) -20 (1) -24 (0) 
C36/Ew (F) -449 (51) -95 (3) 830 (5) 
-792 






(4) -6 (1) -18 (1) -24 (0) 
A03/D (F) -525 (24) -71 (9) 783 (5) 
-787 






(5) -8 (1) -18 (1) -26 (0) 
C36/D (P) -371 (2) -60 (2) 815 (2) -867 (1) 21 (0) 537 (1) -153 (3) -846 (0) -999 (3) -4 (0) -20 (0) -24 (0) 
C22*/D (U) -386 (19) -70 (5) 828 (3) 
-844 




(15) -980 (3) -4 (0) -20 (0) -23 (0) 
A03Ws/2005 (U) -490 (8) -24 (9) 725 (2) -828 (6) 23 (1) 520 (3) -310 (1) -805 (7) -1115 (6) -7 (0) -19 (0) -27 (0) 
C36m/mTIP3 (U) -347 (26) -45 (6) 816 (3) 
-897 




(23) -996 (6) -3 (1) -21 (0) -24 (0) 
C36m/sTIP3 (U) -382 (20) -46 (10) 812 (1) 
-879 






(8) -4 (1) -20 (0) -24 (0) 
C36/mTIP3NDEL 67 (14) -44 (4) 495 (10) 
-478 






(13) 7 (1) -17 (0) -10 (0) 




(11) -301 (5) 5 (1) -16 (0) -11 (0) 
C22*/DNDEL 164 (2) -27 (2) 486 (3) -576 (4) 15 (0) 339 (2) 284 (5) -561 (4) -277 (1) 11 (0) -20 (0) -10 (0) 
A03Ws/2005NDEL -326 (17) -10 (2) 503 (0) 
-490 




(20) -627 (2) -6 (1) -18 (0) -23 (0) 
 
 










(3) 9 (0) -30 (0) -20 (0) 
C36/TIP4 (F) -876 (23) -337 (3) 2660 (4) 
-2692 






(6) -2 (0) -19 (0) -20 (0) 
C36/Ew (F) -35 (106) 
-385 
(11) 2653 (4) 
-3491 






(21) 4 (1) -25 (1) -21 (0) 
C36m/mTIP3 (F) -120 (120) 
-308 
(15) 2620 (8) 
-3469 






(8) 3 (1) -24 (1) -21 (0) 
C36m/sTIP3 (P) -104 (174) -268 (7) 2631 (4) 
-3438 






(8) 4 (1) -25 (1) -21 (0) 
C36/2005 (U) 337 (119) -224 (4) 2630 (4) 
-3439 






(2) 7 (1) -27 (1) -19 (0) 






(10) 10 (0) -29 (0) -19 (0) 






(1) 9 (0) -28 (0) -19 (0) 












(124) 0 (1) -26 (0) -26 (1) 
A03Ws/2005 (U) -546 (96) -62 (25) 2288 (4) 
-4130 




(9) 0 (1) -29 (1) -29 (0) 








(65) 5 (0) -17 (0) -12 (1) 
C36m/mTIP3CDEL -379 (6) -233 (6) 1896 (80) 
-1366 




(112) 2 (1) -14 (0) -12 (1) 
C22*/DCDEL -71 (11) -202 (1) 1740 (18) 
-1620 




(33) 4 (0) -17 (0) -13 (0) 










(54) -8 (1) -17 (0) -24 (1) 
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Table C3. Average Interaction energies with standard errors within parentheses between different 
interacting domains of the F/P and U states of (A) Ab42 and (B) aS showing the Pearson correlation 
coefficient (P.C.C.) with total conformational energy (EMM/PBSA) for the last 200 ns of simulations. We 
used NAMD75 energy plugin in VMD76. The corresponding charges of the force fields were retained 
during calculation. The EMM/PBSA (see Methods) calculated by the MM/PBSA66 method  are composed 















F or P states 
C36/mTIP3 -121 (0) -37 (0) -52 (10) -87 (2) -19 (6) -9 (3) -509 (3) 
C36/TIP4 -88 (17) -38 (3) -49 (2) -7 (7) -20 (0) -19 (0) -529 (6) 
C36/2005 -83 (14) -19 (0) -22 (1) -3 (3) -10 (1) -13 (1) -497 (4) 
C36/Ew -67 (0) -35 (16) -27 (1) -32 (10) -24 (3) -12 (7) -488 (6) 
A03/D -91 (1) -32 (4) -31 (0) -49 (12) -13 (3) -29 (11) -582 (16) 
C36/D -42 (1) -25 (1) -29 (5) -6 (3) -8 (13) -35 (0) -462 (2) 
P.C.C. 0.6 0.4 0.2 0.3 0.1 0.1  
U states 
C22*/D -53 (4) -17 (6) -69 (10) -12 (3) -17 (1) -18 (1) -453 (7) 
A03Ws/2005 -81 (3) -16 (2) -41 (4) -9 (1) -2 (1) -2 (0) -594 (10) 
C36m/mTIP3 -88 (8) -17 (1) -44 (3) -2 (0) -30 (1) -11 (1) -449 (7) 
C36m/sTIP3 -88 (12) -9 (7) -28 (3) -2 (1) -9 (0) -7 (3) -472 (12) 
P.C.C. 0.2 0.1 -0.3 0.3 -0.8 -0.8  
 
B 
FF/WM NTR-NAC NAC-CTR NTR-CTR EMM/PBSA  
F or P states 
C36/mTIP3 -47 (2) -138 (23) -3 (3) -1079 (9) 
C36/TIP4 -223 (9) -208 (2) -826 (34) -1195 (8) 
C36/Ew -160 (18) -165 (5) -271 (26) -1208 (14) 
C36m/mTIP3 -154 (2) -186 (23) -137 (35) -1219 (12) 
C36m/sTIP3 -202 (11) -70 (2) -430 (71) -1119 (16) 
P.C.C. 0.2 0.7 0.3  
U states 
C36/2005 -130 (9) -58 (1) -240 (42) -966 (30) 
C36/D -73 (14) -49 (11) -135 (46) -943 (25) 
C22*/D -200 (12) -33 (4) -43 (8) -950 (5) 
A03/D -150 (22) -70 (20) -143 (16) -2087 (116) 
A03Ws/2005 -143 (3) -25 (6) -62 (51) -2376 (23) 
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Fig. D1.  Time convergence of cumulative average helical content (%) for the equilibrium MD (EMD) 
and one Hamiltonian replica exchange with solute scaling (H-REST) for comparison. 
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Fig. D2. Comparison of the helical conformational subspaces sampled by equilibrium MD (EMD) and 




Fig. D3. Temporal evolution of helicity (%) in folded (C36/mTIP3 and C36/TIP4), partially folded 
(C22*/D and A03Ws/2005, following unfolding and prior to complete disordering), and unfolded 
(C22*/D and A03Ws/2005, from completely unfolded to end of simulation) states of (A) Ab42 and 
(B) aS. The broken vertical lines represent the time for complete unfolding for C22*/D (red) and 
A03Ws/2005 (orange). Running averages over 40 data points are shown. See 4.2. Methods under 
Chapter 4 for more details. 
Note: All helical populations (percentages) calculated throughout the main text and this supporting 




Fig. D4. Time-averaged residue-wise secondary structure probabilities (%) for the last 200 ns of (A) 





Fig. D5. Time-averaged residue-wise secondary structure populations (%) during 200 ns of unfolded 






































Fig. D6. Computed 2D free-energy surfaces of solvent accessible surface area (SASA) and radius of 
gyration (Rg) for (A) Ab42 and (B) aS in folded (top rows) and partially folded (bottom rows) states. 
The SASA scales monotonically with Rg for Ab42 in both folded and partially folded states, while the 
































Fig. D7. Free-energy maps of end-to-end distance (Re) and radius of gyration (Rg) for (A) Ab42 and 
(B) aS in folded (top rows) and partially folded (bottom rows) states. For Ab42, a broad Re is sampled 
within the narrow Rg of the folded states. This is because the preservation of helices keeps Ab42 
compact, but with divergent directionality of N- and the C-termini. Rg and Re are more correlated in 
the partially folded states due to overall extension. In contrast, the Re and Rg scale similarly for both 
folded and partially folded states for aS due mainly to compact structures enabling unfolding of 



































Fig. D8. Free-energy surfaces of helical percentages and radius of gyration (Rg) (top rows), solvent 
accessible surface area (SASA) and Rg (middle rows), and end-to-end distance (Re) and Rg (bottom 


















Fig. D9. Dynamic cross-correlation analyses of the helically folded states of Ab42. (A) Network 
graphs (overlaid on the original PDB structure 1IYT) showing connections between residue nodes and 
nodal clusters (community nodes). Community structures change with increasing values of |cij|. A |cij| 
≥ 0.4 is considered for rest of the network analyses (see Methods). (B) Consensus DCCM with a 
correlation filter of 0.4 and above showing positively (red), negatively (blue) correlated and 
uncorrelated (white) domains. NTR, CHC, turn region and CTR are marked on top of the map with 
the initial helical regions shown as black bars. (C) Path length distribution and (D) Node degeneracy 
showing number distribution of paths (out of 500) for each of the source and sink pairs. (E) Consensus 
networks corresponding to regions Helix 1 (source = S8 and sink = G25) and Helix 2 (source = K28 
and sink = G38) visualized in VMD with all possible paths. The thickness of the paths indicates how 
strongly the two residues are correlated. The network structures are overlaid on the most representative 
folded state, and the corresponding optimal/shortest path of correlated motions is shown below each 





Fig. D10. Dynamic cross-correlation analyses of the partially folded states of Ab42 with consensus 
correlation map and network properties bearing the same description of (A) – (F) as in Fig. S9. Broken 
















Fg. D11. Dynamic cross-correlation analyses of the unfolded states of Ab42 with correlation map and 










Fig. D12. Dynamic cross-correlation analyses of the helically folded states of aS, with correlation 
map and network properties bearing the same description of (A) – (F) as in Fig. S8. For aS, the 
overlaid PDB structure in (A) is 1XQ8), regions marked in (B) are NTR, NAC and CTR, and the 
helices in (C), (D) and (E) are Helix 1 (source = V3 and sink = V37) and Helix 2 (source = K45 and 







Fig. D13. Dynamic cross-correlation analyses of the partially folded states of aS with correlation map 
and network properties following same description of (A) – (F) as in Fig. S12. Broken lines between 
two nodes (E) represent coupling including all residues in between.  
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Fig. D14. Dynamic cross-correlation analyses of the predominantly unfolded states of aS with 





Fig. D15. Number of retained water molecules within a 10 Å hydration layer around the (A) CHC of 
Ab42 and (B) the hydrophobic core (G68 – A78) of NAC in aS. The last 200ns of simulations are 







Table D1. Details of equilibrium MD simulations (EMD) for different states 
 






Folded (C36/mTIP3) 2014 N/A 50±4 
Folded (C36/TIP4) 2018 N/A 52±4 
Partially folded and 
Unfolded (C22*/D) 
2011 206 18±6 
Partially folded and 
Unfolded 
(A03Ws/2005) 
2020 1527 20±4 
 





Folded (C36/mTIP3) 1540 N/A 44±8 
Folded (C36/TIP4) 1411 N/A 37±5 
Partially folded and 
Unfolded (C22*/D) 
1413 625 8±6 
Partially folded and 
Unfolded 
(A03Ws/2005) 
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Fig. E1. MD simulations of different aS helical NAC tetramers T1–T4 in side and top views. The 
heavy atoms of residues 71–82 are represented as van der Waals spheres with hydrophobic, acidic, 
basic, and polar residues colored white, red, blue, and green, respectively. 
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Fig. E2. MD simulations of bS NAC tetramer, approximately corresponding to the T4 helical aS 




KTK60   αS 
1MDVFMKGLSMAKEGVVAAAEKTKQGVTEAAEKTKEGVLYVGSKTREGVVQGVASVAE
KTK60   bS 
NAC 
61EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAATGFV95  αS 
61EQASHLGGAVFSG-------------------AGNIAAATGLVKR86  bS 
C- 
96KKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA140  αS 




Fig. E3. MD simulations of the aS tetramer T3 (the initial structure was kindly provided by Prof. 





Fig. E4. The fraction of native contacts Q for both (A) wild type and (B) mutated helical aS 




Fig. E5. The temporal evolution of helix structures over 200 ns simulations of different (A) wild 
type and (B) quadruple mutant aS tetramers. The percentage of helix is the sum of a-helix, 310-helix 




Fig. E6. Distribution of conformational energy (see Table E1) calculated for different (A) wild type 










Fig. E7. MD simulations of a bS tetramer. This βS tetramer shares the same a1 and a2 segments as 
aS tetramer T4. (A) Initial and final conformations of the full-length bS tetramer in both side and top 












Fig. E8. Contact maps for (A) T1, (B) T2, and (C) T4 tetramers. The contact maps of wild type and 
mutant are shown in the bottom right and top left half of each figure. Molecular interaction maps were 
generated by contact analysis. using the CONAN tool.2 A contact occurs if the distance between any 







Fig. E9. MD simulations of different helical NAC tetramers designated here as (A) Model 1 (M1), 
(B) Model 2 (M2), (C) Model 4 (M4), and (D)-(F) the corresponding quadruple mutants of the 
tetramer models, with the initial conformations generated from 200-ns simulations of the 
corresponding full-length aS tetramers. The heavy atoms of residues 71–82 are represented as van der 
Waals spheres with hydrophobic, acidic, basic, and polar residues colored white, red, blue, and green, 












Fig. E10. (A) Interaction energy and Pearson Correlation Coefficient (P.C.C.) between 
conformational energy and (B) NT-CT, (C) NT-NAC, and (D) NAC-CT interaction energy for 








Fig. E11. MD simulations of helical a and b monomers. M1, M2 and M4 have the same initial 
conformations as M1_M, M2_M and M4_M, respectively. The N-terminal, NAC region, and C-








Fig. E12. Number of protein-water hydrogen bonds for residues of interest in (A) M4, (B) M4_M, 
(C) T4, and (D) T4-M. These residues were chosen in order to compare their hydration properties 
with random coil aS monomers reported recently.3 The number of protein-water hydrogen bonds 










Fig. E14. Comparison of (A) 3JHNHα coupling constants, and (B) Ha and (C) N chemical shifts 
between the simulation-optimized helical aS structures (M4 and M4_M) and micelle-bound structure 






Fig. E15. Initial structures of the four extended 11/3-helical tetramer models generated from aS(9-
89) monomer structure as determined from site-directed spin labelling and EPR experiments4 (the 
initial 11/3-helical monomer structures were kindly provided by Prof. Ralf Langen). For details on the 
design strategies, see section 5.2.2. under 5.2. Methods in Chapter 5. The heavy atoms of residues 
71–82 are represented as van der Waals spheres with hydrophobic, acidic, basic, and polar residues 









Fig. E16. Initial and final structures of short simulations runs on the NAC(61-89) region of 11/3- 




Fig. E17. The initial and the final structures after simulations of full-length aS 11/3-extended helical 
tetramers of the three complexes selected out of four in Fig. E16 (to be consistent, the same 
nomenclature of complexes are used here). Mutable Glu residue (E35, E46 and E61) sidechains are 




Fig. E18. The representative structures of 100 ns simulations (left: initial structures; right: final 
structures) of WT and E→K mutant 11/3-helical full-length aS tetramers of complexes III and IV 
showing the conformational energy values alongside. Mutated Lys residue (K35, K46 and K61) 






Fig. E19. Side and top views of the final conformations of NAC in mutants. Number 2 to 8 indicates 














Fig. E22. Side and top views of the final conformations of quadruple mutant (E46K + H50Q + G51D 





Fig. E23. Comparison of conformational energy between the WT (A) and mutated (B) aS tetramer in 
our previous work5 (the first de novo broken a-helical tetramer in Chapter 5) and in this work (the 
more stable de novo broken a-helical tetramer designed along with other multimers in Chapter 5). 
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Fig. E24. Conformations of different wild type aS octamers after simulations in both side and top 
views. Octamer shown in (A) is the same as shown in Fig. E20 and the NAC region is shown by itself 






Fig. E25. Designed αS NAC octamer consisting of one NAC pentamer and one trimer with no direct 
contact between them (A) before and (B) after simulations. The non-NAC pentamer-trimer contacts 











Fig. E26. The fraction of native contacts Q for both aS octamers shown in Fig. E27. The fraction of 




Fig. E27. The fraction of native contacts Q for all aS oligomers. The fraction of native contacts was 
calculated using the same method as in Fig. E26. 
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Fig. E28. Percentage helicity for all aS oligomers averaged over the last 20 ns of dynamics. The 
percentage of helix is the sum of a-helix, 310-helix and p-helix as specified in the Define Secondary 
Structure of Proteins (DSSP) algorithm. The percentage of helix structure in the initial structure is 










Fig. E29. Binding energy calculated using separate trajectories. The highest binding affinity shown 
here was the difference in the conformational energy between each oligomer and corresponding n 
times of monomers, that is, BE(n) = H(n) – nH(1), where H(n) is the conformation energy of the 
oligomer, and H(1) is the conformational energy of free monomer. For calculation details, see Table 






Fig. E30. The average activation energy calculated for each system. The activation energy was 
calculated as the energy difference between the averaged conformational energy of each monomer 










Fig. E31. Normalized number of water molecules within 3.5Å of NAC, solvent accessible surface 
area (SASA) and water excluded volume for both WT (A, C, and E) and mutated (B, D, and F) helical 
NAC oligomers. The normalized properties were calculated by the total number of water molecules, 




Fig. E32. Normalized number of water molecules within 3.5Å of the NAC region of helical monomer 
and oligomers. The normalized values were calculated by the total number of water molecules near 








Fig. E33. Representative conformations showing water molecules within 3.5 Å of residues 67–76 and 
77–95 of the NAC regions for the (A) WT and (B) mutated helical oligomers (trimers to octamers). 












Fig. E34. Pair interaction energies (in kcal/mol) amongst (A) all NAC regions and (B) all full-length 
monomers in different mutated oligomers. Interactions energies (absolute value) less than 6 kcal/mol 
in (A) and 82 kcal/mol in (B) were not shown. The pair interactions between monomers stronger or 


























Notes: (1) The net charge decreases by -1e and -4e for mutated monomer and tetramer, respectively. 
(2) The conformational energy refers to the total energy shown in the table.  
(3) <. > indicates energy averaged over the four monomers within a tetramer. 
(4) first indicates energy calculated based on the first 10 ns trajectory due to fast conformational 




System Total vdW Electrostatic Solvation Bonded 
T1 -10923.7 (1.3) -1881.7 (15.3) 2028.2 (312.0) -17102.6 (329.6) 6032.4 (3.6) 
T2 -10846.7 (11.4) -1859.6 (2.6) 1911.0 (313.8) 
-16919.5 
(298.5) 6021.4 (6.5) 
T4 -11115.1 (11.4) -2014.3 (10.9) 93.3 (157.2) 
-15249.1 
(175.3) 6054.9 (4.2) 
<M1>T1 -2586.0 (23.5) -338.8 (59.5) 164.4 (344.5) -3916.2 (366.1) 1504.7 (14.5) 
<M2>T2 -2560.6 (11.8) -319.5 (18.0) 347.6 (110.5) -4090.0 (65.6) 1501.4 (15.2) 
<M4>T4 -2623.1 (2.1) -358.0 (2.9) -70.9 (242.8) -3703.6 (246.4) 1509.4 (12.8) 
M1 -2606.8 (6.8) -374.7 (8.8) 97.8 (246.7) -3843.5 (245.2) 1513.5 (3.5) 
M2 -2617.6 (8.2) -454.3 (11.9) -359.9 (15.7) -3336.6 (20.9) 1533.2 (8.8) 
M4 -2647.9 (15.8) -408.5 (2.1) -436.3 (23.4) -3315.6 (43.6) 1512.6 (2.3) 
M1first -2563.2 (26.7) -280.8 (5.4) 602.3 (168.8) -4384.9 (142.9) 1500.2 (4.7) 
M2first -2540.5 (3.0) -332.8 (22.6) 318.4 (244.5) -4073.2 (240.4) 1547.2 (15.5) 
M4first -2636.9 (0.1) -334.6 (5.9) 280.8 (31.7) -4073.5 (37.2) 1490.5 (11.5) 
T1_M -11187.0 (6.6) -1770.1 (24.3) 1430.9 (296.9) -16965.6 (290.8) 6116.7 (11.6) 
T2_M -11139.3 (14.7) -1875.1 (15.9) 3126.1 (68.1) 
-18534.0 
(86.6) 6143.8 (17.2) 
T4_M -11423.9 (12.8) -1982.6 (10.1) -1261.1 (68.9) 
-14339.3 
(94.3) 6159.1 (2.5) 
<M1_M>T1_M -2682.1 (55.0) -332.3 (16.6) 123.1 (192.4) -3998.3 (171.8) 1525.4 (17.8) 
<M2_M>T2_M -2649.4 (0.6) -323.1 (19.2) 444.6 (38.4) -4302.7 (59.5) 1531.8 (6.5) 
<M4_M>T4_M -2696.7 (10.8) -327.9 (3.6) 14.6 (201.8) -3917.0 (197.5) 1533.4 (7.8) 
M1_M -2740.3 (0.6) -409.0 (10.9) -406.7 (88.3) -3460.6 (86.8) 1536.1 (11.7) 
M2_M -2707.1 (8.2) -388.2 (9.1) -101.0 (39.3) -3742.1 (37.1) 1524.2 (15.1) 
M4_M -2751.2 (3.0) -400.0 (6.2) -329.2 (128.7) -3555.3 (117.5) 1533.3 (14.3) 
M1_Mfirst -2680.5 (9.1) -283.4 (12.8) 527.5 (8.8) -4446.1 (13.7) 1521.4 (1.1) 
M2_Mfirst -2676.1 (14.6) -357.3 (18.6) 277.0 (92.0) -4144.0 (72.9) 1548.3 (14.1) 
M4_Mfirst -2754.5 (3.6) -342.5 (7.2) 69.1 (89.2) -4008.4 (82.3) 1527.3 (3.9) 
βStetramer -12777.4 (19.5) -1736.9 (0.9) 7470.7 (429.3) 
-24600.7 
(422.6) 6089.6 (25.3) 
<βSmonomer> -2931.9 (22.5) -316.7 (34.5) 627.4 (267.7) -4761.8 (248.2) 1519.2 (22.3) 
βSmonomer -2980.8 (0.8) -395.7 (6.7) 297.5 (35.8) -4406.3 (32.6) 1523.7 (9.0) 
 LXXXVI 
 
Table E2. Conformational energy (kcal/mol) calculated using the GBMV method for the chosen 
extended helical complexes. 
Free energies Complex II Complex III Complex IV 
Total -10819 (20) -11045 (62) -10907 (0) 
vdW -1682 (26) -1942 (22) -1665 (22) 
Electrostatic 6049 (5) 6276 (59) 3135 (72) 
Solvation -21178 (3) -21368 (127) -18331 (100) 
 
 
Table E3. Binding energy of WT αS oligomers calculated using separate trajectories. The largest 
binding affinity for each oligomer is shown in Fig. E35. “1+1” indicates that the dimer is formed by 
binding of two monomers; and “1+3” indicates that the tetramer is formed by binding of one monomer 
and one C3 trimer. 









































































Table E4. Binding energy of mutated αS oligomers calculated using separate trajectories. The largest 
binding affinity for each oligomer was shown in Fig. E35.  
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Fig. F1. Fraction of native contacts1 (Q) as a function of time showing that the simulations in all three 











Fig. F2. The initial (0 ns) and final (100 ns) snapshots from MD simulations of all three orientations 
of 5OQV2 model. The residues are represented as liquorice and coloured according to residue types 











Fig. F3. 3-D AFM image of Ab40 protofibrils (size: 580 nm × 300 nm) and a 3-D AFM image of the 
Ab42 protofibrils (size: 550 nm × 650 nm). The images were kindly provided by collaborator Dr. 










Fig. F4. Representative structures of the most populated Ab40 and Ab42 oligomer from MD 
simulations in all three orientations obtained by the deterministic and iterative algorithm based on 









References for Appendix F 
 
1 Best, R. B., Hummer, G. & Eaton, W. A. Native contacts determine protein 
folding mechanisms in atomistic simulations. Proc Natl Acad Sci U S A 110, 
17874-17879, doi:10.1073/pnas.1311599110 (2013). 
2 Gremer, L. et al. Fibril structure of amyloid-beta(1-42) by cryo-electron 
microscopy. Science 358, 116-119, doi:10.1126/science.aao2825 (2017). 
3 Daura, X. et al. Peptide folding: when simulation meets experiment. Angewandte 
Chemie International Edition 38, 236-240 (1999). 
 
 
 
 
